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In addition to the accepted abbreviations (instructions 
to Authors Biochem. J. (1985) 225 1-26) the following have 
been adopted:
ANT adenine nucleotide translocase
BCDC branched chain 2-oxo acid dehydrogenase complex
BRL Buffalo rat liver cells
BSA bovine serum albumin
CHAPS 3- |j[3—Cholamidopropyl )dimethyl-ammonio "j -1-
propanesulphonate 
DMSI dimethyl suberimidate
DMSO dimethylsulphoxide
2 t k  DNP 2*4-dinitrophenol 
DOC deoxycholate* sodium salt
DTNB 3-5*-dithiobis ^2-nitrobenzoic acidj
DTT dithiothreitol
FCCP carbonyl cyanide p-trifluromethoxy phenyl hydrazone
HTP Biogel^-hydroxylapatite
Iodogen 1*3*k 96-tetrachloro-3a, 6a diphenyl glycoluril
leupeptin acetyl-L-leucyl-L-leucyl-L—argininal
LMM low methionine medium
MMM minus methionine medium
NBL-1 bovine kidney cells
NEM N-ethylmaleimide
NGM normal growth medium
OAA oxaloacetate
OGDC 2-oxoglutarate dehydrogenase complex
PAGE polyacrylamide gel electrophoresis
PBS phosphate buffered saline
PDC pyruvate dehydrogenase complex
PDM phenylene dimaleimide
PK-15 pig kidney cells
PMSF phenylmethyl sulphonyl fluoride
PPO 2*5 diphenyloxazole
PTP phosphate transport protein
SDS sodium dodecyl sulphate
SMP submitochondrial particles
TEMED NjNjN'N^tetramethylethylenediamine
TLCK N-a-p-tosyl-L-lysine-chloromethyl ketone
TPCK L-l-to sylamide-2-phenyl ethyl chloromethyl ketone
TPP thiamine pyrophosphate
Tween 20 polyoxyethylenesorbitan monolaureate
URF unidentified reading frame*
SDH succinate dehydrogenase
pCMB p-chloromercuriobenzoate
PTS phosphate transport system
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SUMMARY ,
I (a ) Binding of bovine heart pyruvate dehydrogenase
complex (PDC) to the inner mitochondrial membrane.
The interaction of bovine heart PDC with the inner 
mitochondrial membrane was investigated using a combined 
enzymological and immunological approach. Employment of 
high-titre monospecific antisera directed against intact PDC 
and its constituent subunits allowed the investigation of 
this association under conditions which inactivate the enzyme.
Initial studies demonstrated that the bulk of PDC 
activity (70-80$>) remains bound to the membrane while soluble 
control enzymes (citrate synthase and fumarase) are readily 
released into the supernatant fraction? with only minimal 
activity remaining membrane associated.
Preferential association of PDC with the inner membrane 
was further investigated using the immune-replica technique.
; PDC remains bound to the membrane 
following prolonged sonication and repeated washing in high 
or low ionic strength buffers (0.15M - 2M NaCl). Only under 
the stringent conditions employed as criteria for integral 
membrane proteins e.g. 6M urea and 100 mM Na^GO^ (pH 11) is 
the bulk of PDC removed from the membranes. Under these 
conditions it was found that only trace amounts of E2 and/or 
X (subunit of PDC) remained associated with the membrane.
I
The specific attachment of the multi enzyme complex to 
the inner mitochondrial membrane has been confirmed by parallel 
studies on three Krebs cycle enzymes, namely succinate 
dehydrogenase (an integral membrane protein), fumarase and
citrate synthase (both soluble matrix enzymes).
Dissociation of the complex to its constitutive enzymes 
was achieved by washing submitochondrial particles in 0.25M 
MgCl^ or 0.1M glycine buffer, pH 9*5* Immune-blot analysis 
demonstrated the preferential release of El and E3 while the 
E2-X 1 core* assembly remains in association with the membrane. 
These results suggest that PDC is bound to the inner mito­
chondrial membrane exhibiting the characteristics of a 
tightly—bound peripherally located membrane protein. It is 
likely that this association is mediated via the E2 and/or 
X subunits of the complex.
Immune-blot analysis, probing purified NADH dehydrogenase 
with a variety of antisera demonstrated an interaction
of PDC with this complex array of polypeptides. It ^ 
postulated that this interaction of PDC with this region 
of the respiratory chain may be of functional significance 
in that it will allow the direct channeling of NADH into 
the electron chain, thereby coupling NADH production and 
oxidation in an,efficient manner.
(B) Topographical and biosynthetic studies on phosphate
transport protein (PTP).
For these studies high-titre monospecific antiserum 
was produced against the purified phosphate transport protein 
from rat liver. This anti serum was shown to elicit a 
strong reaction against the parent antigen, i.e. the
rat liver enzyme and also the corresponding protein from 
bovine heart when mitochondrial extracts were immunoblotted
and challenged with anti-PTP-serum. The 3k 000 M polypeptide 
was detected in crude extracts of the cell lines chosen for 
the biosynthetic studies on this protein i.e. Buffalo rat 
liver (BRL), rat kidney (NBL) and pig kidney (PK 15) cells.
Initial studies to elucidate the mode of synthesis of 
PTP were carried out by labelling BRL and PK 13 cells overnight 
in the presence of |_"^s] -methionine. Immunoprecipitation 
with anti-PTP-serum and subsequent detection of radiolabelled 
polypeptides by fluorography failed to identify the parent 
antigen, although several other mitochondrial proteins and 
their precursors were detected in this manner. However, 
immunoblotting of a non-radiolabelled immunoprecipitate 
from bovine heart mitochondria successfully demonstrated 
the 3k 000 polypeptide.
Topographical studies on the final membrane organisation 
of PTP were initiated by proteolytic digestion of bovine 
heart mitoplasts and sonicated particles. After resolving 
the protease-resistant membrane-bound polypeptides by SDS-PAGE, 
they were transferred to nitrocellulose and analysed by 
immunoblotting with anti-PTP-serum. It was found that PTP 
contains no protease-sensitive domains exposed at either 
the matrix or cytoplasmic surface of the inner mitochondrial 
membrane. Solubilisation of the protecting membrane by 
either Triton X-100 or SDS demonstrated that the protein was 
not inherently resistant to protease digestion while parallel 
incubations and subsequent analysis of the membranes using 
anti-SDH-serum provided an excellent control system for 
these studies.
Results from these studies, native determination 
and crosslinking data have allowed the presentation of a 
model for the molecular arrangement of PTP within the inner 
mitochondrial membrane of bovine heart.
CHAPTER 1 
INTRODUCTION
1.1 THE MITOCHONDRION
The average mitochondrion in a mammalian cell has 
approximately the same dimensions as the bacterium Escherichia 
coli. It is most commonly observed as an oval particle,
1-2 p.m long and 0.5 P-m - 1 V-ni wide. Mitochondria, therefore, 
are sufficiently large to be seen in the light microscope, 
and the earliest descriptions of this organelle were based 
on the observations of fixed and stained tissue. Although 
mitochondria were first observed microscopically in the 
mid-nineteenth century, it was not until 19^ -7 that Pallade 
and coworkers successfully isolated these organelles in an 
intact state.
Electron micrographs of negatively stained mitochondria 
in transverse section clearly show two membraness a limiting 
outer membrane and a highly invaginated inner membrane.
The enzymes involved in oxidative phosphorylation are housed 
in the inner membrane, and thus those tissues, such as 
muscle, that demand the greatest output of oxidatively 
derived ATP will have mitochondria best adapted for this 
purpose - at the morphological level this is expressed in 
a highly invaginated inner membrane. These membranes 
divide the mitochondrion into two separate compartments 
creating a total of four locations, outer membrane, inner 
membrane, matrix and intermembrane space, where an enzyme 
can be situated in the organelle.
1.1.2 Composition of* the inner and outer membranes
The outer mitochondrial membrane is 6-7 nm thick? smooth 
and unfolded. This membrane is enriched in phosphatidyl 
choline (see Table l.l) and also contains a considerable 
amount of cholesterol (Parsons and Yano? 1967; Levy jet al. > 
1969)* The membrane structure is relatively inelastic but 
is freely permeable to molecules of value below 10 000. 
Further analysis of this membrane indicates that it contains 
aheterogeneous group of enzymes which catalyse various 
aspects of lipid metabolism plus several important hydroxylation 
reactions. These enzymes do not constitute any integrated 
pathway and consequently compositional data do not j indicate j 
the function of this membrane. The most frequently used 
marker for this membrane is the enzyme monoamine oxidase.
Lipid Mi to chondri a
Inner
Membrane
Outer
Membrane Microsomes
Phospholipids 
(mg/mg protein) 0.16 0.30 0.88 0.30
Cholesterol 
(p-g/mg protein) 2.28 3.26 '30.1 30.2
Percentage of total phospholipid
Pho sphatidyl 
choline 40.0 44.3 55-2 62.8
Pho sphatidyl 
ethanolamine 28.4 27.7 2 3 0 18.6
Cardiolipin 22.5 21.3 3.2 0.3
Phosphatidyl
inositol 7.0 4.2 13.5 13.4
Table 1.1: Lipid composition of mitochondrial membranes 
(Adapted from Parsons ejfc al.» 1967)*
In contrast? the inner membrane shows some evidence 
of substructure on its matrix—facing surface and exhibits 
differential solute permeabilities. Small uncharged 
molecules (e.g. H^O? 0^? NH^ and ethanol) are freely
permeable but j permeability to hydrophilic ions 
(nicotinamide and adenine nucleotides? H+) is extremely 
limited except via specific transport systems (see Section 
1.1.4). Thus? this membrane represents the major permeability 
barrier between the cytoplasm and the matrix. This 6-8 ran 
thick membrane has a low phospholipid to protein ratio and 
offers a very large surface area by virtue of its highly 
invaginated surface. A characteristic feature of the inner 
mitochondrial membrane is its high content of the phospholipid 
cardiolipin?and low cholesterol levels which renders it 
relatively resistant to digitonin treatment (see Table l.l).
It houses the respiratory chain? ATP-synthesising apparatus 
and a variety of solute carriers.
The intermembrane space is? excepting areas known as 
contact points? generally 6-8 ran wide and contains relatively 
few enzymes? most of which catalyse the interconversion of 
adenine nucleotides. The matrix? on the other hand? is 
extremely viscous and contains the vast array of enzymes 
that compose the tricarboxylic acid cycle (excepting 
succinate dehydrogenase which is a component of the inner 
mitochondrial membrane)?fatty acid oxidation? part of the 
urea cycle in certain tissues? together with those that 
catalyse the synthesis of mitochondrial DNA and RNA. The 
first two catabolic pathways provide the adjacent respiratory 
chain with its major oxidisable substrate? NADH.
1,1.3 The electron transfer chain and oxidative phosphorylation
The most important function of mitochondria is that of 
oxidative phosphorylation. In this process the two electrons 
resulting from the oxidation of reduced coenzymes NADH or 
FADH^ are ultimately transferred to oxygen with the concomitant 
generation of ATP,
Protons generated from this oxidation are soluble in 
aqueous solution as hydronium ions whilst free electrons are 
not. These are passed from NADH or FADH^ to oxygen along a 
chain of electron carriers which are components of the inner 
mitochondrial membrane. Twelve or more electron carriers 
are grouped into four multiprotein intramembraneous particles. 
Each of the electron transport complexes exhibit* lateral ->
mobility in the plane of the membrane. There do not appear 
to be stable contacts between two or more enzymes. Transport 
of electrons from one complex to another may involve random 
collisions of the two. The lipid-soluble coenzyme Q 
shuttles electrons from the NADH-CoQ reductase and succinate 
dehydrogenase complexes to the Co QH,,-cytochrome c reductase 
complex. Cytochrome e interacts with specific sites both 
on the CoQH^-cytochrome c reductase complex and on cytochrome 
c oxidase complex and thus transfers electrons from one to 
the other (see Fig. l.l)> acting as a mobile carrier. This 
random collision of the enzyme complexes involved in electron 
transport is sufficient to account for the rate of respiration 
in many tissues.
Fig.1.1 Electron transport in mitochondria.
Matrix Inner mitochondrial Intermembrane
membrane space
NADH.H
NADH-CoQ
ReductaseNAD'
CoQ
CoQH
CoQH
Cvt.b Cvt.b CoQ Ho - cytochrome c 
ReductaseFeS
V2 02 + 2H
- Cvt.a
Cytochrome c
Oxidase
Cyt.a
  Electron movement
— —  Proton movement
The stoicheiometry of oxidative phosphorylation 
is not represented in this figure.
1.1.4 Mitochondrial transport systems
The specialised role of mitochondria in intermediary 
metabolism requires that only certain substrates, cofactors 
and metal ions must be accessible to the interior compartment. 
Of the substrates that must be capable of entering the 
matrix, the most important are 0^, **,,0, (Section 1.3)^
pyruvate and fatty acids. At the same time products of 
mitochondrial oxidation must have means of exiting, these 
include citrate, and ATP. Virtually all mitochondria,
irrespective of source, are either freely permeable or 
have specific transport systems (see Table 1.2) that 
accommodate the efficient passage of these metabolites 
across the inner membrane.
From Table 1.2, it is apparent that mitochondria possess 
a broad spectrum of transport systems. Homogeneous preparations 
of mitochondria are easily obtainable providing convenient 
experimental material for transport studies. This shuttle 
of certain intermediates between the cytoplasm and 
mitochondria influences and regulates the overall metabolic 
balance of the cell. This aspect of transport will be 
discussed more fully in Section 1*3 (for review see Chappell, 
1968).
1.1.3 Mitochondrial genome
The mitochondrial genome of higher eukaryotes is 
extremely well organised (Roe jet al •, 1983; Anderson et al. > 
I98I; Anderson ejfc al., 1982). There are genes for two 
ribosomal RNAs, twenty two tRNAs and for no more than
Fig.1.2 Genomic map of mammalian mt.DNA.
(D-loop)
MAMMALIAN
MITOCHONDRIAL
DNA
a
-nto
CO I j
URF3
AT Pase
URFA6L
Genomic map of mammalian mtDNA. The stippled areas represent 
tRNA genes designated by the single-letter amino acid code,with p ol ­
arity given by the arrows. All protein^coding genes are encoded on 
the H strand (with counterclockwise polarity),with the exception of 
URF6, which is encoded on the L strand. C0I,C0II, and C O I I I : c y t o ­
chrome oxidase subunits I,II, and I I I . Cyt.b.URF: unassinged reading 
frame. 0H and 0L : the origins of H and L strand replication respect­
ively.
(Reproduction from Clayton 1984).
URF's have now all been assigned (Chomyn _et al. , 1986)
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1. Transfer of reducing 
equivalents
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in urea synthesis in 
cytosol
3. In gluconeogenesis
l\!H„ production in 
kianey
In operation of the 
urea cycle
Movement of fatty 
acids across the 
membrane
2+
Storage of Ca 
in the matrix
Table 1.2: Specific transport systems of the inner mitochondrial membrane.
thirteen proteins? most or all of which are involved in 
electron transport. Some of the protein—coding regions 
initially only identified as unassigned reading frames
or TJRF although recent studies have assigned components 
of the NADH dehydrogenase complex to these URF (Chomyn 
et al.? 1985)* There are no introns or spacers between 
the genes in higher eukaryotes? though some have been found 
in yeast? and a few genes even overlap slightly. It is now 
well documented that the overwhelming majority of mitochondrial 
proteins (> 90fo) are encoded by nuclear genes and imported 
to the mitochondria in a post-translational fashion (for 
review? see Reid? 1985)*
The only region of the mammalian mitochondrial DNA 
which is non-coding is the D-loop region which is involved 
in the initiation of replication. This is also the region 
at which the transcription of both strands is initiated
(Montoya ejb al • ? 1982; Montoya ejfc al • ? 1983). Transcription
- u ' ’l ' ”
continues uninterrupted around thecircularmolecule and the 
transcripts are then processed to give individual messenger? 
ribosomal and transfer RNAs. The transfer RNA forms the 
punctuation between the various protein coding regions and 
provides the signal for the processing enzymes (see Fig. 1.2).
All of this information suggests that the mitochondrial 
genome in higher eukaryotes has been stripped of all elements 
that could be moved to the nucleus or dispensed with 
altogether. It also lends support to the popular? current 
hypothesis suggesting that mitochondria have arisen as
symbiotic prokaryotes providing oxidative metabolism to 
their pre—eukaryotic hosts* The application of the sensitive 
technique of Southern Blotting with cloned DNA fragments 
has allowed the identification of regions of mitochondrial- 
like DNA within the nuclear DNA of organisms as diverse as 
yeast (Farelly ejb al • ? 1983)? insects (Gellissen et al.> 1983) 
and rat (Hadles ejb al• ? 1983)* This transfer of genes between 
the mitochondria and the nucleus is most readily recognised 
by the fact that the gene for the ATPase subunit IX is nuclear
encoded in Neurospora crassa though a copy is found within 
mitochondrial DNA (Van den Boogaart? 1982). This copy is 
apparently silent and neither its origin nor physiological 
significance is known. Since the rate of production of 
base pair substitutions in mitochondrial DNA is about 10 times 
that in nuclear DNAj it provides a highly sensitive tool for
studying short-time divergences amongst related species
' i
(Barton and Jones? 1983)*
1.1.6 Mitochondrial biogenesis
Mitochondria were one of the first organelles to be 
isolated free of other cellular membranes and therefore 
served as a useful system for studying various aspects of 
structure? function? and? more recently? membrane biogenesis. 
There were several key discoveries which directed research 
in mitochondrial biogenesis? the most important of which 
was the observation that mitochondria possess their own 
protein synthesising machinery (Section 1.1.5)*
Information to date suggests that cellular membranes 
do not form de novo but through the growth and division of 
pre-existing structures (for review see Palade? 1978). It 
therefore follows that the biogenesis of intracellular 
membranes must involve the addition of new constituents 
(proteins and lipid) to pre-existing compartments under 
conditions where the functional integrity of their membranes 
remains intact. With the existence of four mitochondrial 
sublocations where a given protein can be directed? this 
incorporation must be very specific (Sections 1.1.1 and
1.1.4) and be mediated via an intramitochondrial sorting 
process.
Considerable information on the biogenesis of mitochondri 
has been provided? in recent years? primarily through genetic 
and biochemical studies in yeast. The presence of cytosolic 
pools for many mitochondrial proteins? and the incorporation 
of these proteins into mitochondria can be divided
conceptually into five steps (Fig. 1.3)*
(i) synthesis of the polypeptide? usually as a 
larger precursor on free cytoplasmic ribosomes.
(ii) recognition and binding of the precursor to the 
mitochondrial surface.
(iii) translocation of the precursor across or into 
one or both mitochondrial membranes? depending
on its final destination. This step is dependent
on the membrane potential.
(iv) processing of the polypeptide chain to the 
mature protein (may involve cleavage and/or 
other covalent modifications).
(v) assembly of the subunits to functional holo- 
enzymes (which in some cases may be associated 
with mitochondrial gene products).
Evidence for a post-translational import mechanism? 
in vivo? has come primarily from the fractionation of pulse- 
labelled yeast sphaeroplasts. After a short pulse with 
methionine? labelled precursor forms of mitochondrial poly­
peptides are found in the cytosolic fraction whilst mature 
forms are located within mitochondria and are thus
protected from externally-added proteases (Janussi eij al • ?
1981; Mori ejb al• ? 1981; Reid and Schatz? 1982). The mature 
polypeptide appears only after a lag period indicating the 
existence of cytosolic precursor pools.
Precursor molecules have also been identified and 
characterised using both in vitro translation? and in vivo 
pulse-chase labelling studies in mammalian cells.
The in vitro assay employs isolated mRNA which is 
translated in a cell-free system in the presence of radio­
active amino acids. The precursor form of a mitochondrial 
polypeptide can then be immunoprbcipitated from the translation 
mixture r usiug antibodies directed against the mature polypeptide.
In the majority of cases? the precursor molecule migrates 
with a higher apparent M value than the mature-sized 
subunit.
Figure 1.3: Steps in the biogenesis of an imported
mitochondrial protein.
1. Precursor synthesis
2. Delivery and binding of precursors 
to mitochondrial surface
3* Translocation across membranes
4. Processing of precursor polypeptide
5. Refolding and assembly into functional 
units.
mRNA
Nucleus
Free
polysomes.
Outer
membrane
Inner
membrane
Other
organelles
m w m w  - Pre sequence 
(MMM. - Mature protein
Mitochondria
The in vivo approach (see Chapter 5B) again employs highly 
specific antisera to precipitate selectively radiolabelled 
polypeptides from either cytosolic and mitochondrial fractions 
or from detergent-solubilised cell extracts. Resolution of 
precipitated polypeptides is achieved by SDS-PAGE and 
identification of radiolabelled bands by fluorography.
Both these methods and the fact that completed poly­
peptides from a cell-free translation system can be sequestered 
into isolated mitochondria strongly support a post-translational 
mechanism for import.
The N-terminal extension polypeptide is required to 
direct the precursor molecule to the organelle. Specific 
proteolytic processing enzymes exist within mitochondria 
for the maturation of the delivered precursor (Bflhni et al. ?
1980). This has been confirmed by gene fusion studies (see 
below). There are however? a number of precursor proteins 
which are targeted into each of the mitochondrial compartments 
without exhibiting transient signal sequences. For these 
proteins Gasser and Schatz (1983) have proposed an internal 
s equence which directs their mitochondrial delivery. The 
absence of a cleavable polypeptide extension has been 
documented for the inner mitochondrial membrane protein? 
adenine nucleotide translocase (Zimmerman and Neupert? 1980); 
a matrix protein? 2-isopropylmalate synthase (Gasser ejfc al• ?
1982) and an inter-membrane space component? cytochrome c?
(Korb and Neupert? 1978).
In some instances? this N-terminal extension might serve 
to maintain the precursor in a conformation that prevents 
premature assembly outside the mitochondrion. Also the 
mitochondrial precursor of N. crassa adenine nucleotide 
translocase binds to hydroxylapatite whilst the mature form 
not (Zimmerman and Neupert? 1980).
The specificity of the sorting process implies a receptor 
mediated process. Since the outer membrane of the mito­
chondrion is in direct contact with the cytoplasm? this 
bilayer has been the focus of studies to define components 
which specifically bind mitochondrial precursors. Different 
studies have demonstrated protease-sensitive regions on the 
mitochondrial surface (Hennig _et al • ? 1983; Riezman jet al. ? 
1983? Zwizinski et al.? 1983) which exhibit specific and 
saturable binding for mitochondrial precursors and not the 
mature forms. The potential number of protein candidates 
(about 20) available in the outer membrane suggests that a 
more involved mechanism may be required for the initial 
binding of precursor molecules to the outer mitochondrial 
membrane? rather than a receptor-mediated process. Indeed? 
on recent evidence showing that soluble factors present in 
a homologous cell free lysate can be substituted by a 
yeast cytosolic fraction (Ohta and Schatz? 1984) and be 
shown to stimulate the import of a precursor to mitochondria, 
it is tempting to speculate that cytoplasmic components may 
directly participate in the sorting of precursor proteins 
for mitochondrial delivery.
Although it is generally believed that import of 
precursors occurs at 1 point's of contact* between the inner 
and outer membrane? no compelling experimental evidence has 
been provided to document jfchese ‘points*1 as import sites for 
precursor protein uptake.
The well described cell biology of the mitochondrial 
import pathway in yeast provides the foundation for applying 
various genetic techniques to the molecular aspects of import.
\ Studies have demonstrated that the information required
to direct the cytoplasmically synthesised precursors to the 
mitochondria is contained within its primary sequence.
Following the isolation of nuclear genes encoding mitochondrial 
components? gene fusion studies allowed the definition of the 
sequences which participate in targeting • This was established 
by the observation that gene constructs encoding a mito­
chondrial amino terminus could import hybrid proteins consisting
of a non—mitochondrial protein at the carboxy—terminus (Douglas 
et al.? 1984; Hase et al • ? 1984). Hurt at al./(1985) extended 
these studies and demonstrated that the first twelve amino 
acids were sufficient to direct import to the correct 
mitochondrial compartment. The dodecapeptide retained the prop- 
the complete cleavable mitochondrial sequence in being hydro­
philic? rich in basic and hydroxylated amino acids and devoid 
of acidic amino acids. Indeed? Roise at al.v (1986) have 
proposed a model in which mitochondrial presequences can form 
an amphilic a helix which enables the presequence to 
interact directly with energised mitochondrial membranes.
Fig.1.4 A model for intramitochondrial protein sorting 
(Adapted from Hurt and Van Loon, 1986).
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(Adapted from Hurt and Van Loon, 1986)
Based on elegant gene fusion studies, Hurt and van Loon 
(1986) have proposed a model for intracellular targeting 
and intramitochondrial sorting of imported proteins. In this 
model they propose that each precursor molecule contains 
essentially a matrix-targeting sequence (as described above) . „
£f this domain is followed immediately by a stop-transport 
sequence (i.e. long interrupted stretch of uncharged amino 
acids followed by charged residues) protein transport across 
the outer or inner membrane is prevented. This precursor molecule 
becomes either an outer membrane protein or an intermembrane 
space protein. Cleavage sites may be present for proteolytic 
removal of all or part of the presequence (see Fig. 1.4).
The final stage of the import pathway remains to be 
elucidated, i.e. the assembly of these proteins to functional 
units. The interaction between the nuclear and mitochondrial 
genome requires that a mechanism must exist I ; not only 
regulate cytoplasmic precursor protein synthesis but also to 
control the rate of mitochondrial growth with that of the 
cell. This coordination has been shown to exist, in that 
haem (a mitochondrial product) regulates the transcription 
of cytochrome c (Guarente and Mason, 1983)* Further analysis 
of the mechanism of mitochondrial communication with the 
nucleus will elucidate much of the remaining mystery of 
mitochondrial biogenesis.
1.1.7 The future of mitochondrial research
This introductory section (Section l*l) serves to 
illustrate the major advances in mitochondrial research 
during the past thirty years.
In the early stages mitochondria were generally assumed\ v
to be self-contained organelles •fed* by small molecules 
from the cytoplasm. This classical model of mitochondria 
originated from studies which demonstrated that mitochondria 
could carry out all their major functions in the absence of 
proteins and co-factors from the cytoplasm (Hogeboom et al., 
19^8). The discovery that mitochondria also contained their 
own genome (Section 1.1.5) further emphasised this autonomy.
A view of the eukaryotic cell is now emerging in which 
mitochondria interact structurally, functionally and 
biosynthetically with other cellular components (see Fig. 1«5)* 
The complexity of many cellular functions and their regulation 
emphasises the need for communication and co-ordination between 
this* organelle? and the other cellular components.
The autonomy of mitochondria was first challenged in 
1962 by Wildman and coworkers who observed mitochondria to 
be continually breaking up and fusing with each other. More 
recent observations, including the discovery that more than 
90$ of mitochondrial proteins are encoded by the nuclear 
genome, suggest that mitochondria interact extensively with 
other cellular structures. Also the high level of genetic 
recombination between mitochondrial genome populations in 
yeast cells during somatic growth (Birky, 1978) suggests 
that fusion of mitochondrial inner membranes, and hence the 
mixing^of DNA-containing matrix compartments, may be a 
frequent event.
F i g . 1.5 Int eractions between m it oc hon d ri a and other 
su bcellu lar structures.
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(Adapted from Yaffe and Schatz (1984a).
The demonstration that mitochondria have the ability 
to transfer DNA to the host nucleus (Section 1.1,5) further 
supports the endosymbiotic hypothesis o*f mitochondrial 
evolution. Indeed it has been argued that the cells need 
for a mitochondrial genome is only because nuclearly encoded 
mitochondrial proteins have to be compatible with a pre- 
existing co-translational export machinery and those 
mitochondrially encoded proteins are confined to this genome 
by virtue of their hydrophobic segments (von Heijne, 1986).
This hypothesis can be tested by applying the recent advances 
in gene fusion studies i.e. by fusing a mitochondrial 
targeting sequence to mitochondrially encoded proteins and 
transferring the resulting gene to the nucleus.
Interactions between mitochondria and the nucleus are 
not limited to occasional exchanges of DNA. As mentioned 
previously^mitochondrial biogenesis must require a continuously 
operating regulatory system linking the two organelles.
Very little is known about this regulating system and thus 
it must represent the next major area of mitochondrial 
research to be investigated.
It was previously believed that mitochondria were static 
organelles or that any movement was via random diffusion 
rather than in any specific or guided fashion. The observation 
that mitochondria exhibit saltatory motion (Adams* 1982) 
and that they often occupy specific intracellular positions 
that correlate with the microtubular network (Ball and 
Singer* 1982) suggest that mitochondria are tethered to 
the cytoskeleton and that this association controls mitochondris
movement. These interactions have escaped chemical 
detection, so far, but they may explain why, upon cell 
fractionation, t'_ a large percentage of mitochondria are 
lost in the rapidly sedimenting fraction (Shore and Tata, 1977)* 
Smith and coworkers (1983) found that expression of a 
class I component of the major histocompatibility complex 
is maternally controlled and correlated with a sequence 
difference in mitochondrial DNAs. Despite the nuclear 
location of this gene and the inability of mitochondria to 
export proteins it is difficult to explain how the mito­
chondrial genome can exert this influence on a protein 
component of the plasma membrane. This observation illustrates 
dramatically the limits of our knowledge on how mitochondria 
interact within the eukaryotic cell.
These interactions are difficult to study by conventional 
biochemical methods since, by and large, they are lost upon 
cell fractionation. As many of these interactions are 
probably mediated by the outer mitochondrial membrane, the 
isolation of sealed outer membrane vesicles and the cloning 
of the polypeptides within these vesicles may help clarify 
these ambiguities.
By exploiting the advances in genetic techniques and 
applying these principles to the well characterised yeast 
system, Xaffe and Schatz (1984) have isolated two mutants 
in which mitochondrial assembly has been rendered temperature 
sensitive. These mutants can be used to isolate known 
proteins of the import machinery, to clone the genes coding
for these proteins, and to overproduce these components.
Moreover they might help to identify additional cellular 
components that are necessary for mitochondrial assembly.
The future of mitochondrial research will concentrate 
increasingly on attempting to understand more fully the 
phenomena described above.
The classical view of mitochondria has almost completely 
been replaced, despite sufficiently explaining such important 
functions as oxidative phosphorylation and electron transport, 
and mitochondrial research will focus primarily on understanding 
the complex interactions between mitochondria and other 
cellular components.
1.2 PYRUVATE DEHYDROGENASE MULTIENZYME COMPLEX
1.2.1 Multienzyme complexes
The eukaryotic cell exhibits a high degree of organisational 
complexity, being subdivided into a number of organelles 
and compartments, each of which has a set of unique functions 
and|differentprotein composition. These spatially distinct 
functions are interdependent and the basic cellular processes 
from DNA synthesis to ATP generation depend upon the inter­
action of proteins and cofactors from these compartments.
Much of the metabolism within the cell can be explained 
by the action of a few thousand enzymes promoting the specific 
reactions of their substrates. These enzymes channel their 
products into a network of metabolic pathways, often organised 
as cycles. It has become apparent that a major part of
metabolism is concerned with the creation of* complex 
molecules that aggregate spontaneously in highly specific 
ways to generate structure. Thus when a number of* enzymes 
are physically associated together to form a defined particle 
which can catalyse a series of linked biochemical conversions, 
such an aggregate is termed a multienzyme complex. The 
physical interaction of the enzymes in these complexes 
results in a distinct morphology and the most highly organised 
multimeric complexes in the cell are probably the arrays 
of membrane bound enzymes of oxidative phosphorylation (Section
1.1.4) in mitochondria.
There are several well characterised examples of multi­
enzyme complexes e.g. tryptophan synthetase from E. coli 
(Yanofsky and Crawford, 1972); fatty acid synthetase from 
eukaryotic sources (yeast: Lynen, 1972; mammalian: Stoops 
et al., 1978) and the 2-oxo acid dehydrogenases from all
organisms so far studied (Reed, 1974; Perham, 1975)*
■.  j
This organisation of individual enzymes into multi enzyme 
complexes can provide a number of functional advantages e.g. 
it f may facilitate the opportunity for increased specificity 
and modes of control not possible with structurally independent 
enzymes. For example, tryptophan synthetase from E. coli, 
(Yanofsky and Crawford, 1972) is a tetrameric enzyme with 
subunit structure Resolution of the complex results
in and ^2 dimeric species, both of which are catalytically 
active, being involved in two partial reactions. In the 
assembled complex, however, the overall reaction is catalysed 
with greater efficiency than either of the constituent
activities and potentially competitive reactions involving 
subunit-specific activities are suppressed ej, dvmtnosz,.
The channeling of substrates and co-factors which may 
be retained on the surface of the complex may be considered 
as a form of compartmentalisation and may exclude competition 
from enzymes of another pathway. Examples of this may be 
found in the arom complex of N. crassa (Giles ejfc al., 1967) 
or any of the 2-oxo acid dehydrogenase complexes so far 
studied. The compartmentalisation within multienzyme complexes 
may also serve to prevent degradation |0‘f unstable intermediates 
I in an aqueous solutionj ••
Within multienzyme complexes the association of components 
is stable. This stability allows their isolation/purification 
as discrete entities, thus providing the opportunity for 
detailed in vitro study of their assembly and the interaction 
of subunits. Indeed, in some cases the individual components 
have been resolved and reconstituted to form functional 
aggregates indistinguishable from the native complex.
The association of enzymes within cells may be far 
more extensive than was originally imagined. There are 
indications that the enzymes of the glycolytic pathway form 
functional particles in trypanosomes which are known as 
glycosomes (Gorringer and Moses, 1978) and also that certain 
enzymes of the citric acid cycle are physically linked 
(D1Souza and Srere, 1983; Sumegi and Srere, 1984J.
Apart from an interest in each multi enzyme complex as 
an object in itself, 'ds study will result in a deeper 
understanding of the mechanisms whereby proteins influence
the action of other proteins and the integration of protein 
function. This knowledge can thus be applied to the 
principles governing cellular organisation.
1.2.2 2-oxo acid dehydrogenase complexes
The three major 2-oxo acid dehydrogenase complexes in 
mitochondria consist of three enzymic activities that function 
successively to catalyse the following overall reaction:
The specific reactions catalysed by the pyruvate dehydrogenase
complex (PDC); the 2-oxo glutarate complex (OGDC) and the
branched-chain 2-oxo acid complex (BCDC) are shown in Table
1.3. There are no fewer than five coenzymes and prosthetic
groups involved in the sequence of reactions catalysed by
.the complexes; thiamine diphosphate (TPP); lipoic acid;
coenzyme A; flavin adenine dinucleotide (FAD) and nicotinamide
adenine dinucleotide (NAD+). The complex also has an absolute
2+requirement for Mg •
The PDC catalyses the oxidative decarboxylation of 
pyruvate to acetyl CoA (Fig. 1.6). In vivo this is an 
irreversible process? and the regulation of this complex is 
of crucial importance? particularly in mammals which lack 
the ability to synthesise glucose from acetyl CoA. As will 
be illustrated in Section 1.2.6? PDC is subject to control
lipoic acid? FAD
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Table 1.3s Specific reactions catalysed by the 2-oxo acid 
dehydrogenase complexes.
Figure 1.6 Reaction sequence of PDC
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by feed-back inhibition (NADH, acetyl CoA) and by a 
phosphorylation-dephosphorylation mechanism involving 
covalent modification of specific serine residues on the 
El a subunit (Yeaman e_t al., 1978).
PDC provides acetyl CoA, an important biosynthetic 
metabolite utilised in the synthesis of fatty acids, steroids^, 
and^in most aerobic organisms^ the oxidation of acetyl CoA 
via the tricarboxylic acid cycle is the source of metabolically
utilisable energy in the form of ATP.
6PDC from ox heart (M^ 8.5 x 10 ) is a large catalytic 
array of three enzymess pyruvate decarboxylase (EC 1.2.4.1); 
dihydro1ipoamide acetyltransferase (EC 2.3»1«12) and 
dihydrolipoamide dehydrogenase (EC 1.6.4*3) (Linn jet al.,
1972). These and the corresponding activities in the 
analogous 2-oxo acid dehydrogenase complexes are frequently 
termed El, E2 and E3^ respectively. While the E3 component 
is common to all three complexes, each contains a distinct 
carboxylase and acetyltransferase subunit. The general 
sequence of reactions catalysed is shown schematically in 
Figure 1.6.
These subunits are self-assembling and form an ordered 
and symmetrical structure as determined by evidence from 
reconstitution and electron microscopic studies.
The BCDC and OGDC have also been characterised in 
mammalian tissues. The branched-chain complex, like the PDC, 
is regulated by the reversible phosphorylation of the a 
subunit of its decarboxylase component (Fatania ejfc al•, 1983;
Lau e t al•, 1983; Cooke ejfc al•> 1983)* No evidence exists 
for the regulation of OGDC activity by a similar mechanism.
The 2-oxo glutarate complex is an enzyme of the tri­
carboxylic acid cycle producing succinyl CoA which is required 
in the biosynthesis of porphyrins, lysine and methionine.
The branched-chain 2-oxo acid complex catalyses the committed 
step in the degradation of the branched-chain amino acids.
In mammals this is of nutritional importance in dealing 
with excess valine, leucine and isoleucine in the diet 
(Goldberg and Chang, 1978). These amino acids are ultimately 
converted to the corresponding derivatives of CoA. A 
deficiency of this enzyme activity in humans results in the 
elevation of the 2-oxo acid in blood and urine. This elevation 
ultimately causes Maple Syrup Urine Disease (Chuang et_ al.,
1981) which unless patients are restricted to a diet with 
low levels of these amino acids from an early age, is fatal.
Each of the 2-oxo acid dehydrogenase complexes has 
been purified from several mammalian sources: PDC has been
isolated from ox kidney (Kresze and Steber, 1979; Cate and 
Roche, 1979); porcine liver (Roche and Cate, 1977) and 
bovine heart (Stanley and Perham, 1980). 2-oxo glutarate 
complex has been purified from ox kidney (Reed and Oliver, 
1968) and porcine heart (Koike and Koike, 1976). The 
branched-chain enzyme has been isolated from bovine liver 
and heart mitochondria (Danner eslb al. , 1979; Petit et al. , 
1978).
Although PDC has been well characterised from other 
sources, in particular E. coli (for review see Reed and 
Petit, 1981) and yeast (Kresze and Ronft, 1981a,b), the 
remainder of this study will concentrate on the mammalian 
enzyme.
1.2.3. Composition of mammalian PDC
The mammalian pyruvate dehydrogenase complex can be 
resolved into four major polypeptides by SDS-PAGE (Reed,
1974; Koike and Koike, 1976; Stanley and Perham, 1980) 
although on substitution of the phosphate-buffered system 
(Weber and Osborne, 1969) the Tris-glycine system of
Laemmli, a fifth polypeptide (component X) 50 000 is 
readily resolved from the E3 component (Kresze and Steber, 
1979; Stanley and Perham, I98O; de Marcucci ejt al., 1985; 
de Marcucci and Lindsay, 1985)* The identity and function 
of this band has not yet been fully elucidated.
The El component migrates as two bands of M^ 42 000
(Ela ) and M^ 37 000 (El^) following resolution by SDS-PAGE
(ox hearts Barrera <et al•, 1972; porcine heart: Koike and
Koike, 1976). The isolated El enzyme of mammalian PDC has
an a 3 tetrameric subunit composition (M 154 000) rather 2 2  r
than the larger (M^ 100 000) dimer forming the El of the 
E. coli PDC (Reed, 1974). In ox heart, the E3 enzyme is 
composed of two identical FAD-containing subunits, migrating 
with an apparent M^ value of 55 000. The E2 component 
consists of a single polypeptide chain which assembles to the 
high M^ core structure. Conflicting reports on the M^ values
of the core subunits have been attributed to methodological 
differences: electrophoresis in SDS yields an apparent M
in the range of 70 - 74 000 (Barrera ejfc al* , 1972; Machicao 
and Wieland, 1980) whereas Barrera ef al. (1972) estimated, 
by means of sedimentation equilibrium, an of 52 000, a 
value confirmed by Kresze ejfc al. (1980) on determining the 
value by gel electrophoresis in 6M guanidine.
6The assembled complex has a high value 8.5 x 10 from 
ox heart and is composed of multiple copies of the El and E3 
subunits which are tightly but non-covalently bound to the E2 
core assembly (M^ 3*1 x 10^). Electron microscopic studies 
(Reed and Oliver, 1968) revealed that the E2 * core complex* 
has the appearance of a pentagonal dodecahedron. The inferred 
icosahedral symmetry (532), together with molecular mass 
considerations, predicted the presence of 60 subunits in the 
intact E2 component.
The mammalian complex also contains small amounts of 
two regulatory enzymes, a kinase and a phosphatase, that 
modulate the activity by phosphorylation (inactivation) and 
dephosphorylation (activation) respectively (Fig. 1.7)*
The PDC kinase activity is apparently associated with 
both the El and E2 components of the complex (jilka _et al. 9 
1986). Although its precise stoicheiometry with respect 
to the other components is unknown, it has been shown to 
vary in a tissue-specific manner with estimations of 1-2 
mole# per mole of heart complex and 3-5 moles for
the kidney enzyme. The ATP-dependent kinase activity 
copurifies with the complex, a key factor in its isolation 
and subsequent characterisation (Stepp et al., 1983)*
Inactivation of the complex is achieved by the phosphorylation 
of one of three possible serine residues in the a subunit 
(Yeaman et al., 1978)# PDC kinase contains subunits, a and 3, 
of M^ 48 000 and 45 000, respectively. Stepps ejfc al. (1983) 
have identified the a subunit as the catalytic subunit from 
proteolysis studies and have proposed that the 3 subunit may 
function in a regulatory capacity.
The phosphatase, in contrast to the kinase, is only 
loosely bound to the complex. Reed and Petit (1981) obtained 
a highly-purified phosphatase from bovine kidney and 
subsequent characterisation revealed that it consisted of
two non-identical subunits of 97 000 and 50 000. The .
2+phosphatase reaction requires Mg and in addition the 
binding of the phosphatase has an absolute requirement for 
Ca^+ (Denton et_ al_., 1972).
These two 'converter* enzymes are integrated into the 
complex and comprise a monocyclic interconvertible enzyme 
cascade (Stadtman and Chock, 1977) (Fig. 1*7)*
1.2.4 Structural and functional studies on mammalian PDC
Despite the requirement for the participation of all 
three constituent enzymes in the overall reaction, it is 
clear that the active sites are not necessarily represented 
in equal numbers in the enzyme complex (Table 1.4). This 
suggests that PDC and the analogous 2-oxo acid dehydrogenases 
do not function by simple direct transfer of substrate among 
three active sites arranged on a 1:1:1 basis and therefore 
that the structure and organisation of the multi enzyme
Enzyme Mr
Subuni t 
No. Mr
Subunits 
per molecule 
complex
Native
complex 8.5 x 106
PDH 154 000 2 42 000 
2 37 000
60
Dihydrolip- 
oyl acetyl- 
transferase 3 1 x 10 60 72 000 60
Dihydrolip- 
oyl
d ehydro gen- 
ase 110 000 2 35 000 12
PDC kinase 100 000 1 48 000
1 43 000
2
PDC
phosphatase 130 000 1 97 000 
1 50 000
0
Table 1.4: Subunit composition of bovine heart PDC.
complexes must relate to the enzyme mechanism* Indeed, 
early electron microscopic studies (Hayakawa ejfc al• , 1969) 
indicate that the molecules of the El and E3 components are 
apparently bound to the lipoate acetyltransferase core and 
are distributed in such a manner as to allow the efficient 
interaction of subunits and cofactors* Latterly, this 
interaction has been probed using both biochemical and 
biophysical techniques in an attempt to clarify the relation­
ship between the structure and function of PDC.
1.2.4.1 Use of limited proteolysis to probe subunit structure 
PDC activity in crude extracts from rat liver decreases 
rapidly and irreversibly (Wieland, 1975)* This inactivation 
was attributed to a lysosomal protease which Kresze and 
Steber (1979) have termed INACTIVASE. This leupeptin-sensitive 
protease was shown to act on the E2 core without affecting 
its quaternary structure butto lead to the release of the 
other subunits (Kresze and Steber, 1979)* Each of the 
individual enzymes retained} its ,:iactivity while that of 
complex was almost completely lost. This evidence suggests 
that there are probably no gross conformational changes at 
the active site of each constituent enzyme on assembly to 
form the high value multienzyme complex.
The lysosomal pro tease, and similarly trypsin and 
papain (Kresze e_t al•, 1980) cleave the core component, 
lipoate acetyltransferase, to yield two principal fragments 
which have been isolated following separation on SDS-PAGE.
It is now established from this and further studies on the 
native enzyme by Bleile _et al •, (1981), that the acetyl- 
transferase subunit consists of two non-identical domains: 
a compact domain of approximately 26 000 M^, identified as 
the subunit binding domain which also contains the catalytic 
site for transacetylation; attached to this is a flexible 
extended domain of approximately 28 000 M carrying the 
covalently-bound lipoyl moiety.
Immune mapping studies following proteolysis with 
elastase of the native enzyme gave similar results (de 
Marcucci et al., 1986). Employing subunit— specific antisera 
directed against the E2 component, the authors demonstrated 
the generation of two major fragments. The larger 45 000 
fragment was shown to be particularly immunoreactive. This 
enhanced reactivity, relative to the second fragment, is 
primarily thought to be as a consequence of its unusual 
structural features i.e. an extended domain structure 
protruding from the inner core of the acetyltransferase 
assembly (Bleile ej; al., 1981). The high antigenic reactivity 
of epitopes located in flexible or mobile regions of protein 
has been reported previously (Westhof ejb al•, 1984).
Release of the lipoylated domain from native PDC following 
limited proteolysis with trypsin has also been reported for 
the E. coli enzyme (Bleile ejfc al., 1979; Hale and Perham, 1979)* 
The large C-terminal domain of the E2 chain that remains 
aggregated to form the inner core of the complex retains both 
the acetyl transferase active site and the binding site for
the El and E3 subunits. Indeed* it has proven possible 
to isolate these lipoyl domains as three distinct functional 
entities after limited proteolysis of the complex with 
Staphylococcus aureus V8 proteinase.
The susceptibility of this region of polypeptide chain 
to various proteases is thought to be as a result of its 
protrusion from the aggregated core complex* a structural 
domain believed to be an integral feature of the enzyme 
mechanism.
1.2.4.2 Mobility of the E2 polypeptide
Proton NMR studies have often been used to demonstrate 
significant internal mobility in the structure of several 
small molecules. This has been shown to involve not only 
specific amino acid side chains but also larger regions of 
polypeptide chain.
Wawrzynczak et_ al.j (1981) have demonstrated that ox 
heart PDC contains a highly mobile region* which, when 
coupled to the limited proteolysis and electron microscopic 
data* was assigned to the E2 component. More elaborate 
studies were carried out by Perham et al •h (1981) who reported
it
on similar observations for the E. coli complex. Perham 
and coworkers resolved E. coli PDC into two subcomplexes: 
E1-E2 and E2-E3* Both these subcomplexes were shown to 
enjoy the prominent features of the proton NMR spectra of 
the intact complex. This mobility was attributed to the 
core complex since the lipoate acetyltransferase was the 
only common polypeptide (Roberts jet al• * 1983)*
This mobility is an intrinsic property of the protein 
and is unrelated to any substrate-induced conformational 
change and may explain some features of the enzyme complex.
It may permit the lipoyl-lysine swinging arm structure to 
interact over more of the complex surface than the length 
of the lysine lipoate arm (l.4 nm) would suggest at first.
Spin label experiments (Ambrose and Perham, 1976) are 
consistent with this idea^ although fluorescent energy transfer 
measurements (Angelides and Hammes, 1979) have indicated 
that the distance between active sites is almost twice the 
span of the swinging arm.
1•2•h •3 Number of lipoic acid residues per E2 subunit
The lipoic acid cofactor is reductively acetylated via 
a hydroxyethyl-TPP intermediate formed by decarboxylation of 
pyruvate on the El component of the complex. This acetyl 
group is transferred to CoA(SH) at an active site on enzyme 
E2, forming the product acetyl CoA. This transfer generates 
the reduced form of lipoic acid and its subsequent re­
oxidation is achieved by lipoamide dehydrogenase (Fig. 1.6). 
Thus lipoic acid plays the key role in the mechanism of the 
pyruvate dehydrogenase complex, visiting three active sites 
on El, E2 and E3» respectively, and mediating the transfer 
of acetyl groups to CoA (SH).
There is still some controversy concerning the number of 
lipoyl residues bound per E2 chain. Most evidence suggests 
that only a single lipoyl moiety is present on each E2 
polypeptide ('White ejb al •, 1980; Hamada et al •, 1975;
Staniey >et al • ? 1981). These authors studied the extent of* 
incorporation of* radiolabelinto PDC [ ?nthe absence of acetyl
have suggested that this second? slower phase of acetylation 
may not be the reductive acetylation of* a second lipoyl 
group as it results in protection against N-ethylmaleimide 
modification of lipoyl groups on E2? but perhaps a reactive 
cysteine residue which may be of catalytic significance*
Extensive studies have been carried out on the lipoyl 
domains of the E. coli enzyme* The primary structure of the 
E2 polypeptide inferred from the DNA sequence (Stephens et al * ?
1983) has revealed three highly homologous^sequences bontaining 
a lysine residue which is capable of lipoylation (Hale and 
Perham? 1980)* The lipoyl group of each domain? like the 
mammalian counterpart? becomes reductively acetylated? in 
the intact complex? in the presence of substrate (Packman 
et al«? 1984a). Genetic reconstructions (Graham et. al • ? 1986)
of E* coli PDC have demonstrated that lowering the number of
: ' “    ' |
lipoyl segments from 3*2 or 2*1. per E2 chain still permits 
the assembly of functional PDC. This is consistent with the 
view that the three lipoyl domains are folded as independent 
units* These truncated polypeptides have been shown to be 
unimpaired in catalytic activity and in the intramolecular 
coupling of active sites* This genetically-reconstructed 
E. coli PDC thus closely resembles the PDC (icosahedral 
symmetry) of B. stearothermonhilus (Packman et_ al. ? 1984b);
CoA, In contrast? Cate and Roche
(1979). in a similar study? estimated the number of lipoyl 
groups per E2 chain to be 2* However? Hodgson est al • (1986)
p
B. subtilis (Hodgson et al• ? 1983) and i&r ox heart 
mitochondria (Reed? 1974; Bleile et al. ? 1981; Stanley e t al • ? 
1981b) and suggests that the two f extra lipoyl* groups 
are catalytically redundant with no role attributable to 
them.
1.2.4.4 Conclusion relating PDC structure to catalytic function 
During the catalytic cycle of the PDC? the substrate is 
transferred between the physically separate active sites by 
the lipoyl-lysine 1 swinging arms1 on which it is retained 
in thioester linkage (Reed? 1974; Ambrose and Perham? 1976; 
Grande ejfc al • ? 1976). Proteolysis studies and proton NMR 
spectroscopy have located these flexible regions on the E2 
polypeptide? in segments which protrude from the aggregated 
core assembly which binds the El and E3 components and which 
contain the lipoyl group. Acetylation studiesousing 
radiolabelled pyruvate^have demonstrated that an extensive 
network of coupling reactions exist) which permits the 
intramolecular transfer of acetyl groups between lipoic 
acid residues of different E2 subunits in the same enzyme 
core (Bates jet al• ? 1977? Collins and Reed? 1977? Packman 
et al.? 1983). Also? a lipoyl group can visit the active
site of several El subunits in the same complex (Cate and Roche? 
1979? Stanley ejfc al• ? I98I; Stepp .et al. ? 1981; Hackert e_t al. ? 
1983).
The elegant genetic studies of Graham «*t al. (1986) 
when coupled to existing data from tryptic digests (Bleble 
et al.? 1979) or NEM inactivation experiments (Ambrose- 
Griffin .et al• ? I98O) demonstrate that more than half of
the E. coli PDC lipoyl groups can be removed without 
impairing the enzyme's activity. These extra lipoyl domains 
can be regarded as being redundant with respect to the 
catalytic cycle of the enzyme-complex though perhaps more 
stringent kinetic analysis may elucidate a role for them.
1.2*5 Structural and functional studies on component X
Recently a previously-unrecognised fifth polypeptide? 
component X? has been detected in mammalian PDC. This 
polypeptide is readily resolved from the E3 subunit by SDS- 
PAGE in Tris-glycine buffers (de Marcucci and Lindsay? 1985? 
de Marcucci _et al. ? 1985)* This component has been demonstrated 
subsequently to form a close physical and functional union 
with the E2 core assembly (de Marcucci and Lindsay? 1985)*
A similar component may be tightly bound to the E2 assembly 
of Sac charomyce s cerevisiae where an additional 50 000 M^ 
component is also present in comparable amounts to that of 
the mammalian complex.
■While component X in mammalian PDC has been observed 
previously? reports demonstrating that it is capable of 
becoming acetylated suggested that it was a proteolytic 
fragment of the E2 polypeptide. It was also thought to be 
the intrinsic kinase activity prior to its isolation. However 
by employing refined immunological techniques and standard 
protein chemistry (de Marcucci et al.» 1985* 1986; Jilka 
et al.? 1986) it has been shown that component X is a 
distinct polypeptide.
1.2.5*1 Physical association of component X with the E2 
assembly
Immunoblotting analysis of SDS extracts of bovine? rat 
and pig cell lines have indicated that protein X is a normal 
cellular component with a specific mitochondrial location.
The presence of protein X in mammalian PDC may be a unique 
feature of this multienzyme complex? since analysis of the 
two analogous complexes? OGDC and BCDC? has failed to detect 
a similar polypeptide. This may? then? indicate that component 
X is involved in the metabolism of two carbon units.
Component X remains bound to E2 during purification of 
this subunit and is not removed by p-hydroxymercuriphenyl 
sulphonate? a reagent that promotes the release of the 
intrinsic kinase from the assembly (Stepp jet al• ? 1983)* Under 
conditions that are known to dissociate the constituent enzymes 
of the complex i.e. treatment with 0.25M MgCl^ or high pH? 
component X remains tightly associated with the core enzyme.
It has proved impossible to destroy this specific interaction 
without employing denaturing conditions e.g. 6M urea or 
SDS.
1.2.5.2 Structural studies on component X
Employing the immune replica technique de Marcucci et al. 
(1986) were unable to detect any cross reactivity of anti- 
X-serum with E2 or any other component of the complex. In 
this context? Jilka et al. ' (1986) reported that their anti—X— 
serum also reacts with the lipoyl-bearing domain of the 
acetyltransferase. This conflicting observation may simply 
reflect differences in the method of antigen preparation or 
in the nature of the polyclonal response in mice and rabbits.
125One-dimensional peptide mapping studies with IE- 
labelled lipoyl acetyltransferase and component X subunits 
indicate? by the absence of any proteolytic fragment common 
to each digest? that these two proteins are structurally 
distinct entities. Similar analysis of purified subunits? 
initially radiolabelled with J^c] — pyruvate and |j^ c| — NEM 
confirms that distinct y-labelled fragments are generated 
from these two subunits. This result suggests? therefore? 
that despite both being acetylated? the domains containing 
the acetyl groups are structurally dissimilar. Th&sedata 
also support the immunological findings? which demonstrate 
that component X is not a proteolytic fragment of the E2 
subunit.
1.2.5*3 Functional studies on component X
Component X has been shown to incorporate N-ethylmaleimide
only in the presence of pyruvate or NADH (Hodgson erfc al. ? 1986).
f 14 I
Incubation of the native complex in the presence of [ 2 -  C l  
pyruvate also results in the rapid uptake of radiolabel into 
both E2 and X. Deacetylation of both components is achieved 
by the addition of C o A S H  but whether both proteins interact 
independently with the cofactor is hot known.
Hodgson e^fc al. (1986) investigated the nature of the 
group on component X which became modified with I Cj - NEM
r  i i +  “ i
only in the presence of pyruvate. Identification of the C I 
acetylated groups on component X as a lipoyl moiety was 
achieved by comparative elution of the I g-labelled acid 
hydrolysis products generated from the E2 and X peptides.
These peptides were readily distinguishable from the hydrolysis
products of NEM-derivatised cysteine. This eliminated 
the possibility that the site of N-ethylmaleimide incorporation 
on protein X was a cysteine thiol exposed by conformational 
change on addition of substrate.
Hodgson and Lindsay (1986) have subsequently demonstrated? 
''via cross-linking experiments with the bifunetional agent 
phenylene dimaleimide? that the lipoyl groups on E2 and 
component X can interact spatially. Subunit-specific antisera 
were employed to distinguish between E2/E2 and X/X homodimers 
and also E2/X hetereodimers• These results also suggest 
that E2 and component X are present on the same core assembly.
1.2.5*^ Possible functions of component X
The relative abundance of component X? approaching levels 
of E3 in the complex? argues against its possible role as a 
regulatory component. However? it has been suggested (Cate 
and Roche? 1978) that PDC activity may be influenced by the 
degree of acetylation of the lipoyl transacetylase. In a 
more recent study Jilka jet al./ (1986) have shown that the 
intrinsic PDC kinase can be stimulated two-fold to three-fold 
when as few as six lipoyl groups are acetylated per E2 core.
It is possible that this effect is mediated via component X.
The parallel behaviour of E2 and protein X in the 
acetylation/deacetylation reactions may reflect the close 
physical and functional relationship between these two 
proteins; it may also suggest that component X is an 
isoenzyme of E2.
Alternatively? component X may represent an associated 
enzyme engaged in the transfer of two carbon units? derived 
from pyruvate? to other physiological substrates e.g. 
carnitine.
The protein may also provide an anchoring function i.e. 
in allowing the PDC to bind to the inner mitochondrial 
membrane (see Chapter 3)« Prior io Halestrapfs (1978) 
preliminary identification of a 15 000 polypeptide as a 
candidate for the pyruvate transporter? the possibility existed 
for component X to fulfil this function.
1.2.6 Regulation of mammalian PDC
The central role of mammalian PDC in metabolism has 
prompted an extensive investigation of its regulatory properties. 
PDC provides acetyl CoA? an important biosynthetic metabolite 
utilised in the synthesis of fatty acids? leucine and steroids.
In animals this conversion of pyruvate to acetyl CoA 
is irreversible and thus represents a net loss of carbohydrate 
reserves to the cell. Garland and Randle (1964) first 
suggested that the activity of the complex was regulated by 
feedback inhibition of the products? NADH and acetyl CoA.
It was found that if PDC activity was measured in a system 
which allowed the accumulation of products? the rate of 
reaction declined rapidly to less than 10 fo of the original 
value. When the removal of acetyl CoA was achieved by the 
addition of carnitine and carnitine acetyltransferase? this 
caused the reaction rate to return to 70Jo of the original 
value. Tsai ejfc al. (1973) demonstrated subsequently that 
acetyl CoA and NADH are effective competitive inhibitors of
Fig. 1.7 Phosphorylation - dephosphorylation cycle 
of'mammalian PDC.
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+
CoA and NAD ? respectively. This mode of control of PDC 
activity is of particular importance in heart and diaphragm 
tissue (Denton et al# > 1975)*
Linn erfc al.j (1969a? 1969b) demonstrated that the complex 
existed in an inactive phosphorylated form and an active de- 
phosphorylated form. Covalent modification of the complex 
is mediated by an intrinsic ATP-dependent kinase and a 
phosphatase which is loosely associated with the complex.
The activity of PDC from several mammalian and avian tissues? 
Neurospora crassa and plants is controlled in a similar manner. 
BCDC is also modulated by an analogous phosphorylation- 
dephosphorylation cycle. No evidence exists for similar 
control of PDC in prokaryotes or yeast or for OGDC in 
eukaryotic or prokaryotic cells.
The characteristics and composition of the kinase and 
phosphatase are discussed in Section 1.2.3*
A novel mechanism has been postulated whereby lipoate 
may act as the transmitter of regulatory interactions of PDC 
kinase (Kerbey _et al • ? 1976). It has been suggested (Cate and 
Roche? 1975) that the 'regulatory effects on the El component 
are mediated by the extent of acetylation or degree of 
oxidation/reduction of E2 (and possibly component X? i.e. 
Section 1.2.6). This controversy has not yet been resolved.
In diabetes and starvation? there is a marked decrease 
in the activity of the complex in heart? liver and kidney 
(Wieland ejfc al.? 1971)* This effect is reversed upon feeding? 
the administration of insulin or inhibitors of fatty acid 
oxidation. This modulation of activity has been attributed
to stimulation of the pyruvate dehydrogenase kinase or an 
increased synthesis of a protein activator of the kinase or 
the kinase itself (Hutson and Randle? 1978; Kerbey and Randle? 
1982). For reviews on this subject see Wieland (1983) and 
Reed and Yeaman (1985)*
1 .2.7 Localisation of PDC within the mitochondria
PDC can be prepared from disrupted mitochondria? generally 
by employing a freeze-thaw procedure to destroy the integrity 
of the membrane (Linn ejt al• ? 1972; Cooper ejb al• ? 197^0*
Both?the above methods rely on the preliminary preparation 
and accumulation of large stocks of mitochondria. A more 
recent method (Stanley and Perham? 1980) dispensed with 
stock-piling of mitochondria and achieved a much greater 
yield of the 2-oxo acid dehydrogenase by the inclusion of 
Triton X-100 in the buffer used for the initial disruption of 
the heart tissue. These authors found that all of the 
assayable activity was soluble and represented a three-fold 
increase in the activity recovered in the absence of Triton 
X-100. This large increase in yield? which accompanies 
the addition of detergent? is consistent with the hypothesis 
that much? if not all? of the PDC activity is associated 
with the inner mitochondrial membrane. This observation 
will be discussed more fully in Chapter Three.
1.3 THE PHOSPHATE TRANSPORT SYSTEM
In the aerobic cells of eukaryotic organisms almost 
all the ATP is synthesised in mitochondria with the remainder 
being generated via substrate-level phosphorylation reactions 
which occur largely in the cytoplasm. ATP? once synthesised? 
is transported into the cytoplasm via the adenine nucleotide 
translocase (ANT) to be used in the many endergonic reactions 
of cellular metabolism? generating ADP? AMP and P^. Thus 
two mitochondrial uptake systems are required which must 
be directly linked to ATP synthesis: namely adenine
nucleotide transport (ADP) and the transport of inorganic 
phosphate (P^)«
As a consequence of the pioneering work of Chappell 
(1965) and Fonyo (1966) on phosphate efflux and its inhibition 
by thiol group reagents? respectively? it is now well 
established that two P^ systems exist in the inner mitochondrial 
membrane:
(i) an electroneutral dicarboxylate/P^ antiporter
which is mainly involved in the exchange of substrates 
between the matrix and the cytoplasm (McGivan ejfc al • ? 
1971? Palmieri e_t al. ? 1971)* 
and (ii) an electroneutral phosphate/proton symporter or
phosphate/hydroxyl antiporter (for review see Fonyo?
1978) which catalyses the influx of 90°fo of the 
mitochondrial P^ (Coty ejb al. ? 1975)*
The latter system is dependent on the transmembrane pH 
gradient and is inhibited by sulphydryl group reagents such 
as NEM? mersalyl and pC-MB (Fonyo and Bessman? 1968;
Fig. 1.8 The importance of Pj and Pj transport processes to cell metabolism.
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Tyler* 1969; Coty and Pedersen* 197^> 1975* Wohlrab and 
Flowers* 1982). The other carrier* the P^/dicarboxylate 
antiporter is insensitive to NEM but is inhibited by mersalyl* 
pC-MB or substrate analogues such as n-butyl malonate or 
2 phenyl-succinate (Meyer and Tager* 1969* Meijer ejb al. *
1970; Coty and Pedersen, 197^)*
1*3*1 Importance of phosphate transport in cell physiology
The importance of phosphate transport in cell physiology 
is evident from the numerous regulatory processes to which 
it is linked (Fig. 1*8).
(a) it controls the influx of P^ required for ATP 
synthesis and consequently maintains the phosphate 
potential in the cell*
(b) it is directly involved in the H+ cycle which takes 
place in the inner mitochondrial membrane and thus 
lends support to Mitchells Chemiosmotic Theory 
which states that ATP synthesis and electron 
transport are coupled to a proton gradient (Fig. 1*9) 
(Mitchell, 1961).
(c) through its link with the P^/dicarboxylate exchange^ 
it controls the distribution of a certain number of 
Krebfs cycle intermediates e.g. malate.
On the basis of these observations any protein(s) which 
is (are) responsible for the bulk of mitochondrial phosphate 
transport must have an affinity for its substrate* P^; j ^  j 
must react with sulphydryl group reagents which inhibit 
transport and must catalyse P^ transport when incorporated 
into liposomes in the correct orientation.
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To this end* the key factor in elucidating the mechanism 
of phosphate transport in mitochondria would be the 
identification of the protein(s) responsible and its 
characterisation on the basis of the above criteria.
1.3.2 Identification of the phosphate transport protein
Kadenbach and Hadvary (1973) were first to demonstrate 
that chloroform extracts from rat liver mitochondria exhibited 
an affinity for P^. These extracts were found to contain 
proteins with free sulphydryl groups and the addition of 
sulphydryl group reagents was observed to reduce their 
affinity for P^.
The same approach was used by Guerin (1978) who succeeded 
in isolating a 10 000 proteolipid from yeast which was 
associated with cardiolipin. This proteolipid contained 
sulphydryl groups and also exhibited an affinity for 
Subsequent studies with yeast grown in the presence of 
chloramphenicol and with mitochondria from DNA-deficient 
*petiie! mutants suggested that the isolated proteolipid was 
translated from mitochondrial ribosomes (Rigoulet et al.,
1977).
Coty and Pedersen (1975) found that if limiting amounts
of | ^ h ] NEM were added to rat liver mitochondria such that
phosphate transport was inhibited* analysis by SDS-PAGE
revealed the presence of at least ten different radiolabelled
polypeptides, demonstrating that NEM reacts non-specifically
with a variety of proteins in the mitochondrial inner membrane.
By exploiting the reversibility and specificity of the
/ *{*inhibition by mercurials of the phosphate/H symporter, Coty
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and Pedersen (1975) developed an elegant procedure for
labelling the sulphydryl groups involved in phosphate
transport in a more specific manner. The phosphate transport
system (PTS) was initially protected by inhibition with
mersalyl? and then all free sulphydryl groups
!__ W & y c .  b t o c b x l /
unassociated with transport*by the addition of non-radiolabelled 
NEM. Mersalyl inhibition of the PTP was reversed by addition 
of DTT? restoring about 65-75$ of the original activity of 
the carrier. Subsequent inhibition of transport with l_pH_i 
NEM resulted in a marked increase in specificity? modifying 
only five polypeptides in the M^ range of 30 000 — 32 000 
(Fig. 1.10)•
These prominent NEM-modified bands were localised in the 
inner membrane of various types of mitochondria (Briand at al. ? 
1976; Hadvary and Kadenbach? 1976; Touraille e t al•? 1977? 
Wohlrab and Greaney? 1978; Wohlrab? 1979)* However? no 
protein of M^ value between 8 000 - 10 000 was protected by 
the mercurial (Kadenbach and Hadvary? 1973)*
After this treatment phosphate transport? as measured 
by the rate of uptake of could be shown to be
controlled by the transmembrane pH gradient since transport 
was strongly stimulated by the ionophore? valinomycin. Thus 
it was concluded that mersalyl protects those proteins which 
are essential for phosphate transport (Coty and Pedersen?
1975).
Of these five protein bands? studies on the flight 
muscle of the adult blowfly? Sacrophaga bullata? labelled 
two bands of Mr 32 000 and 45 000 with [^ h J NEM. This
membrane system is particularly well suited to these studies 
since it is highly specialised containing only the NEM- 
sensitive carrier and not the dicarboxylate carrier. On 
comparison of* this labelling pattern to that obtained in 
the rat liver system^ Coty and Pedersen (1975) suggested 0. /
that the 32 000 M^ peptide was the most likely NEM binding 
component of thex PTS (Wohlrab and Greaney, 1978).
Further studies on the blowfly flight muscle and on 
rat heart SMP confirmed this result by identifying a 32 000 
polypeptide via high resolution SDS-PAGE as the strongest 
candidate for the alkylated component of the PTS (Wohlrab,
1979).
1*3*3 Purification of the proteinfs) involved In the phosphate 
transport system
The NEM-sensitive carrier of bovine and pig heart 
mitochondria haj|i been isolated and reconstituted into 
liposomes (Kolbe et al., 1981; Touraille ejfc al• , 1981).
This protein was identifiedjas a single band (M^ 3 k  000) 
by conventional SDS-PAGE analysis which could be labelled 
with [ NEM (Wohlrab, I98O; Kolbe et al., 1981; Touraille 
et aJL. , I98I). The adenine nucleotide translocase which 
copurified in the preparation of Wohlrab (1980) and Wohlrab 
and Flowers (1982) was removed by chromatography on Celite 
(Kolbe et al., 1981) or on mersalyl-ultrogel (Touraille ejfc al.,
1981).
One of the criteria to be fulfilled by the purified 
component of the PTS is that it should catalyse a 
exchange when reconstituted into liposomes. The 3 k  000
species as isolated by Kolbe jet al*/ (1981), and Touraille
/  ,
et al. (1981) could only maintain 2$ of the activity achieved <
in isolated mitochondria by Coty and Pedersen (l975)> although
the exchange was found to be insensitive to carboxyatractyloside
and n-butyl malonate (the ANT inhibitors) but sensitive to
NEM and mercurials.
Gradient SDS-PAGE revealed that the purified PTP described
above could be resolved into five bands of similar M value.r
It has been suggested (Kolbe et; al• , 1981) that the mitochondrial 
phosphate transporter occurs as a complex of different poly­
peptides and more recently that at least two of these bands 
represent proteolytic fragments of the parent polypeptide* 
although protease inhibitors had no effect on the apparent 
heterogeneity of the purified carrier (Kolbe £t al., 1982). 
Recently, Gibb et ale (1986) reported an improved scheme for 
the purification of the PTP from rat liver which involves a 
modification of the method of Kolbe ejfc al./ (1981). A single 
polypeptide, subunit M^ 34 000, can be visualised after 
Coomassie Blue staining at the final stage of the purification, 
in general agreement with t'*10 value quoted from other mammalian; 
sources (Wohlrab, 1980; Kolbe et al., 1981).
1*3*4 Effect of cardiolipin on the reconstituted activity of 
the phosphate transport protein 
Bisaccia and Palmieri (1984) have obtained evidence that 
ardiolipin can be used to improve the purification of the 
phosphate transport protein to such an extent that only one 
major protein band is detectable in gradient SDS gel
electrophoresis. Previous studies have demonstrated that 
the reconstituted transport activity could be increased 
several fold by the inclusion of cardiolipin in the 
solubilisation buffer (Kadenbach at al•, 1982; Mende et_ al.,
1982). The specific effect of cardiolipin was corroborated 
by results showing a reversal of the enhanced activity by 
the presence of doxorubcin, which forms a specific complex 
with cardiolipin (Cheneval ejfc al. , 1983)* This apparent 
affinity for cardiolipin strongly supports the idea of a 
specific interaction of the carrier protein with cardiolipin, 
which, in reconstitution studies, may maintain the phosphate 
carrier in its native conformation. This specific effect 
was not observed with other phospholipids tested.
1.3*5 Further characterisation of the phosphate transport protein 
Kolbe ejfc al. (1984) attempted to characterise the PTP ,r 
further by purifying the protein from bovine heart on a large 
scale. Silver— staining of the SDS polyacrylamide gel resulted 
in two bands, designated putatively as the a and P subunits 
of the phosphate transport protein. These 1 subunits* were 
shown to exist in the ratio of 1:1. + p migrated
with similar mobilities (M^ 34 000), also exhibiting
identical peptide maps if fragmented with either CNBr or 
HCl/dimethyl sulphoxide/HBr. The amino acid composition was 
determined and! comparative studies with the adenine ^
nucleotide translo case (Aquila e t al. , 1982) and S 
the phosphate carrier demonstrates that both proteins have 
markedly hydrophobic characteristics.
Edman degradation shows that both bands of the PTP
. i '
display the same amino terminus• Both proteins lack either 
a methionine or a formylated methionine in the first position? 
suggesting that^unlike the yeast phosphate carrier (Guerin 
and| Napias 1978; Rigoulet et al. ? 1977) and the cytochrome 
c oxidase subunits I? II and III (Schatz and Mason? 197*0^
; the PTP is not of mitochondrial origin but is coded 
for by a nuclear gene and synthesised cytoplasmically.
Comparison of the amino terminal sequence generated from 
Edman degradation with the reported reading frames of the 
bovine heart mitochondrial genome (Anderson et al.? 1982) 
further supported the nuclear origin of the carrier protein.
Whether the differences observed between PTP and PTPoa P
are of any functional significance remains to be elucidated. 
Kolbe? in the above publication? has suggested that these 
proteins may constitute the subunits of the phosphate carrier - 
an hypothesis prompted by functional existence of the PTP!s 
sister protein? ANT? as a dimer (Klingenberg eHfc al• ? 1978). 
This apparent subunit heterogeneity may be explained by 
transient disulphide bond formation during electrophoresis 
as carboxymethylation prior to SDS-PAGE results in the 
detection of a single polypeptide. To this end further 
characterisation of a and 0 is required? with possible studies 
on the native membrane system to further discriminate between 
the two proteins.
1.3*6 Location of the NEM binding site of the phosphate
transport protein
As a consequence of the hydrophobic nature of this
protein, amino acid sequencing by conventional methods has
proven difficulty with complications arising as a result of
the purified protein aggregating, thereby rendering it
inaccessible to Edman degradation reactions.
To overcome these technical problems Kolbe and Wohlrab
(1985) developed an elaborate protocol to isolate a formic
acid fragment generated from ( H) NEM labelled bovine
mitochondrial PTP. By thermolysin digestion of the radioactive
jBrmic acid fragment and high performance liquid chromatography
3 9  24.3
isolation of the radioactive subfragment, Leu -Arg » the 
sole NEM binding residue has been identified as cysteine 
(residue ^2).
Further characterisation of this formic acid fragment
(FAl) revealed significant homology in the triplicated gene
regions of the mitochondrial adenine nucleotide translocase
from bovine heart and Neurospora crassa. The fragment is
/ 15 ^3\predicted to contain a transmembrane segment (Phe —Val j.
The nuclear origin of this carrier protein has again been 
suggested (Section 1.3*3) from the lack of significant 
homology between the reverse-translated FAI (utilising 
mitochondrial codons) and the bovine mitochondrial genome.
1.3*7 Identifying the substrate-binding site of the phosphate 
transport protein 
Despite the identification of cysteine at residue k 2  
as the binding site of the inhibitor N-ethylmaleimide> very 
little information is available on the substrate binding site
of the phosphate transport protein. Indeed? it has not 
yet been established whether the particular -SH group 
responsible for the inhibition by N-ethyl maleimide is 
located at or near the phosphate binding site? although 
the presence of phosphate decreases, to some extent? the 
reactivity of -SH blocking reagents with the phosphate 
transport protein (Klingenberg e_t al• ? 197^5 Fonyo and 
Vignais, I98O; Ligeti and Fonyo, 198^)•
Utilising a photoreactive phosphate analogue (Lauquin 
et al.» 1980)? Tommasino and coworkers (1987) sought to 
investigate the effect of 4-azido-2-nitrophenyl phosphate 
(ANPP) on the activity of the phosphate carrier of pig heart
ANPP inhibits phosphate transport in the dark in a competitive 
manner, and that upon photoirradiation the probe becomes 
irreversibly bound to the carrier. Under these conditions 
inhibition is dependent on both the pH of the medium and 
concentration of the probe.
Therefore ANPP appears to be a suitable reagent for 
characterising the phosphate binding site of the mitochondrial 
carrier although further investigations should concentrate 
on locating the modified amino acid(s) in the primary structure 
of the protein.
1.3« 8 Concluding remarks
The identification? purification and subsequent 
characterisation of the protein(s) involved in P^ transport 
has (have) proven much more difficult than that of the 
protein(s) responsible for adenine nucleotide transport.
mitochondria. They have successfully demonstrated that
The main reasons for this are;
(a) its affinity for its substrate? P^? is neither 
very high (Km 1-2 mM) nor very specific since 
other proteins and phospholipids can also exhibit 
an affinity for P^.
(b) -SH group reagents are not very specific; however? 
the strong affinity of the transporter for mercurials
■ ‘ is noteworthy.
 _ ■ r h/.
isfaction of the third criterion , i.e. the reconstitution of the
protein(s) responsible for phosphate transport in mitochondria 
is clearly difficult in view of these uncertainties.
A complete understanding of the phosphate carrier as 
well as the adenine nucleotide translocase? which in terms 
of amount probably constitute two of the main membrane
/
transport systems in aerobic eukaryotic organisms? would 
provide an excellent model system for the investigation of 
ion transport across biological membranes.
Successful reconstitution experiments involving the 
purified protein may provide an insight into the mechanism 
whereby the free energy? supplied through the respiratory 
chain? is used for ATP synthesis? and what chemical groups 
are involved in the fixation and translocation of hydrogen 
ions released by the respiratory chain.
The data generated from amino acid composition and 
sequencing studies may provide a molecular link between 
phosphate transport and ATP synthesis? which Houstek jet al - 
(l98l) have already suggested by demonstrating that the DCCD- 
reactive protein often isolated in association with the 
mitochondrial ATP synthase (M^ 33 000) is identical with the 
phosphate carrier.
AIMS AND SCOPE OF THIS THESIS:
Two important mitochondrial proteins were chosen? 
namely the pyruvate dehydrogenase multienzyme complex and 
the phosphate transport protein? to investigate the relation­
ship between protein structure and function. Each aspect 
of this investigation necessitated the production of high- 
titre monospecific antisera directed against each protein.
(a) Pyruvate dehydrogenase complex:
(i) to investigate the distribution of PDC activity 
within the matrix-inner membrane compartment.
(ii) to probe the nature of the enzyme’s association 
with the inner mitochondrial membrane.
(iii) to determine if PDC is associated exclusively
with a specific region of the respiratory chain.
.(b) Phosphate transport protein:
(i) to investigate the biosynthesis of nuclearly— 
encoded protein.
(ii) to probe the intramembrane organisation of PTP? 
which? in view of its role in P^/OH exchange 
' would be expected to be transmembraneous and 
contain accessible domains on both matrix and 
cytoplasmic faces of the inner membrane.
CHAPTER TWO 
MATERIALS AND METHODS
2.1 MATERIALS
2.1.1 Chemicals and biochemicals
Acetyl CoA? p-amino benzamidine? benzamidine-HCl? 
Coomassie Brilliant Blue R-250? CHAPS? digitonin? DTNB?
2?4 DNP? DOC? EGTA? guanidine-HCl? iodoacetamide? leupeptin? 
malic acid? mannitol? MOPS? NAD+? NEM? oxaloacetic acid? 
2-oxoglutaric acid (monosodium salt)? pyruvic acid (monosodium 
salt)? PMSF? 1?10 phenanthroline? TEMED? and Tween 20 were 
purchased from Sigma Chemical Co.? Poole? Dorset? U.K.
DMSO? DTT? PPO? sucrose and toluene were obtained 
from Koch Light Laboratories Ltd.? Colnbrook? Berks.? U.K..
ATP? CoA (trilithium salt) and Tris were the products 
of Boehringer Corporation (London) Ltd.? Lewes? East Sussex? 
U.K..
Acrylamide? L-cysteine-HCl? EDTA? Folin Ciocalteu’s
Phenol Reagent? N?N-methylenebisacrylamide and SDS were
obtained from BDH Chemicals Ltd.? Poole? Dorset? U.K.
DMSI was generously donated by Professor J.R. Coggins
of this Department. FCCP was the gift of Dr P.G. Heytler?
E.I. Du Pont De Nemours and Co. (inc)? Delaware? U.S.A.
TMIodogen was purchased from Pierce and Varriner? Chester? 
(U.K.) Ltd.? 2-mercaptoethanol was supplied by Riedel-de- 
Ha8n? via A. & J. Beveridge Ltd.? Edinburgh? U.K.. Pyronin 
Y was obtained from George T. Gurr Ltd.? London SW6? U.K.•. 
Salicylate (sodium salt or free acid) came from Aldrich 
Chemical Co.? Gillingham? Dorset? U.K.. Triton X-100 was 
bought from Robson & Haas (U.K.) Ltd.? Croydon? U.K.
All other chemicals were of analytical grade or of 
the highest available purity.
2.1.2 Radiochemicals
N- j^Et-2-3Hj Ethylmaleimide (50 Ci/mmol) was purchased
from New England Nucleur, Southampton, U.K.. N- |jEt-2,3-^cJ
Ethylmaleimide, (10 mCi/mmol), L- [35s] methionine (approx.
1200 Ci/mmol) and jj9,10(n)-^Hj palmitic acid (55 Ci/mmol)
were supplied by Amersham International p.I.e., Bucks.,
125U.K.. Na I , carrier free, was obtained from the Western 
Infirmary, Glasgow, U.K.•
2.1.3 Chromatography materials
Celite (Type 535) was from Serva via Uniscience, 
Cambridge, U.K.. Biogel Hydroxyapatite was supplied by 
Bio-Rad Laboratories, Holywell Industrial Estate, Watford, 
Herts., U.K.. Sephadex G-25 and Superose 12 were the 
products of Pharmacia (G.B.) Ltd., Milton Keynes, Bucks.,
U.K..
2.1.4 Proteins and enzymes
The following commercial enzyme and protein preparations 
were purchased from Sigma Chemical Co., Poole, Dorset, U.K.
Aldolase (EC 4.1.2.13) from rabbit muscle, BSA 
(essentially fatty acid and globulin free), TLCK-treated 
a-chymotrypsin (EC 3*4.21.4) from bovine pancreas, clostripain 
(EC 3*4.22.8) from Clostridium welchi, citrate synthase 
(EC 4.1.3*7) from porcine heart, elastase (EC 3*4.21.11) 
from porcine pancreas, fumarase (EC 4.2.1.2) from porcine
heart, papain (EC 3*4.22.2) type (ill) from Papaya latex, 
Provlase E type (XIV) from Streptomyces griseus, protein A- 
Sepharose CL-4B, protein A from Staphylococcus aureus,
Cowan I strain, TPCK-treated trypsin (EC 3*4.21.4) type 
(XII) from bovine pancreas.
Diaphorase (lipoamide dehydrogenase) (EC 1.8.1.4) 
from porcine heart and protease K (EC 3*4.21.4) type (Xl) 
from Tritirachium album was obtained from Boehringer 
Corporation (London) Ltd., Sussex, U.K.•
Electrophoresis calibration kit for low proteins 
was purchased from Pharmacia (G.B.) Ltd., Milton Keynes, 
Bucks., U.K..
2.1.5 Cell-culture materials
Glasgow-modified Eagle's medium and L-glut amine (200 mM 
were purchased from Flow Laboratories Ltd., Irvine, Ayrshire 
U.K. .
Glasgow-modified Eagle's medium without L-methionine 
and L-glutamine, myo-clone foetal calf serum, new born 
calf serum, MEM non-essential amino acids (lOOx), sodium 
bicarbonate solution (7• 5 i° (w/v ))* trypsin ((lOx, 2.5$
(w/v)) and Nunc, sterile Roux flasks and petri-dishes
were obtained from Gibco Europe Ltd., Paisley, Renfrewshire,
U.K..
Sterile glassware and the following sterile solutions 
were provided by the staff of the Wellcome Tissue Culture 
Unit associated with this departments-
Penicillin/Streptomycin
penicillin 10 000 000.00 U
streptomycin 10; g
distilled water to 1 litre
Sterilise via Millipore filtration. Store at -20°C 
in 10 ml aliquots.
Versene
NaCl 80.00 g
KC1 2.00 g j
Na^HPO^ 11.50 g !.
KH2P0^ 2.00 g
Versene (EDTA) 2.00 g
phenol red
(lfo (w/v) ) 15*00 ml
distilled water to 10 litres.
Sterilise by autoclaving. Store? in small batches? 
at room temperature.
2.1.6 Biological materials
BRL (rat liver)? NBL-1 (bovine kidney) and PK-15 
(pig kidney) cell lines were supplied by Flow Laboratories 
Ltd.? Irvine? Ayrshire? Scotland. Bovine hearts were 
obtained from Paisley Abbatoir? Sandyford Road? Paisley- 
Bovine hearts were removed from the animals within 1 h 
of slaughter? chilled immediately on ice and used in the 
laboratory within 2 h of slaughter. New Zealand ‘White 
Rabbits and 150-350 S female rats (Albino Wistar strain) 
were provided by the departmental animal house.
2.1*7 Photographic materials 
TM
Hyper-Film -MP was supplied by Amersham International 
p.l.c.? Bucks.? U.K. X-Omat S and XAR-5 X-ray films?
Kodak? FX-40 liquid fixer and Kodak LX-24 X-ray developer 
were purchased from Kodak Ltd.? Manchester? U.K..
2.1.8 Miscellaneous
Cronex ’Lightening-Plus1 intensifying screens were 
purchased from Du Pont (U.K.) Ltd.? Stevenage? Herts.?
U.K.. Ecoscint Scintillation Fluid is the product of 
National Diagnostics? Somerville? New Jersey? U.S.A.
Freund’s Adjuvants (complete and incomplete) were supplied 
by Difco Laboratories? West Moseley? Sussex? U.K.. Heat 
inactivated horse-serum was obtained from Gibco Europe 
Ltd.? Paisley? Renfrewshire? U.K.• Nalgene sterilisation 
filter units? type S (115 ml? 0.2 p,m pore size) were from 
Nalge Company? Rochester? New York? U.S.A. Nitrocellulose 
paper (0.45 pore size) was the product of Schlercher 
and Schflll? Dassel? West Germany. Normal rabbit serum came 
from the Scottish Antibody Production Unit? Law Hospital? 
Carluke? Lanarkshire? U.K. .i Pansorbin (standardised 10^ 
(w/v) formalinised Staphylococcus aureus cells) was supplied 
by Calbiochem-Behring Corp.? Bishop Stortford? Herts.? U.K.. 
Plast-X cassettes? for exposure of X-ray films were obtained 
from Anthony Monk (Eng.) Ltd.? Sutton-in—Ashfield? U.K. •
2.2 METHODS
2.2.1 Protein determination
Protein concentration was determined by using the 
method of Lowry et al. (l95l) as described by Markwell ejb al.
(1978) using BSA as a standard.
The following stock solutions were prepared:- 
Solution A : 2$ (w/v) Na^CO^? 0 •h fo (w/v) NaOH? 0 , l 6 f o  (w/v)
sodium tartrate and 1 fo (w/v) SDS.
Solution B s kfo (w/v) CuSO^ • 5H20
Solution C : 100 parts A mixed with 1 part B.
BSA Stock: 1 mg/ml BSA stock stored at —20°C.
Folin Ciocalteu1 sphenol reagent: diluted 1:1 (v/v) with
distilled water on day of use.
A sample volume of 1.0 ml containing 10 - 100 p,g 
protein was mixed with 3«0 ml of solution C and at room 
temperature for 10-60 min. Samples were then mixed vigorously 
with 0.3 ml of diluted phenol reagent and incubated at room 
temperature for a further 45 min. before the absorbances at 
660 nm were read.
Alternatively? where appropriate? the Biuret method 
(Gomall jet al• ? 1949) was employed. Stock solutions were 
prepared as follows:-
Biuret Reagent: 3 mM CuSO^? 5H20? 10 mM NaK C^H^O^* 4H20?
0.6# (v/v) NaOH, 6 mM KI.
BSA Stock: 10 mg/ml BSA stored at -20°C.
A sample volume of 0.5 ml containing 100 y,g - 5 mg protein 
was mixed with 2.0 ml of Buiret reagent and incubated for 15 min. 
at room temperature before the absorbance was read at 540 nm.
2.2.2 Enzyme assays
(a) Citrate Synthase
Citrate synthase activity was assayed as described by 
Srere (1969)* The assay involves measuring the appearance 
of the free sulphydryl group of the released CoA using DTNB. 
The reaction is monitored at 412 nm where the resultant 
mercaptide absorbs strongly ( E ^ 2 -**3 600).
Assays were followed at 25°C by adding in this order? 
200 pi of 0.5 M. Tris-HCl, pH 8.0; 200 pi of 0.5 mM DTNB;
100 pi of 3 mM acetyl-CoA; distilled water and enzyme to 
0.9 ml. The initial change in absorbance at 412 nm is 
measured to check acetyl CoA deacylase activity. 100 pi 
of 5 mM oxaloacetate was added to start the reaction and 
the change in absorbance at 412 nm was followed once more.
1 unit of activity is defined as the amount of enzyme 
required to release 1 pmole CoA per min. at 25°C.
(b) Fumarase
Fumarase was assayed using a modification of the method
of Racker (l950)«
The reaction mixture was made up as follows
336 mg of L-malic acid was dissolved in approximately 40 ml
of 0.1M potassium phosphate buffer? pH 7*6. The pH was
readjusted to 7*6 with approximately 5 ml of 2N NaOH before
the volume was finally adjusted to 50 ml with 0.1M potassium
phosphate buffer? pH 7*6.
0*97 ml of the reaction mixture was placed in a cuvette
and the reaction initiated by following the appearance of
fumarate? which absorbs at 240 nm due to the presence of a
carbon-carbon double bond (E?-^  2.44).' 1 cm 240 nm '
(c) 2-Oxo acid dehydrogenase complexes
The overall activities of pyruvate dehydrogenase and 
the 2-oxoglutarate dehydrogenase complexes were assayed 
according to the method of Danson ejfc al. (1978). The 
following stock solutions were employed in the assay:- 
Solution A : 30 mM potassium phosphate buffer? pH 7*6
containing 3 mM NAD+? 2 mM MgCl^? and 0.2 mM TPP. 
The pH was adjusted to 7*6 with KOH as required. 
Stored? in 10 ml batches? at -20°C.
Solution B : 130 mM L-cysteine-HCl containing 6.8 mM ^a2
CoAsH.
Solution C : 100 mM 2 oxo-acid.
The reaction mixture included 670 pi of solution A?
14 pi of solution B and 14 pi of solution C. This mixture 
was pre-incubated at 30°C for 2 min. and the reaction was 
initiated by the addition of approximately 2 pg of enzyme.
The production of NADH was followed at 340 nm.
1 unit of activity (katal) is defined as the amount of 
enzyme required to catalyse the conversion of one mole of 
substrate per second under the conditions of the assay.
2.2.3 Polyacrylamide gel electrophoresis (SDS-PAGE)
2.2.3*1 Tris-Glycine buffered system
(a) Analytical gels
SDS-PAGE was carried out using the discontinuous buffer 
system of Laemmli (1970). The following stock solutions 
were prepared:-
Solution A : 3«0M Tris-HCl, pH 8.8, containing 0.25% (v/v )
TEMED.
Solution B : 28% (w/v) acrylamide containing 0*733% (w/v)
N,N’-methylenebisacrylamide, deionised using
Amberlite IRA-^00.
Solution C : 0.1M Tris-HCl, pH 6.8 containing 0.8% (w/v)
SDS and 0.25% (v/v) TEMED.
Reservoir 25 mM Tris base containing 192 mM glycine and 
Buffer:
0.1% (w/v) SDS. The pH of this buffer should 
be 8.3 »
Gels were cast in our own, home-made apparatus in 
glass slabs of 19*0 cm x 9*5 cm. Spacers were made of teflon 
and were 0.15 cm thick. The Bio-rad Protean 16 cm apparatus 
was used if longer gels were required. The dimensions of 
these gels were 18.0 cm x 14.0 cm x 0.15 cm.
Resolving gels of the required percentage were prepared,
from the above stock 
table:-
solutions, according to the following
Percentage acrylamide
7.5% 10% 12 . 3$
Solution A 25.0 25.0 25.0
Solution B 52.9 71.5 89.3
Solution C 1.0
O•H O•H
Distilled water 118.6 100 82.2
(all volumes in the table are in ml.)
These solutions were mixed in a Buchner flask, degassed 
and 150 mg of ammonium persulphate was added to initiate 
polymerisation. The mixture was degassed again before 
being poured into the casting apparatus. The resolving 
gels were overlaid with isopropanol.
Stacking gels were generally of 5*3% (v/v) acrylamide 
and made from the stock solutions as follows: 17•5 ml of
solution B, 10.0 ml of solution C and 55*0 ml of distilled 
water. As before, polymerisation was initiated with the 
addition of 150 mg of ammonium persulphate following degassing. 
To facilitate well formation, polymerisation was allowed to 
occur around a teflon template.
(b) Preparation of samples for SDS-PAGE and conditions for 
electrophoresis
Samples of protein were prepared for electrophoresis by 
boiling for 3 min. in Laemmli sample buffer (62.3 mM Tris-HCl, 
pH 6.8, containing 2% (w/v) SDS, 10% (w/v) sucrose and 0.1% 
(w/v) pyronine Y) containing either 5% (v/v) 2-mercaptoethanol 
or 10 mM DTT. Following boiling, iodoacetamide was added 
to 0.1M. Electrophoresis was carried out at 50 mA until the 
dye front was within 0.5 cm of the bottom of the gel.
(c) Staining and scanning of polyacrylamide gels
Protein bands were detected by immersing the gels in 
a solution of:-
(i) 0.0kfo (w/v) Coomassie Brilliant Blue R. 230 in 25%
(v/v) isopropanol, 10% (v/v) acetic acid for l6-20h 
followed by destaining in 10% (v/v) acetic acid.
or (ii) 0.1 $ (w/v) Coomassie Brilliant Blue R. 250 in 
50$ (v/v) isopropanol? 10$ (v/v) acetic acid 
for lh followed by destaining in 20$ (v/v) 
methanol? 10$ (v/v) acetic acid.
Destained polyacrylamide gels were scanned using an LKB 
2203 Ultrascan Laser Densitometer.
(d) Determination of M _^ values from SDS-polyacrylamide gels 
Apparent values were calculated with reference to 
the mobility of a set of standard marker proteins which 
included:- phosphorylase b? 92 000; BSA? 67 000; ovalbumin? 
45 000; carbonic anhydrase? 30 000; trypsin inhibitor? 21 000 
and a-1actalbumin? 14 000.
2.2.3*2 Phosphate buffered system
(a) Preparation of gels (5*0$ (w/v) acrylamide)
The following stock solutions were used.
Solution A : 1M sodium phosphate buffer? pH 6.5* This was
prepared by dissolving 81.Og NaH^PO^/l and
59-3g NaH2P0^/l. The pH was checked and adjusted
as required.
Solution B: 20$ (w/v) SDS.
Solution C: Acrylamide: bisacrylamide solution: 28$ (w/v)
acrylamide containing 0 .735$ (w/v) N 1-N1-methyl-
enebisacrylamide.
Solution D: Running buffer: a solution of 0.1M sodium
phosphate buffer? pH 6.5* containing 0.1$ (w/v) 
SDS.
A solution was prepared containing 35 ml acrylamide: 
bisacrylamide stock (c); 1^1 ml distilled water; 20 ml 1M
sodium phosphate buffer? pH 6.5? (a); 1 ml 20$ (w/v) SDS
solution (b); 100 p.1 TEMED. This solution was degassed 
prior to the addition of 150 mg of ammonium persulphate to 
initiate polymerisation. The degassing procedure was 
followed? as before. The gels were cast in slabs using the 
apparatus described in Section 2.2.3*la. Again? teflon 
templates were utilised to allow well formation. As before? 
the gels were stored at k ° C  and generally used within one 
week.
(b) Preparation of samples for SDS-PAGE and conditions for 
electrophoresis
Protein solution was mixed in the following buffer:- 
0.23 ml 20$ (w/v) SDS; 30 V-l 2—mercaptoethanol; 1.0 ml 
glycerol? 30 V-l 1M sodium phosphate buffer? pH 6.3? 0.1 ml 
of 0*3$ (w/v) pyronin Y in a final volume made to 3 ml 
with distilled water. Protein samples were mixed in at least 
an equal volume of the dissolving buffer. Samples were 
prepared for electrophoresis by boiling in the above sample 
buffer for 3 min. Gel electrophoresis was performed
at 80 mA until the dye-front was within 0.3 cm of the bottom 
of the gel.
Conditions for staining and destaining of gels were 
as detailed in Section 2.2*3«lc. Apparent values were 
determined as Section 2.2.3*Id.
2*2*4 Gel filtration
Gel filtration was performed on the Pharmacia FPLC 
System and using a pre-packed Superose 12 column supplied 
by Pharmacia* I am grateful for the expert assistance of 
Mr J. Neagle in operating this system*
Apparent determination was carried out by comparing 
the retention time of standard proteins supplied by 
Boehringer—Mannheim and including:
BSA? 67 000; ovalbumin? 44 000; soya bean trypsin inhibitor? 
21 000 and cytochrome C? 12 300*
2.2*3 Radiolabelling techniques
(a) Iodination of protein A and standards
Protein A and standards were iodinated using the
TMsolid phase oxidising agent? Iodogen ? as described by
Salacinski _et al. (1981).
TM1 mg of Iodogen was dissolved in 0*3 ml of chloroform 
and coated onto the surface of a vial by blowing off the 
chloroform under an air current. Protein A (l mg) or 
standards (378 /p,g) dissolved in 0*3 ml of 20 mM Tris-HCl?
pH 7*2? containing 0.13M NaCl was added to the vial coated
TM 125in Iodogen together with 300-500 pCi of Nal • Iodination
was allowed to proceed for 13 min before the reaction was
stopped by removing the sample and applying it to a 8.0 cm x
1*3 cm Sephadex G-23 column equilibrated in 20 mM Tris-HCl?
pH 7*2? containing 0.13M NaCl. Void volume fractions? of
125approximately 1.0 ml? containing I -labelled protein A
were collected? pooled and divided into small aliquots
6 ocontaining 3 x 10 c.p.m.. Aliquots were stored at —20 C.
1 h-(b) Modifying PDC with N- (Et-2, 3- C ) ethylmaleimide
Thiol groups of* PDC were labelled with N-(Et-2,3^C) 
ethylmaleimide as follows
100 pg of* purified PDC was precipitated in 4 volumes 
of acetone for several hours at -20°C. The resultant pellet 
was resuspended in 200 pi of 20 mM Tris-HCl, pH 7«2, 
containing 2$ (w/v) SDS. To facilitate the incorporation of 
label into each of the five constituent bands, the complex 
was pre-incubated for 2 min with a final concentration of 
2 mM pyruvate. 2 pCi of N- (Et-2 , ethylmaleimide was 
then added to the reaction mixture. The reaction was allowed 
to proceed for 30 min at 30°C before being terminated by 
the addition of 2-mercaptoethanol to a final concentration 
of 5$ (v/v )* Labelled protein was precipitated in acetone 
as before. The pellets were washed once in 80$ (v/v) cold 
acetone, dried and resuspended in 20 mM Tris-HCl, pH 7*2, 
containing 2$ (w/v) SDS. A 2 pi aliquot of this solution 
was counted and the radiolabelled protein was stored in 
small aliquots at —20°C.
2.2.6 Detection of radioactivity
1 2 ^
(a) Measurement in samples radiolabelled with I was 
determined by counting in an LKB Wallac 1275 mini gamma 
counter.
(b) Liquid scintillation spectrometry
Aqueous samples of total volume 0*5 ml were either (i) 
made up to 5*0 nil with 0*5$ (w/v) PP0 and 35$ (v/v ) Triton 
X—100 in toluene or (b) made up to 5*0 ml with Ecoscint 
Liquid Scintillation Fluid and counted in a Beckman LS6800 
Liquid Scintillation Counter.
(c) Autoradiography
125Autoradiography was employed to visualise I-labelled 
proteins in polyacrylamide gels or on nitrocellulose paper.
The nitrocellulose paper was dried at room temperature and 
the gels dried under vacuum before being exposed to either 
X-Omat-S-X ray film or Hyper-Film^-MP at -70°C with a 
Cronex ’Lightening Plus1 intensifying screen to enhance 
autoradiographic detection (Laskey & Mills, 1977)•
(d) Fluorography
Gels for analysis using fluorography were stained in 
Coomassie-Blue as outlined in Section 2.2.3«lc, or fixed 
in 25$ (v/v ) methanol, 10$ (v/v) acetic acid before processing 
with DMSO-PPO, as detailed by Bonner and Laskey (l97^)« Gels 
were incubated for 3 x 30 min in DMSO, then for 3-^ b with 
20$ (w/v) PPO in DMSO and finally for 1-2 h under running
water before being dried under vacuum. Gels were thereafter
TM oexposed to Hyper-Film - MP at -70 C.
This method was latterly superceded by that of Chamberlain
(l979)» Gels were stained or fixed (as above) then washed
for 30 min in 2-3 changes of distilled water to remove all
traces of acid. Prior to drying the gel and exposure to
X-ray film, the gels were incubated for 30 min at room
temperature in 1M salicylate.
2.2.7 Tissue culture
(a) Medium
PK-15 cells were routinely grown in Glasgow-modified 
Eagle’s medium supplemented with 5$ (v/v) foetal calf serum,
1$ (v/v) non-essential amino acids, 10 U/l penicillin,
100 mg/l streptomycin and 7• 5$ (w/v ) NaHCO^ (normal growth 
medium)*
BRL and NBL-1 cells were grown in the above medium 
containing 10$ (v/v) new born calf* serum and 10$ (v/v) 
foetal calf serum, respectively.
Minus methionine medium (MMM) consists of Glasgow 
modified Eagle's medium (without L-met or L-glu) supplemented 
with 1$ ( v/v) non-essential amino acids, 2 mM glutamine,
10 U/l penicillin, 100 mg/l streptomycin and the appropriate 
serum type at the concentration described above.
Low methionine medium (LMM), used during the incorporation 
of I > ]  methionine with cellular protein, was 5$ (v/v )
NGM in minus methionine medium.
(b) Routine culture of cells
2Cells were grown in normal growth medium in 175 cm 
plastic Roux batches at 37°C in an atmosphere of 95$ (v/v ) 
air/5$ (v/v) 00^. Cells were subcultured on reaching 
confluency i.e. every 3-^ days.
Monolayers were rinsed twice with versene solution 
(Section 2.1.5) *  once with trypsin prior to an incubation 
at 37°C with sufficient trypsin to cover the monolayer. On 
release of the cells from the plastic surface 20 ml of NGM 
was added and the cells transferred to a sterile universal.
The cells were disaggregated to a single cell suspension by 
gentle passage up and down sterile pipettes of decreasing 
bore size. Cells were counted in a haemocytometer and 
3-5 x 10 cells/ml were returned to the Roux flask in 
approximately 50 nil NGM.
(c) Labelling of cells with |_~^ sj methionine
For the incorporation of [35S] methionine into protein, 
cells were seeded into 10 cm diameter sterile petri-dishes 
and a cover of 3 x 10^ cells/ml in 10 ml of NGM. The cells 
were then incubated at 37°C in a humidified incubator 
containing an atmosphere of 95$ (v/v ) air/5$ (v/v) CO^ for 
24-48 h i.e. until the cells achieved semi-confluency. NGM 
was replaced with 4 ml of LMM following an initial rinse in 
this medium. To deplete the intracellular methionine pools, 
the cells were incubated in this medium for 90 min. prior 
to the addition of 100-200 pCi of methionine. Petri-
dishes were incubated at 37°C for either 4 h or overnight 
prior to lysis and the preparation of extracts as described 
in Section 2.2.8b.
(d) Labelling of cells with methionine in the presence
of uncouplers of oxidative phosphorylation
Replicate dishes of cells cultured in NGM as before, 
including the pre-incubation with LMM for 90 min prior to 
the addition of 4.0 ml of LMM containing either uncoupler 
added from freshly-made stocks of 200 mM DNP or 1 mM FCCP 
(final concentration of 2 mM and 10 pM respectively). 
Incubation was for 5-10 min at 37°C prior to the addition of 
200 pCi of methionine. Cell lysates were prepared
(Section 2.2.8b) following a 4 h incubation at 37°C as 
described previously.
2.2*8 Preparation of* cell extracts and subfractions of cells
(a) Isolation of mitochondria from tissue culture cells
Mitochondria were prepared from cultured cells following
the procedure of Attardi and Ching (1979) starting from
8approximately 2 x 10 cells. All procedures were carried 
out at 4°C.
Cell monolayers were rinsed? harvested into approximately 
40 ml of ice cold PBS (20 mM potassium phosphate buffer? 
pH containing 0.15M NaCl) and centrifuged for 10 min
at 800 x g.The cells were washed twice in 0.13M NaCl 
containing 3 mM KC1 and 1 mM MgCl^ before being resuspended
in 6.0 ml of 10 mM Tris-HCl? pH 6.7* containing 10 mM KC1
and 0.15 mM MgCl^. Homogenisation was carried out in a 
Potter-El venhjem teflon-glass homogeniser at half maximal 
speed for 3 strokes. Cell breakage was monitored under a 
light microscope. On addition of 0.25M sucrose the solution 
was centrifuged at 1500 x g to remove nuclei. Mitochondria 
were pelleted from the supernatant fluid by centrifugation 
at 5000 x g for 10 min. The resultant pellets were resuspended
in 2.0 ml 10 mM Tris-HCl? pH 6.7* containing 0.15 mM MgCl^
and 0.25M sucrose. Mitochondria were washed by repeating 
the last two centrifugation steps. Prior to determining 
the protein concentration by the modified Lowry procedure 
(Section 2.2.1) the remaining mitochondria were resuspended 
in 1.0 ml of 10 mM Tris-acetate? pH 7*0? containing 0.25M 
sucrose.
(b) Preparation of cell lysates from L Si methionine 
labelled cells 
The following standard solutions were prepared and 
sterilised by passage through a Nalgene filter unit (pore 
size 0*2 pm) :-
PBS: 20 mM potassium phosphate buffer, pH 7*^ ->
containing 0.15M NaCl.
Triton-TKM: 100 mM Tris-HCl, pH 8.2, containing 100 mM
KC1, 5 mM MgCl^ and 1 °/o (v/v) Triton X-100.
3D-Lysis Buffer: 100 mM Tris-HCl, pH 8.2, containing 100 mM
KC1, 3 mM MgCl^* 1# (v/v) Triton X-100,
1$ (w/v) SDS and 2fo (w/v) DoC.
All solutions were supplemented with 1 mM benzamidine- 
HC1, 1 mM 1,10 phenanthroline and 1 mM PMSF immediately before 
use. All procedures were carried out at 4°C. Cell monolayers 
were washed three times in ice-cold PBS before being harvested 
into 1.0 ml of Triton-TKM buffer. Low speed centrifugation 
(1000 x g for 5 min) removed the nuclei. The supernatant 
fraction was diluted 1:1 (v/v) with 3H-lysis buffer prior to 
centrifugation at 2h 000 x g for 30 min to remove any 
remaining cellular debris. Lysates were used immediately 
for immune precipitation and stored at -70°C until required.
2.2*9 Preparation and subfractionation of mitochondria
(a) Preparation of rat liver mitochondria
Mitochondria were prepared from rat liver according 
to the method of Chance and Hagihara (1963)* The following 
isolation medium was used throughout the preparation:-
20 mM MOPS, pH 7*2, containing 0.223M mannitol, 0.073M 
sucrose and 0.05 mM EGTA. All procedures were carried out 
at 4°C.
Starved female rats of the Wistar strain (130-330 s )  
were killed by cervical dislocation. Livers were removed 
and washed free of blood using cold isolation medium before 
being chopped finely using scissors. Initial homogenisation 
was carried out in Potter-Elvenhjem homogeniser with a 
loose-fitting teflon pestle. (2 passes at maximal speed) 
to facilitate tissue breakdown. Cell disruption was caused 
by homogenisation using a tight-fitting teflon pestle (5 
passes at setting 3 t clearance 0.006-0.008 in. If 
mitochondria were being prepared in bulk, i.e.35“^0 rats, cell 
breakage was effected by blending for 13 secs at high speed 
in a Waring Blender. The homogenate was centrifuged at 
800 x g for 7 min to remove nuclei, red blood cells and 
cellular debris. Mitochondria were collected from the 
supernatant fraction by centrifugation at 6,300 x g for 13 min. 
The resultant pellets were washed twice in half the initial 
volume of isolation medium and again the mitochondria were 
collected by centrifugation as previously described. A 
low speed centrifugation step (800 x g for 7 min) may be  ^ -
included prior to the final wash if red blood cells remain 
with the mitochondrial fraction. The final pellet was 
stored at -20°C until required or if further purification 
was required the mitochondria were resuspended in isolation 
medium at a final concentration of 20 mg/ml.
Isolated mitochondria were farther purified on a 
discontinuous sucrose density gradient prepared as follows;-
4.0 ml 54$ (w/w) sucrose in 10 mM Tris-HCl, pH 7«5
10*0. ml 45$ (w/w) sucrose in 10 mM Tris-HCl, pH 7*5
10#0 ml 39$ (w/w) sucrose in 10 mM Tris-HCl, pH 7»5
6.0 ml 20$ (w/w) sucrose in 10 mM Tris-HCl, pH 7«5*
The gradients were centrifuged at 49 000 g for 2 h in
a Beckman SW27 rotor.
Following centrifugation 3 bands were visibles the
O
upper band of density 1.16 g/cm consists principally of 
microsomes and plasma membrane; the intermediate band of 
density 1.19 g/cm is composed of purified mitochondria,
O
the lower band of density 1.22 g/cm is composed mainly of 
lysosomes with some mitochondrial contamination. Mitochondria 
harvested from the gradient were diluted slowly in isolation 
medium and centrifuged at 6 $ 0 0 x g for 10 min to remove 
the sucrose and collect the mitochondria.
(b) Preparation of bovine heart mitochondria
Bovine heart mitochondria were prepared according to
the method of Smith (1967)*
Bovine hearts were removed from the animals within an
hour of slaughter, chilled immediately on ice and used within
two hours of slaughter. After trimming off fat and connective
tissue, the heart was cut into 5 cm cubes, 300 g of which
was passed through a mincer. Minced tissue was placed in
400 ml of 10 mM Tris-HCl, pH 7*8, containing 0.25M sucrose
+and the pH was adjusted to 7*5 — 0*1 using 2M Tris base.
After neutralisation, the ground tissue was placed in 
cheese-cloth, squeezed free of blood, then resuspended 
in 400 ml of 10 mM Tris-HCl, pH 7*8, containing 0.25M 
sucrose, 1 mM Tris-succinate, 0.2 mM EDTA (sucrose solution).
3 ml of 2M Tris base was added to maintain the correct pH 
and the material was blended at high speed for 15 sec in
a Waring Blender. A further 3 ml of 2M Tris base was added
and blending continued for a further 5 sec. The pH of the
solution was further adjusted to 7*8 with 2M Tris base and
the suspension homogenised using a Potter-Elvenhjem 
homogeniser with a loose-fitting teflon pestle (3 passes 
at high speed). The homogenate was centrifuged at 1000 x g
for 15 min. The supernatant fluid was centrifuged at 5 000 x S
for 30 min. The resultant pellet was washed once or twice 
more in.the sucrose solution. Unless required immediately, 
the mitochondria were frozen at -20°C as pellets.
(c) Preparation of bovine heart submitochondrial particles 
Bovine heart mitochondria were resuspended in sucrose 
solution (Section 2.2«9b) before being sonicated for 3 x 15 sec
using an MSE sonicator (high amplitude and setting 3)*
Unbroken mitochondria were removed by centrifugation at 6 $ 0 0 x g 
for 7 min, the supernatant fluid removed and the pellet 
resuspended in 3 ml of sucrose solution before being sonicated, 
as before. This procedure was repeated until none of the 
mitochondria remained intact. The broken mitochondria were 
distributed equally to Beckman Ti 50 centrifuge tubes and 
centrifuged at 100 000 x g for 1 h. The resultant extract, 
which is composed primarily of matrix components, was discarded
unless required and the pellet? essentially the inner
? .
mitochondrial membrane? was washed several times in _20jiM [  L K
potassium phosphate buffer? pH This fraction (bovine
heart submitochondrial particles) was frozen at -70°C in 
small aliquots and a protein concentration of 16 m g /m l until 
required*
2*2*10 Purification of the phosphate-hydroxyl ion antiport 
protein from bovine heart and rat liver mitochondria 
This method is essentially that of Kolbe eX al* (1981) 
employing1 the modification of Gibb et_ al. (1986).
Mitochondria? prepared as described in Sections 2*2*9 a  
and 2.2*9h? were allowed to thaw slowly at room temperature 
before being resuspended in 0*5$> (v/v) Triton X-100 buffer
(20 mM JLid? 0.1 mM EDTA, 0*5 mM DTT, 0*5# (v/v) Triton X-100
y
and 20 mM H^PO^ adjusted to pH 7*0 with LiOH) at a protein 
concentration of 10 mg/ml* This pre-extraction effectively 
removes around 9 0 $  of mitochondrial proteins* After 
centrifugation for 1 hr at 100 000 x g? the resulting pellet 
was solubilised by incubating for 15 min on ice with an 8$
(w/v) Triton X-100 buffer (as above) at a protein concentration 
of 10 mg/ml and diluted 1:1 with ice-cold
distilled water. Insoluble material was removed by centrifugati< 
and the supernatant fraction was subjected to adsorptive 
chromatography with Bio-gel hydroxyapatite (0.5 S HTP/ml of 
solubilised membrane). The sample was incubated on ice 
for 15 min before being centrifuged at 27 000 x g for 20 min. 
This step was repeated by re-extracting the pellet in k$>
(w/v) Triton X-100 buffer. The supernatant fractions were 
pooled and residual HTP removed by low speed centrifugation 
(800 x g for 10 min) prior to adsorption chromatography on 
washed Celite 535 (0*5 S Celite/ml supernatant). The 
supernatant fluid was collected and the pellet washed as 
for HTP. The pooled supernatant fractions? again? were 
clarified by low speed centrifugation. The purified protein 
was frozen at —20°C until required.
2.2.11 Immunological Techniques
(a) Immune replica technique
This protocol? which follows a modification (Batteiger 
et al.^1982) of the method of Towbin jst al. (1979)> allows
r
the immunological detection of proteins following their 
electrophoretic transfer from polyacrylamide gels to 
nitrocellulose paper.
Proteins were resolved in polyacrylamide gels (generally 
10$> (v/v) acrylamide). They were then electrophoretically 
transferred to nitrocellulose sheets? as described by Towbin 
et al. (1979). in 25 mM Tris base containing 192 mM glycine? 
0.02$  (w/v) SDS and 20^ (v/v) methanol for either 3 h at 
kOO mA or 16-20 h at 40 mA. Excess binding sites on the 
nitrocellulose were saturated by incubating for 1 h at 
room temperature in 20 mM Tris-HCl? pH 7»2? containing 0.15M 
NaCl? 0.5$ (v/v) Tween 20 and 5 mg/ml NaN^ (wash buffer).
This buffer was discarded and the nitrocellulose incubated 
for 90 min at room temperature in wash buffer supplemented 
with 0.5% (v/v) heat-inactivated horse serum and the
appropriate dilution of antiserum (generally 1:100). The
nitrocellulose membrane was then washed five times in
wash buffer over 30 min before being incubated for 60 min
125in wash buffer supplemented with I-labelled Protein A
£
(approximately 3 x 10 c.p.m.). The nitrocellulose was
washed another five times in wash buffer before being dried 
and the antigen located by autoradiography (Section 2.2.6c).
The nitrocellulose membrane may be stained for protein 
before being processed i.e. immediately following electro­
phoretic transfer, or following autoradiography. For this 
the nitrocellulose should be immersed in 0.1 $ (w/v) Amido 
Black, 50$ (v/v) methanol, 10$ (v/v) acetic acid for 2-3 min 
followed by destaining in 50$ (v/v) methanol, 10$ (v/v) 
acetic acid for 2-5 min (Schaffner & Weissman, 1973)*
(b) Purification of IgG from antisera
Approximately 5 ml antisera was extensively dialysed 
against 20 mM Tris-HCl, pH 8.0, containing 28 mM NaCl 
and 0.02$ (w/v) NaN^. The dialysed antiserum was applied 
to a DEAE-Affigel Blue column (18 cm x 1 cm) and eluted 
with the above buffer. The fractions containing IgG were 
collected, pooled and concentrated by freeze-drying. The 
resultant material was resuspended to 65$ of the original 
volume and dialysed against 10 mM Tris-HCl, pH 7*^> 
containing 0.02$ (w/v) NaN^ at 4°C. Samples of IgG were 
aliquoted and frozen at -20°C until required.
(c) Immune precipitation from methionine-labelled 
cellular extracts
The composition of the buffer containing the cell extracts
was adjusted to that of 3^-TKM by diluting 1:1 with 3D-lysis
buffer (Section 2.2.8a). Aliquots (100 - 1000 ]il) of 
cell extract containing 10 x 10 c.p.m. were incubated 
with 10-20 ill of the appropriate antiserum for 2 h at room 
temperature. At this stage 2 volumes of 10$ (v/v) Pansorbin 
was added and the incubation proceeded for 1 h to precipitate 
the antibody-antigen complexes. The resultant pellets were 
collected by centrifugation (l4 000 x g for 2 min). The 
pellets were washed 3 times in 3D-TKM buffer and once in 
10 mM Tris-HCl, pH hy resuspending the pellets in 1 ml
of the appropriate buffer and then collecting the immune 
complexes by centrifugation as above. Immune complexes were 
eluted from the surface of the S • aureus cells by boiling 
for 5 min in 50 P-l of Laemmli sample buffer containing 10 mM 
DTT (Section 2.2.3h). A 5 aliquot was counted for 
radioactivity and the remainder of the sample was analysed 
by SDS-polyacrylamide gel electrophoresis followed by 
fluorography (Section 2.2.6d).
(d) Immune precipitation of non-radiolabelled cell lysates
This method was adapted from that of Anderson and 
Blobel (1983).
The antigen, in a volume of 10-100 )il, was solubilised 
by boiling for 2 min in a final concentration of 1$ (w/v)
SDS. The suspension was then diluted with four volumes of 
dilution buffer (60 mM Tris-HCl, pH 7*6, containing 190 mM 
NaCl, 6 mM EDTA and 1.25$ (w/v) Triton X-100. This buffer 
was supplemented with 1 mM PMSF, 0.2 mM leupeptin and 1 mM 
p-amino benzamidine) • 10 p,l of non-immune rabbit ser um *
was added and the mixture was incubated overnight at 4°C.
100 p.1 of 10$ (w/v) Pansorbin was added and the 
suspension was incubated for 1 h at room temperature with 
end-over-end mixing* The cells were collected by centrifugation 
(l4 000 x g for 2 min) and 10-100p,l of specific anti serum 
was added to the supemate. After an incubation for 1 h at 
room temperature, adsorption with Pansorbin was carried out 
as before* The immune complexes were collected as previously 
described* The resultant pellet was washed three times with 
1 ml of 50 mM Tris-HCl, pH 7*3 containing 150 mM NaCl, 5 mM 
EDTA, 0*1$ (w/v) Triton X-100 and 0.02$ (w/v) SDS. A final 
wash was carried out in the above buffer in the absence of 
detergents. The antigen-antibody complex was dissociated 
from the S. aureus cells by boiling in 50 V>1 of Laemmli 
sample buffer containing 10 mM DTT (Section 2.2*3h). The 
supernatant fraction was analysed by the immune replica 
technique and autoradiography.
2.2.12 Cross-linking of proteins using dimethyl suberimidate 
Crosslinking was carried out essentially by the method 
of Coggins (l978)*
The following stock solutions were useds-
(i) TNM buffers 0.05M Triethanolamine buffer, pH 8.0,
containing 0.1M NaCl and 0.01M MgCl^
(ii) 0.4M NaOH
(iii) 2 x TNM buffers 0.1M Tri ethanol amine buffer, pH 8.0,
containing 0.2M NaCl and 0.02M MgCl^.
(iv) Dissolving buffer: 1 volume NaOH (ii) and 1 volume
2 x TNM buffer (iii).
(v) 0.1M Stock DMSI solution.
Solid DMSI was stored at -20°C. Since this material 
is very hygroscopic, stock bottles were allowed to reach 
room temperature for 1 h and were not opened for longer 
than necessary. A small amount of DMSI was transferred to 
a stoppered bottle, weighed accurately and dissolved in the 
appropriate volume of dissolving buffer (iv) to give 0.1M 
DMSI. DMSI prepared in this manner had a pH of 8.0. This 
stock solution was used within 5 min of preparation.
(a) Crosslinking of aldolase using DMSI
A sufficient volume of DMSI was added to a solution of 
aldolase (l-2 mg/ml) in TNM buffer, pH 8.0 to give a final 
DMSI concentration of 6 mM. The mixture was incubated for 
60 min. at room temperature (23-25°C) with gentle swirling. 
Crosslinked proteins were examined by SDS-PAGE using the 
phosphate buffered system (Section 2.2.3*2).
CHAPTER 3
BINDING OF BOVINE HEART PDC TO THE INNER MITO-
CHONDRIAL MEMBRANE
3.1 INTRODUCTION
There are several levels of organisation within the 
eukaryotic cell* At the structural level this is evident 
by the presence of a complex internal network of membranes 
and the existence of several types of membrane-bound 
organelles which exhibit a characteristic morphology e.g. 
the mitochondrion or chloroplast. The existence of multi­
enzyme complexes e.g. pyruvate dehydrogenase complex (PDC) 
offers the cell yet another level of compartmentation, the 
advantages of which are discussed in Section 1.2.
Until recently it was generally believed that most 
enzyme components of different metabolic pathways located 
within compartments e.g. within the cytoplasm or mitochondrial 
matrix, were randomly dispersed. Although interactions 
have been observed previously these were 
thought to be an artefact of the isolation procedure, 
primarily caused by the redistribution of structural 
components e.g. membranes. The situation within the 
eukaryotic cell has been further complicated by the existence 
of the microtubular lattice, an extensive network of inter­
connecting filaments (Wolosewik and Porter, 1979; Porter 
and Tucker, 1981). Recent studies have suggested that the 
classical soluble enzymes of the cytoplasm are not freely 
diffusable because they are associated with this structure 
(Clegg, 1984a,b). Indeed, it has been postulated that the 
subcellular distribution of some enzymes may not be invariant, 
but alter in response to the changing requirements of
the cell (Masters? 1981). For example? it has been
reported that most glycolytic enzymes are associated with
actin filaments within skeletal muscle (Clarke and Masters?
1975? Walsh afc al• ? 1981)* The extent of binding of these
enzymes and their catalytic properties are influenced by
2+a variety of factors including substrates? pH? ATP? Ca 
2+and Mg • This suggests that the enzymes1 function in vivo 
may be regulated by an interaction with structural proteins.
Studies on the organisation of enzymes within compart­
ments have been extended to those located within the 
mitochondrial matrix. In particular? Srere and coworkers 
(1974? 1978? I98O? 1982) have proposed that enzymes of the 
Krebs cycle interact? spatially? in the mitochondrial matrix 
as a multienzyme complex. This complex is proposed to 
operate functionally near? or on? the matrix side of the 
inner mitochondrial membrane.
There have been a number of conflicting reports 
concerning the association of matrix Krebs cycle enzymes 
with the mitochondrial inner membrane. Wit-Peeters afc al. 
(1971) concluded that no clear distinction could be made 
between membrane-bound and soluble enzymes but that the 
enzymes differed only in the affinity of their binding 
to this membrane. Other workers (Landriscina erfc al.? 1976) 
have reported that aspartate aminotransferase and glutamate 
dehydrogenase were isolated in a membrane-free fraction. 
Thus? early studies so far have not provided unequivocal 
evidence for or against specific interactions of matrix
proteins with the inner mitochondrial membrane? although 
these differences are thought to reflect more the variety 
of methods used than to be of any functional significance.
Early studies which attempted to demonstrate the 
existence of a high aggregate of Krebs cycle enzymes 
by either sucrose density gradient centrifugation or gel 
filtration of mitochondrial extracts were unsuccessful.
Experimental support for this hypothesis was provided 
by employing a variety of techniques to demonstrate the 
presence of a Krebs cycle complex? which Robinson and 
Srere (1985) have termed a metabolon.
(i) Studies with intact swollen mitochondria
In swollen mitochondria one would expect a reduction 
in the rate of oxidation of substrate since the mean free 
path between an intermediate and the next enzyme is increased. 
Extensive swelling of mitochondria accompanied by gross 
disorganisation of the matrix and at least a three-fold 
increase in mitochondrial volume resulted in the reduction 
of rates of respiration with NAD-linked Krebs TCA cycle 
enzymes. This reduction of rates of respiration was due 
not solely to the loss of NAD? since it did not restore 
respiration completely. Matlib and Srere (1976) suggested 
that this could be explained by the disruption of a putative 
Krebs cycle complex.
(ii) Studies with crosslinking reagents
It was postulated that if Krebs cycle enzymes interacted 
with the inner mitochondrial membrane? crosslinking with a
variety of reagents would stabilise these structures.
Indeed? disorganisation of the membrane by either sonication 
or swelling reduced the degree of crosslinking. From this 
it was concluded that Krebs cycle enzymes were preferentially 
located within the matrix next to the inner membrane.
(iii) Studies with purified enzymes
Studies with purified enzymes have demonstrated specific 
interactions between sequential enzymes in metabolic 
pathways i.e. between fumarase and malate dehydrogenase 
(Beekman and Kanarek? 1981); citrate synthase and malate 
dehydrogenase (Halper and Srere? 1977)9 and PDC with citrate 
synthase (Sumegi at al•? 1980). Immobilised enzyme systems 
of malate dehydrogenase and citrate synthase (either 
immobilised as separate enzymes or as aggregates on a solid 
support e.g. Sepharose beads) were shown to operate at a 
faster rate than the equivalent amounts of free enzymes 
(Koch-Schmidt et al.? 1977)*
Criticisms of these observations were primarily concerned 
with those interactions which had not been detected at 
physiological ionic strength. Srere (198O? I98I? 1982) 
has argued that we have no accurate assessment of ionic 
strength within the cell and since protein concentrations 
within the mitochondrial matrix are approximately 100 mg/ml? 
these interactions are possible under physiological 
conditions. Srere (198^) also argued that these interactions 
were specific for enzymes of sequential metabolic reactions.
To date? investigation of these protein:protein interactions 
has relied solely on the ability to assay for enzymic 
activity and the limitations of this approach will be 
discussed in Section 3.4.
Although commonly regarded as a soluble multienzyme 
system, there have been occasional reports which suggest 
that PDC may interact with the inner mitochondrial membrane 
(Stanley and Perham, I98O; Matlib and 0*Brien, 1975)* 
Stanley and Perham (1980) found that by including detergents 
in the initial buffers employed to disrupt mitochondria a 
three-fold increase in yield was achieved and that all of 
the assayable material was found in the soluble fraction.
In earlier procedures (Linn et al•, 1972; Cooper at al., 
197*0 no detergents were used; however, it was necessary 
to subject mitochondrial membranes to freeze/thaw treatment 
to induce the release of the enzyme. These observations 
are consistent with PDC being associated with the inner 
mitochondrial membrane.
Availability of subunit-specific antisera prompted us 
to investigate the nature of this association in a refined 
and sensitive fashion by immunological means. The major 
advantages of this approach are that it can detect (a) 
if specific components are involved in the binding to the 
inner membrane and (b) allow detection of antigens after 
washing the membrane under stringent conditions which 
cause loss of PDC activity.
\
3.2 METHODS
3.2.1 Preparation of antibodies to native PDC 
Production of high-titre monospecific antiserum
against ox heart PDC required highly-purified preparations 
of antigen. Samples of PDC (20-30 l^g) were electrophoresed 
in 10$ (w/v) SDS/polyacrylamide gels and their purity was 
estimated by densitometric scanning of the Coomassie-Blue 
stained bands. Samples judged to contain between 96-98$ 
pure PDC, were used to raise antibodies to the whole complex.
PDC (l mg), dissolved in 30 mM Mops buffer containing 
2 mM EDTA, 0.1 mM DTT, adjusted to pH 7*0 with NaOH, was 
mixed with an equal volume of Freund*s complete adjuvant.
This sample was injected subcutaneously at multiple sites 
on the neck and back of a New Zealand White rabbit. Similar 
amounts were administered at 2-3 week intervals thereafter, 
in Freund's incomplete adjuvant. Ten to fourteen days 
after the fourth injection blood was obtained from a 
marginal ear vein. Additional booster injections vrere 
administered at approximately one month intervals with 
0*3 mg of protein with Freund’s incomplete adjuvant.
Serum was collected, aliquoted in 1.0 ml fractions 
and frozen at -20°C until required.
3.2.2 Preparation of antibodies to PDC subunits
For the production of subunit-specific antisera, 
samples of PDC (approximately 2.3 mg) were resolved on 
preparative slab gels (Section 2.2.3; dimensions as for
analytical gels but gel thickness increased to 3 mm).
After staining with Coomassie Blue? protein bands were 
excised from the gels with a scalpel? diced and rinsed 
twice with water to remove solvents. The gel sections 
were frozen using liquid nitrogen before being ground 
finely using a mortar and pestle. The frozen powder was 
weighed and stored at -20°C until use. This technique 
yielded between 100-300 pg protein per gram of gel 
(Mihard and Blobel? 1980).
Before injecting into rabbits? 1 g of gel was homo­
genised in 0.3 ml of 0*9$> (w/v) NaCl with a tight fitting 
glass-teflon homogeniser. The gel slurry was mixed with 
an equal volume of Freund*s complete adjuvant and injected 
subcutaneously into a rabbit. The procedure for immunisation 
was as described in Section 3»2.1.
I am extremely grateful to Olga de Marcucci? who 
prepared and characterised these antisera.
3*2*3 Assay of mitochondrial fractions for enzyme activity 
Bovine heart mitochondria were prepared as described 
in Section 2.2*9t> and unless required immediately were
?
frozen at -20 C* The mitochondria were sonicated ( k  x 15 sec* a
high amplitude setting 3) and centrifuged at 10 000 x g
. t ' b
for 10 min to remove any intact mitochondria* The resultant
■(3
supernatant fraction was then centrifuged at 100 000 x g
- i
for 1 h to yield two fractions (a) a membrane fraction 1
which was resuspended in 50 mM potassium phosphate buffer? 
pH 7*4 and (b) a supernatant fraction* These fractions
were then assayed for PDC? fumarase and citrate synthase 
activity (Section 2.2.2)? as previously described. When 
assaying for PDC activity in the membrane fraction competing 
activities were inhibited by the inclusion of 5 P-S 
either oligomycin or antimycin A in the assay mixture.
The activity was calculated as a percentage of the total 
recorded in the sonicated mitochondrial fraction.
3.2.4 Treatment of bovine heart submitochondrial particles
Bovine heart submitochondrial particles were prepared 
(Section 2.2.9c) and either used immediately or frozen at 
-20°C until required. Equal aliquots of the membrane 
fractions were washed once in 20 mM potassium phosphate 
buffer? pH 7*4 and collected by centrifugation at 100 000 x g 
for 1 h. The pellets were resuspended in the appropriate 
solution? incubated on ice for 15 min? and again collected 
by centrifugation at 27 000 x g for 20 min. This procedure 
was repeated (x l) before the pellets were washed in 
distilled H^O. When membranes were incubated with 0.1M 
glycine buffer? pH 9*0 containing 1M NaCl? the incubation
was for 1 h at room temperature. "VKjuO '
       ’ ' ~  .....
The extract resulting from the first wash was? in each 
case? concentrated u s i n g  either aquacide or precipitated in 
4 volumes of ice-cold acetone and resuspended in 20 mM 
phosphate buffer? pH 7.4. In both samples? protein 
determination was by the method of Lowry. Samples were 
resolved on 10$ (w/v) SDS polyacrylamide gels before being 
transferred to nitrocellulose and probed with a variety of 
antisera.
3.2.5 Labelling of PK-15 cells with Pul Palmitic Acid
(a) Preparation of palmitate for labelling
1*5 mCi of 10(n) - palmitic acid was removed
to a sterile conical tube. The tube was placed within a 
water bath which was heated to 60°C. The evaporation of 
toluene from the sample was facilitated by blowing N^ over 
the surface of the liquid. "When the evaporation was 
complete? the sample was dissolved in 60 p,l of ethanol.
5 ml of filtered medium (NGM + yfo (v/v) FCS) was added to 
this and the solution was incubated at 37°C for 90 min 
before addition to the cells.
(b) Incubation of cells with [_^h] palmitate
Cells were grown in 10 cm diameter petri dishes? 
as previously described (Section 2.2*7)• On reaching 
semi-confluency? normal growth medium was removed and 
replaced with either 1 ml of NGM containing 250 p.Ci of 
[3H] palmitate or h ml of medium supplemented with 1 jiCi. 
of radiolabel. The cells were grown for 16 h in this 
medium before cell lysates were prepared as previously 
described (Section 2.2.8b).
The radiolabelled cell lysates were used for immuno- 
precipitation of [pli] labelled polypeptides. Replica 
plates of cells were employed for a control incubation 
with [_3^ sJ methionine? with the resultant lysate being 
used for the immunoprecipitation of radiolabelled poly­
peptides.
3*3 RESULTS
Preliminary studies showed that the bulk of PDC 
activity remains associated with the inner mitochondrial 
membrane under conditions which cause the release of other 
soluble enzymes into the supernatant fraction (Fig. 3«1A). 
Further analysis of this result shows that for the Krebs cycle 
enzymes, fumarase and citrate synthase, more than ^ 0 of0 o f the 
activity of the jenzymes partition into the soluble fraction 
in comparison to the 25$ recorded for PDC.
Initially these experiments were performed on frozen 
mitochondria; however, the release of proteins from membranes 
by employing freeze/thaw treatment has been well documented. 
Using freshly-isolated mitochondria and subjecting these 
to sonication demonstrates that the activity profile for 
the two Krebs cycle enzymes is essentially as before, with 
< 10$ of the total activity found in the sedimenting 
fraction (Fig. 3*IB). Comparable analysis of PDC indicates 
that approximately 10$ of the activity is soluble while 
the remainder is associated with mitochondrial membranes.
Thus, the freeze/thaw treatment employed in the initial 
study (Fig. 3*1A) where approximately 25$ of the PDC was 
solubilised appears to have facilitated, to some extent, 
the release of enzymic activity from the inner membrane. 
However, immunoblot analysis of the supernatant fraction 
allowed the detection of a small residual amount of 
succinate dehydrogenase, suggesting that any activity 
recovered in the soluble fraction, either PDC or SDH, 
may result from non-sedimenting membrane particles.
Fig. 3.1: Preferential association of PDC with the
mitochondrial inner membrane
Mitochondria were sonicated (4 x 15 secs) 
with a recovery time of 15 secs between bursts.
Intact mitochondria were removed by low speed 
centrifugation. The resultant extract was 
centrifuged at 100 000 x g for 1 h to yield a 
membraneous fraction (SMP) and a supernatant 
fraction. These fractions were assayed for PDC, 
fumarase and citrate synthase, as previously 
described. Activity was calculated as a percentage 
of the total activity found in sonicated mitochondrial 
fractions.
(A) SMP prepared from frozen mitochondria.
(b ) SMP prepared from freshly prepared mitochondria.
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The availability of high-titre? monospecific polyclonal
antisera against PDC and its constituent enzymes has
/ ~ v
allowed^uisL to investigate this preferential association of
( y
PDC with the inner mitochondrial membrane under conditions 
which lead to a rapid inactivation of the enzyme.
This point is illustrated in Figure 3«2> where 
mitochondrial membranes were washed repeatedly in the 
presence and absence of 0.15M NaCl. It is apparent that 
PDC remains membrane^associated whilst enzyme activity 
could only be recorded in those washed in the absence of 
salt. The presence of 0.15M NaCl is not known to inactivate 
the soluble enzyme? thus this result suggests that the 
higher ionic strength buffer may be removing a necessary 
co-factor from the membranes e.g. TPP. In an attempt to 
stabilise the enzyme activity? bovine heart mitochondria 
were sonicated and washed in a phosphate buffer containing 
0.1 mM EDTA? 0,5 mM DTT? 0.1 mM TPP? 0.5 mM MgCl2 and 0.15 V-M 
leupeptin. The result of this experiment is demonstrated 
in Figure 3*3* As before? PDC could be detected? immuno- 
logically? in each of the fractions? although analysis of 
the resultant extract showed that less protein had been 
released than on the previous occasion. Control enzymes? 
which as demonstrated in Figure 3*1> are readily released 
into the supernatant fluid? could be detected in the 
membraneous pellet. Immunoblot analysis (Fig. 3*3B) shows 
citrate synthase to be membrane-associated even after 
four washes in a low ionic strength buffer. These results
Fig. 3*2: Immune Blot Analysis using Anti-PDC-Serum
of Bovine Heart Submitochondrial Particles 
Repeatedly Washed in Buffers +/- 0.15M NaCl
Bovine heart submitochondrial particles were
\
prepared as previously described (2.2*9c) and washed *
 °;>
repeatedly in 50 -mM potassium phosphate buffer? pH 1 $
(a) or phosphate buffer containing 0.15M NaCl (b).
Aliquots were withdrawn following each wash and analysed 
by immunoblotting using anti-PDC-serum. Each fraction 
was also assayed for PDC activity (data not shown).
1,2?3»^ corresponds to the number of washes.
45 p,g of membrane protein loaded/track.
S = sonicated mitochondria.
c\j r. _
UJ o  ^
UJ UJ
.Q
CD
_Q
CD
JD
CD
jQ
CD
JD
CD
suggest that either the mitochondria remained intact or
that following sonic disruption have sealed right-side-out
and subsequently* soluble activities (fumarase and citrate
synthase) were trapped within closed membrane vesicles.
The formation of right-side out vesicles induced by the 
2+presence of Mg has been reported previously for red blood 
cells (steck and Kant* 1974).
Specific attachment of PDC to the inner mitochondrial 
membrane was further investigated by washing submitochondrial 
particles under a variety of conditions* some of which were 
known to dissociate the soluble complex to its constituent 
enzymes* and other standard procedures for removing peripherally- 
bound membrane proteins (Fig. 3*4).
Immunoblot analysis of the resultant membranes shows that 
PDC is stable after washing in low ionic strength buffer 
(Fig. 3.4A, lane 4). However, increasing the salt concentration, 
from 0.15M NaCl to 3M NaCl, causes the gradual release of ElP 
(Fig. 3.5C, lanes 5-9) into the soluble fraction with E2 and 
X remaining bound to the inner membrane fraction. The parallel 
release of Ela and E3> under similar conditions, had been 
reported previously (de Marcucci, 1985)* Attempts to 
differentiate between the attachment of E2 and X to the inner 
membrane using increasing concentrations of urea proved un­
successful due to the chaotropic nature of this reagent.
Dissociation of the complex into its constituent enzymes 
was achieved by washing submitochondrial particles in 0 .25M 
MgCl^ or 0.1M glycine buffer pH 9»5» Subsequent immunoblot analysi 
illustrates that the membranes are depleted of Ela and ElP 
(Fig. 3.4a, lanes 3 and 6) with a corresponding enrichment of E2 
and component X. It is not clear whether this specific 
association of protein X
Fig. 3.3s Factors Affecting the Orientation
of Vesicle Formation
Bovine heart mitochondria were sonicated 
in 20 mM potassium phosphate buffer, pH 6.5> 
containing 0*1 mM EDTA, 0.5 mM DTT, 0.1 mM TPP, 
0*5 mM MgCl and 0.15 ]iM leupeptin (a) or as (a) 
but supplemented with 0.15M NaCl (b). SMP  ^ J 
resulting from the sonicate were washed (x 3) 
either in buffer (a) or (b), with aliquots being 
retained following each incubation. These 
aliquots were assayed for enzyme activity.
Protein concentration of the membrane fraction 
was estimated by the method of Lowry. Proteins 
were resolved by SDS-PAGE before being analysed 
by immunoblotting prior to autoradiography.
(A) anti-PDC-serum
(B) anti-citrate synthase-serum.
Lane (l) purified antigen, 0.25 P>g> (2) intact 
mitochondria, 40 >ig; (3)a,b sonicated mitochondri 
40 pg (4) a,b membranes following first wash; 
40 y.g (5) a,b membranes following second wash; 40
(6) a,b membranes following third wash; 40 p,g;
(7) a,b membranes following fourth wash; 40 p,g;
(8) purified antigen 0.25 V-S
(9) low M^ standard proteins.
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Fig. 3.4: Immune Blot Analysis Using anti-PDC-serum of 
the Effect of Washing Bovine Heart Submito- 
chondrial Particles.
Bovine heart SMPs were washed under a variety of 
conditions which were known to either remove peripherally 
bound membrane proteins or to dissociate native PDC.
The soluble fraction was separated from the membrane 
fraction by centrifuging at 27 000 x g for 15 min. The 
samples were resolved by SDS—PAGE (l0$> w/v) and analysed 
by immunoblot ting. The various incubations were as 
follows (lanes 2-7):
Lane (l) Purified PDC (l p.g); (2) 20 mM potassium
phosphate buffer, pH 7*4; (3) 0.1M glycine buffer,
pH 9.5; (4) 0.5M NaCl; (5) 1M NaCl; (6) 0*25M MgCl2;
(7 ) 6M urea; (8) I12^-labelled low standard proteins 
45 V-S protein loaded per track (lanes 2—7)*
(A) mitochondrial membrane fraction
(b ) mitochondrial extract.
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with the membrane fraction occurs by virtue of its strong 
association with E2 or specifically with the inner 
mitochondrial membrane.
This preferential interaction of E2 and/or protein X 
with the membrane fraction was further examined by
! determining the susceptibilitv of other mitochondrial enzymes to washing in the 
j same range of buffers. 'This w a s h i n g  prouedui-e
successfully removes citrate synthase* even in the absence
of salt (Fig. 3-5-A.* lane 3)* In contrast, the integral
membrane protein, succinate dehydrogenase, remains associated
following prolonged washing in 3M NaCl (Fig. 3*5B > lane 9)*
Inspection of Figure 3«5C reveals that ElP is depleted
from the membrane fraction by repeated washing, although
not as readily as the control enzyme, citrate synthase.
Further analysis of this figure shows that the core enzyme,
E2 remains in stable association with the membrane even
after stringent washing in 3M NaCl, a situation analogous
to SDH. Only under the strongly denaturing conditions
employed to remove tightly bound peripheral proteins e.g.
6M urea (Fig. 3 * k ?  lane 7) o r  0.1M Na^CO^, pH 11*3 (data
not shown) is the bulk of PDC released from the membranes.
However, the possibility exists that these stringent
conditions are denaturing the binding sites for this
complex rather than primarily removing the protein from
the membrane, although the parallel release of SDH from
the lipid bilayer under these conditions suggests that the
integrity of the membrane is susceptible to these chaotropic
reagents.
Fig* 3» 5: Immune-blot Analysis of Salt Washed
Bovine Heart Submitochondrial Particles 
Using Subunit Specific Antisera (E2 and 
ElP of PDC)  ^ "
Submitochondrial particles were prepared and 
incubated with various concentrations of* salt.
The membrane fraction was collected by centrifugation
/ ' I
(27 000 x g for 15 secs) and the wash procedures 
repeated before membranes were washed (x 2) in , 
ice-cold distilled H^O. Samples were resolved on 
10 io ( w/v) SDS-polyacrylamide gels* transferred to 
nitrocellulose and probed for antigens using 
(0) anti-E2-serum, followed by anti-ElP-serum;
(B) anti-SDH-serum; (A) anti-citrate synthase-serum.
Lanes (l) Purified PDC, 0.5 P-g; (2) intact mito­
chondria, ^0 p,g; (3) sonicated mitochondria 40 p,g;/ ,\ ■ •
/ . ‘ \
I (4) 0M salt wash, 80 p.g; (5) 0.15M salt wash, 80 p,g;
(6) O.^M salt wash, 80 p,g; (7) 1M salt wash, 80 p,g; 
/(8)/2M salt wash, 80 p,g; (9) 3M salt wash, 80 p,g;
(io) I^^-labelled low standard.
Degradation of the E2 subunit is evident by the presence of 
lower bands which also react with anti-E2-serum,
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Having established the preferential association of 
PDC, and specifically the E2 and/or X subunits, with the 
inner mitochondrial membrane, the nature of this interaction 
was further investigated. It was possible PDC
associated with the membrane via an interaction with either 
other proteins or perhaps by a covalent attachment to 
membrane lipids.
The latter possibility was investigated by incubating 
mammalian tissue culture cells overnight in the presence 
of £3h] -palmitate (Section 3*2*5)* Cell lysates were 
prepared as previously described (Section 2.2*7) and used 
subsequently for immunoprecipitation studies. The results 
obtained are illustrated in Figure 3*6. Analysis of the 
acetone-precipitated cell lysate demonstrates the association 
of radiolabel with a variety of cellular proteins (Fig. 3»6A, 
lane l). Immunoprecipitati on studies using this lysate 
in conjunction with a variety of antisera did not demonstrate 
a specific attachment of —palmitate or p^Hj-myristate
to any component of PDC (Fig. 3*6A, lanes 4-9)* Control
[35 1immunoprecipitations using identical cells with {_ SJ “ 
methionine successfully precipitated the chosen antigen 
by this procedure. Thus, in light of these results, the 
possible attachment of PDC with the inner membrane via a 
covalent bonding to lipids seems unlikely.
Other workers (Sumegi and Srere, 1984) have reported 
on the specific association of several NAD-coupled 
dehydrogenases with Complex I of the electron transport
Fig. 3*6: Labelling of PK 15 Cell With [3h] Palmitic 
Acid.
PK-15 cells were labelled for 16 h either 
in the presence of £^s[ methionine or [pll] - 
palmitic acid, as described in Section 3*2.5» Cell 
lysates were prepared (2.2*7) and subsequently 
used for immunoprecipitation studies with a variety 
of antisera. The immunoprecipitation procedure 
is detailed in Section 2.2.11. Radiolabelled 
proteins were resolved on 10^ (w/v) SDS-poly- 
acrylamide gels before being processed for 
fluorography. (a) Ph] palmitic acid labelled cell 
lysate (b) methionine labelled cell lysate
used for immunoprecipitation.
Lane (l) palmitic acid-labelled cell lysate;
lane (2) £lZ*c”[ -labelled PDC; lanes 3 , 1 0  r e ­
labelled low standard proteins. Lanes(4-9) 
are immunoprecipitates with the following antisera; 
lane (4) non-immune rabbit serum; lane (5) anti— 
PDC-serum; lane (6) anti-E3-serum; lane (7)> 
anti-Ela-serum; lane (8), anti-PTP-serum; 
lane (9) anti-citrate synthase-serum.
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chain* Complex I is known to consist of* approximately 
26 polypeptides (Heron erfc al • ? 1979) > only a few of* which 
have a known function. These workers" (Sumegi and "Srere?
1984) further postulated that perhaps some of* the unassigned 
polypeptides of* Complex I may be involved in binding these 
enzymes? in particular PDC? to the inner mitochondrial 
membrane? thus linking the enzymes involved in NADH 
production to its oxidation*
Further investigation of* this point was achieved by 
resolving both Complex I and PDC on SDS-polyacrylamide gels 
(Fig* 3*7A) and scanning the resultant Coomassie Blue 
profiles. It was found that none of the five constituent 
polypeptides of PDC co-migrated with any of the major 
components of Complex I? eliminating the possibility that 
PDC is an integral part of Complex I* It has been reported 
that? on purifying PDC to apparent homogeneity by a variety 
of methods (Linn _et al* ? 1972; Cooper jet al. ? 1974;
Stanley and Perham? 1980)? that some Complex I activity 
is always recorded in the final preparation* Immunoblot 
analysis? with a variety of antisera? was used to ascertain 
the degree of cross-contamination of purified Complex I 
with PDC and other mitochondrial proteins. Figure 3«7B?C 
demonstrates that this preparation was not contaminated to 
any significant extent with either citrate synthase or 
fumarase. Probing Complex I with anti-SDH-serum also failed 
to detect the presence of the parent antigen (Fig. 3*7D)*
- ye -
In contrast? the clear detection of* the constituent PDC 
polypeptides within Complex I argues for a specificity of 
interaction with this region of the respiratory chain.
As PDC does not co-migrate with any component of Complex I? 
the immune detection of these bands suggests only: that PDC 
polypeptides are a minor contaminant of this preparation. 
However? failure to detect SDH? which is both an integral 
membrane protein and a component of the electron transport 
chain? within this preparation suggests that there may be 
a normal interaction? in situ? between Complex I and PDC.
The results presented in this Chapter suggest that 
PDC binds to the mitochondrial inner membrane with a 
greater affinity than other matrix enzymes. The particular 
strength of interaction of E2 and/or component X with 
this membrane suggests that the complex is a tightly-bound 
peripheral protein and that binding is mediated via one 
or both of these subunits.
/
Fig. 3*75 Immune Blot Analysis of Complex I 
Using a Variety of Antisera
Purified Complex I was resolved on a 10$
(w/v) SDS-polyacrylamide gel and either stained 
with Coomassie Blue (a) or transferred to nitro­
cellulose before being screened using a variety of 
antisera, (b) anti-fumarase-serum; (c) anti-citrat<
synthase serum; (d ) anti-SDH-serum; (e ) anti-PDC- 
serum.
(A): (l) Purified PDC, 2.3 V g ; (2), (3)> (*0 10,20, 
40 pg respectively, of purified Complex I;
(5
(B): (1
(2
(3
(c)s (1 
(2 
(3
(D)s (1 
(2 
(3
(E); (1 
(2 
(5
Low standard proteins
Purified fumarase, 0.2 pg;
Purified Complex I, 20 pg;
125I -labelled low standard proteins
Purified citrate synthase, 0.2 pg
Purified Complex I, 20 pg
125I -labelled low standard proteins
Sonicated mitochondria,
Purified Complex I,
40 pg
20 pg
.123I~"~' -labelled low M standard proteinsr
Purified PDC, 0.23 V-g,
> (3). (4) as (A)
125I -labelled low standard proteins.
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3.*+ DISCUSSION
Evidence presented in this chapter suggests that PDC 
is tightly bound to the inner mitochondrial membrane of 
ox heart. This interaction between PDC and the inner 
mitochondrial membrane has been demonstrated to be significantly 
stronger than for two other matrix enzymes}/fumarase and 
citrate synthase. Despite having similar characteristics 
to the membrane-binding of SDH* data suggest: that PDC
belongs to a class of tightly-bound membrane-associated 
proteins rather than that of integral membrane components.
Initially these investigations were performed on 
mitochondria isolated from rat liver. Several disadvantages 
of this system became apparent^not the least of which was 
the lower amount of enzyme present in comparison to that 
from bovine heart. The identification of a rat liver 
protease which specifically inactivates PDC (Wieland, 1973)
presented an additional disadvantage. In contrast* we
/y
found no evidence for the rapid degradation of the ox heart 
enzyme in crude mitochondrial extracts* thus subsequent 
experiments were performed using this tissue.
By assaying sonicated mitochondria for enzyme activity* 
it was found that the bulk of PDC activity partitioned 
with the membrane* with less than 2 5 f° of the total assayable 
activity present in the soluble fraction. Whether this 
observed distribution is of functional significance and 
perhaps reflects structural differences between the two 
populations or is merely an artefact of the preparation 
remains to be established. However* detection of SDH in
the supernatant fraction suggests that this result may 
reflect the presence of non-sedimenting membrane particles 
rather than a distinct soluble population of PDC. It 
should be noted that > 5°f° of purified PDC was found to 
sediment under these conditions (data not shown).
Several laboratories have reported on the association 
of matrix enzymes with the inner mitochondrial membrane 
(D1 Souza and Srere* 1984; Robinson and Srere, 1985)* There 
have been conflicting reports on the internal mitochondrial 
location of some enzymes* in particular those of the Krebs 
cycle* (Wit-Peeters e*t al• > 1971* Landriscima e t al• * 1970) 
although it is likely that these mainly reflect methodological 
differences.
Our data have established that E2 remains firmly 
attached to the matrix surface of the mitochondrial inner 
membrane (Fig. 3*4) and that the distribution of this 
subunit is radically different to that of El or E3» which 
are both readily released from the complex (de Marcucci*
1985)* In contrast to this, Surmegi and Srere, (1984) 
have reported on the association of PDC with the inner 
mitochondrial membrane and observe that each of the 
constituent enzymes bind with equal affinity. This group 
relied primarily on the ability to detect PDC activity 
as. the sole criterion for binding. Figure 3*3 demonstrates 
the presence of PDC on the inner mitochondrial membrane 
under conditions which inactivate the enzyme. Inactivated 
but membrane jbound enzyme was not accounted for in these 
studies. These workers (Sumegi and Srere* 1984) suggest
that the inability to recover total enzyme activity 
(< 30$ of total PDC was recovered) reflects that the 
reconstituted complex exhibits a lack of co-operativity 
not seen in the soluble> unbound enzyme. The significantly 
greater activity recorded for the partial reactions of 
El? E2 and E3> assayed independently may be accounted for 
by either non-specific binding of each of the subunits 
to the membrane or more probably reflects an interaction 
of each of these constituents with residual E2 still 
associated with the membrane. Studies demonstrate that 
PDC remains membrane-associated following prolonged 
sonication and Figure 3«5 illustrates that PDC remains 
bound after repeated washing of the membrane in low ionic 
strength buffer. The bulk of PDC activity was only 
released after washing membranes in 6M urea (Fig. 3*4? 
lane 7)« With reference to the studies of Sumegi and 
Srere (1984) it seems unlikely that they have prepared 
membranes completely depleted of PDC polypeptides and 
thus their results should be interpreted with caution.
Our studies have illustrated the limitations of 
assessing binding by assaying for enzyme activity and 
have demonstrated the presence of membrane-bound E2? via 
immunoblotting? under conditions which inactivate the 
enzyme. Figure 3*5 illustrates that E2 remains associated 
even at high ionic strength (3M NaCl) while ElP is 
readily released. This result confirms that PDC associates 
with the inner mitochondrial membrane? via an interaction 
with E2 with an affinity comparable to SDH more than
citrate synthase* Component X is also observed to be 
associated with the membrane fraction more tightly than 
either El or E3» which are both readily released* Whether
Thus an alternative to PDC binding to the membrane 
through E2 is that it binds through component X. Another 
possibility is that there is a direct involvement with both subunits.
   . wU'#'"
We have investigated the possibility that PDC could 
interact with the mitochondrial inner membrane via a 
covalent attachment to membrane lipids? in particular 
with myristic acid. This method of membrane association 
has been reported for several proteins? e.g. SV40 large 
T antigen (Klockmann and Doppert? 1985)? retinoid binding 
protein (Bazan ejfc al• ? 1985) picoraavirus capsid protein? 
VP4? (Chow ejfc al • ? 1987) and VP 2 protein of SV40? (Streuli 
and Griffin? 1987)* Despite being able to incorporate 
radiolabel irto a variety of cellular proteins (Fig. 3*6? 
lane l)? none of these was. found to co-migrate with
polypeptides of PDC? immunoprecipitatedor to be.
with anti-PDC-serum or subunit-specific senm (Fig. 3«6a ). 
Thus? in light of this? it seems unlikely that PDC is 
associated with the inner mitochondrial membrane via a 
covalent binding to myristic and/or palmitic acid.
Sumegi and Srere (1984) have suggested that this 
interaction may exist via Complex I of the electron 
transport chain. By examining the interaction of a variety 
of dehydrogenases, including OGDC? PDC and malate dehydrogen­
ase, with the multimeric inner membrane complex? these
workers were able to demonstrate a specificity of interaction 
which could not be detected for either furaarase or citrate 
synthase. The application of these in vitro observations 
has important implications in situ^not the least of which 
is the linking of those enzymes involved in NADH production 
with those of oxidation.
I
The results presented (Fig.3.7) show the presence of PDC in Complex 
I, whereas another membrane protein, SDH, was not detected. This
\.
may support the idea of a specific association between PDC and
Complex I, or may be the result of Complex I being contaminated with j
PDC and not with SDH. j
It is still possible that two distinct populations of 
PDC exist in the mitochondria* one that is free in 
solution and a second which is associated with the inner 
membrane as a tightly-bound extrinsic protein although 
our data suggest ; that this association exists via the 
E2 and/or X components of the complex. The possible 
function of these two populations may be to feed acetyl 
CoA to different pools within the mitochondria (Von Glutz 
and Walter* 1975) that PDC which binds to citrate
synthase (Sumegi et al.* 1980) will channel acetyl CoA 
to the Krebs cycle whilst that which interacts with the 
membrane will feed the acetyl groups to coenzyme Q or 
perhaps to enzymes involved in fatty acid synthesis.
The available evidence indicates that the mitochondrial 
matrix and inner membrane compartments are a semicontinuous 
compartment crowded with proteins that are interacting
with each other in each semiautonomous phase and with 
proteins in the adjacent phase. In this way it is 
possible to'envisage j that only portions of cycles are 
organised such as fumarase* malate dehydrogenase* citrate 
synthesis and PDC* which may be responsible for the 
formation of citrate* whilst the dehydrogenases of the 
Krebs cycle might be bound to Complex I. This proposed’
-I variety of organisational variants may be dependent 
on cell type* on the metabolic requirement of that particular 
cell and perhaps even be responsible for the conflicting 
reports on p;rotein organisation within compartments.
CHAPTER k
PURIFICATION OF THE PHOSPHATE TRANSPORT PROTEIN
AND CHARACTERISATION OF ANTISERUM
4.1 INTRODUCTION
The initial stages of* this project were concerned
primarily with purifying the phosphate transport protein
/
from both rat liver and beef heart mitochondria. The 
purified protein was utilised to raise specific antiserum, 
which was subsequently employed for studies on the topography 
and biosynthesis of the carrier protein.
The phosphate transport protein has proven difficult
to purify as demonstrated by the apparent heterogeneity’
 of preparations). Prior to the publication by Gibb
1 ” ; - ;■ . i t.c'
et al. (1986) other 1 preparation schbmes had at least one 
other protein band evident at the final stage (Kolbe and 
Wohlrabj 1985). This lack of a homogeneous preparation 
presents obvious difficulties when attempting to raise 
antibodies against the PTP. Indeed* any contaminating bands 
may prove to be more immunogenic than the chosen antigen.
The use of antibodies as a biochemical tool has been 
well documented* particularly over the last few years. The 
advantages offered by antibodies are manifold, not the least 
of which is that small amounts of protein can be detected 
by immunoblotting and thus antibodies are ideal probes for 
peptide mapping studies. They allow the detection of antigen 
in both other tissues and the same tissue of different 
species. This has important implications when studying the 
evolutionary aspects of proteins where antibodies could be 
used to detect conserved regions of protein sequence.
Only one other group (Rasmussen and Wohlrab, 1986) 
has reported on the use of antibodies to further characteris 
the PTP. In their hands* anti-PTP-serum elicits a low 
sensitivity of detection of the parent antigen in crude 
extracts when immunoblotted.
4.2 METHODS
4.2.1 Purification of the phosphate transport protein from 
rat liver and bovine heart mitochondria
This procedure is as described in Section 2.2.10. 
Fractions were retained for analysis at each stage in the 
purification. Proteins were precipitated by the addition 
of four volumes of ice-cold acetone and finally prepared 
for analysis by SDS-PAGE as described in Section 2.2.3*
4.2.2 Preparation of antiserum to purified rat liver 
phosphate transport protein
Densitometric scanning of Coomassie Blue-stained gels 
allowed the selection of preparations of greater than 95$ 
purity for immunisation of rabbits with PTP.
Purified PTP was acetone precipitated and the resultant 
pellet (l mg) was resuspended in 0*5 ml of PBS, mixed with 
an equal volume of Freund1s complete adjuvant and injected 
subcutaneously at multiple sites on the neck and back of 
a New Zealand "White rabbit. As a result of the low titre 
of antibody that was obtained on previous occasions, this 
procedure was repeated fx 3W i t h  complete adjuvant over a 
period of six weeks in an attempt to increase the immune 
response. Similar amounts were injected at 2-3 week
intervals thereafter with Freund*s incomplete adjuvant#
Ten days after the sixth injection, blood was obtained 
from a marginal ear vein. Additional booster injections 
were administered at one monthly intervals with 0.5 mg 
of protein. The serum was collected and stored in 0*5 ml 
aliquots at -20°C until required.
4.3 RESULTS
4.3*1 SDS-PAGE analysis of the isolated phosphate transport 
protein
The purification procedure is detailed in Section 2.2.10. 
The Coomassie-Blue staining profiles of different stages of 
the purification of both rat liver and bovine heart mito­
chondrial protein is illustrated in Figure 4.1. Following 
analysis by SDS-PAGE a single apparently homogeneous band is 
evident after chromatography on Celite. The inclusion of 
a 0.596 (w/v) Triton X-100 pre-extraction by Gibb e_t al.
(1986) successfully removes approximately 90$ of mitochondrial 
proteins (Lane 1, Fig. 4.1a,b). This and the subsequent 8$ 
(w/v) Triton X-100 extraction removes many of the contaminating 
proteins, enriching the sample in the PTP. By subjecting 
the 8$ (w/v) Triton X-100 extract to batch chromatography on 
hydroxlapatite, it can be seen that most proteins remain 
bound to the column matrix whilst the PTP and a few other 
proteins of similar value are present in the eluate.
The supernatant from this stage in the purification was 
applied to a Celite column and resulted in the adsorption 
of all other contaminating bands.
Fig. 4.1: SDS-PAGE Analysis of Fractions from the 
Purification of the PTP
Fractions from the various stages of the PTP 
purification were subjected to polyacrylamide gel 
electrophoresis on a 10$ (w/v) SDS-polyacrylamide 
slab gel. The proteins were detected by staining 
with Coomassie Blue. (a ) purification from rat 
liver mitochondria; (b ) purification from beef 
heart mitochondria.
Lane (l) 0.5$ (w/v) Triton X-100 pellet 40 Vg
(2) 8$ (w/v) Triton X-100 extract 40 Vg
(3) HTP fraction 20 V>g
W Celite eluate 20 VS
(5) 0-5$ (w/v) Triton X-100 pellet 40 vs
(6) 8$ (w/v) Triton X-100 extract 40 v>g
(7) HTP eluat e 20 v-g
(8) Celite eluate 20
(?) Low standard proteins.
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Fig. 4.2
Standard curve of electrophoretic mobility of marker 
proteins versus log subunit M r value.
Phosphate transporter.
Rf
value
0.2-
40 50
Log M r (10“3 )
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To estimate the M r value of the phosphate transport 
protein; on an SDS - polyacrylamide gel (10% W/V) its rel­
ative mobility (Rf) was compared to that of a set of standard 
proteins .(section 2.2.3d).
PTP was purified from bovine heart mitochondria
Figure 4.2 shows the standard curve used to determine
the M value of the purified protein. This was determined
by calculating the relative mobility of the PTP in comparison
to a set of standard marker proteins of known M value.r
The value obtained* i.e. of 34 000 M^* is in agreement with 
that of other workers (Gibb ejb al. > 1986; Kolbe ejt al. >
1981; and Wohlrab* 1980).
Densitometric scanning of the final stage of this 
preparation following SDS-PAGE indicated the protein to be 
of greater than 95$ purity. This was then considered as 
a homogeneous preparation since any other contaminants were 
less than 1$ of the preparation and not visible following 
staining with Coomassie Blue.
4.3*2 Native M ■ determination of the PTP using gel filtration
Approximately 200 p,g of the final Celite eluate from
the PTP purification scheme was applied to a Superose 12
column after being passed through a Millex filter. The
column had been pre-equilibriated in 20 mM Tris-HCl* pH 7*4
containing 0.5$ (v/v ) Triton X-100 and calibrated using
standard proteins (Section 2.2.4) which had been prepared
in the above buffer. Figure 4.4 illustrates the trace
obtained following gel filtration of the purified PTP.
The M value of the PTP was estimated relative to the r
elution volume of standard proteins. Fractions corresponding 
to the observed peak were pooled and identified as the PTP 
by immunoblot analysis using anti-PTP-serum (Fig. 4*5)*
The lower M value band observed was thought to be a degradation 
product of the 3 ^ ' 0 0 0  'M polypeptide since immunoblot 
analysis prior to gel filtration failed to detect any other 
bands*
It has been suggested previously (Kolbe at al•, 1982) 
that, like its sister protein, the adenine nucleotide 
translocase, PTP would exist as a dimer in its functional 
state* This study on determination of the native protein 
and also cross-linking data, using both dimethyl suberimidate 
and phenylene dimaleimide under conditions which crosslink 
control proteins (aldolase and PDC) have failed to provide 
any evidence to support this theory! (Fig. b , 6 ) t Indeed all of our 
available information suggests that this protein exists as
a 3 b 000 M^j monomer. 'Whether this subunit exists as a 
component of a multimeric transport system or as an integral 
functional unit remains to be seen.
b . b  DISCUSSION
The purified rat liver and beef heart mitochondrial 
phosphate transport prot eins we.^ sub jected to SDS-PAGE and 
their Coomassie Blue staining profiles compared* In each 
case one major polypeptide of 3 b 000 vfiis observed following 
chromatography on Celite* In this and other preparations 
this final stage in the purification successfully removes 
a 31 000 band which is the major contaminant following 
chromatography on hydroxlapatite* Wohlrab (1980) demonstrated 
this latter result when purifying the carrier protein from
Fig.4.3 Densitometric scan of the Coomasste Blue 
profile of the Celite fraction of purified PTP
; from bovine heart. |
Dye front
Fig. 4.4; Gel Filtration of Purified PTP Using
the FPLC System and Superose 12 Column
PTP, purified as described in Section 2.2.10, 
was applied to a Superose 12 column. The flow 
rate was set at 0*5 ml/min and the column was pre- 
equilibriated in 20 mM Tris-HCl, pH 7*4 containing 
0.59° (v/v ) Triton X-100. 1.0 ml fractions were
collected and those corresponding to the peak were 
pooled and precipitated in 4 volumes of ice-cold 
acetone. The resultant pellet was resuspended in 
50 ill of Laemmli sample buffer containing 10 mM DTT 
in preparation for SDS-PAGE.
PTP was purified from bovine heart mitochondria*
The second peak represents the absorbance, at 280 nm, 
due to Triton X-100
A.
280nm
Volume (ml)
/
Table 4.1s Native M Determination of the PTP by -------- r  d-
Gel Filtration
Sample M x X 0 ~ 3  r Elution vol. (mm)
BSA 67 84
Ovalbumin 44 90
a Chymotryps- 
inogen
21 140
Cytochrome c 12.5 152
BH.PTP 34- 96
Standard proteins of known value were applied 
to the Superose 12 column* as described in Section 
4.3.2. The elution volume was measured as the mean 
value of at least three sample applications to the 
column.
the same tissue and identified the contaminating protein 
as the adenine nucleotide translocase. In marked contrast 
to the findings of Kolbe <et al*, (1985) we find no evidence 
for the existence of any other band following chromatography 
on Celite. Alkylation of these bands* resolved by Kolbe et_ al . 
(1983). putatively designated a and P, caused them to co- 
migrate with an value of 34 000 whilst peptide mapping 
failed to detect any differences. These results suggest 
that the apparent subunit composition may be artefactual 
and arise from intramolecular disulphide bond formation 
during electrophoresis and that PTP consists of one 34 000 
polypeptide.
Densitometric scanning of the Coomassie Blue profile 
(Fig. 4.3) allowed confirmation of the purity of the isolated 
carrier and estimated it to be greater than 95$ pure. These 
preparations were used to mount an immune response. The
protein was identified as the PTP as a result of its
i ■t
sensitivity to NEM (data not shown) and the determination 
following purification of the protein by the method of
Gibb at al.> (1986). The antiserum was also shown to cross-
/
react with the equivalent antigen from bovine heart 
mitochondria.
The high selectivity and sensitivity of the antiserum 
was monitored by immunoblotting against the purified protein 
and against whole cell and mitochondrial extracts. Transfer 
of proteins to nitrocellulose has several advantages: 
filters are easier to manage* the same replica can be used
Fig* 4.5s Immune Blot Analysis of the Fractions
Corresponding to the Peak Obtained 
from Gel Filtration Studies
Fractions corresponding to the .A ^gQ ^
profile (Fig. 4.4) were pooled and precipitated
in 4 volumes of ice-cold acetone. The resultant
pellet was prepared for SDS-PAGE and analysed
using the immune replica technique* probing with
anti-PTP-serum. Lanes (l*2*3) 5 10 pi and
20 pi respectively of the resultant pellet.
125Lane 45 ^I-labelled low standard proteins.
• Mf x 1
, ---67
— • j 44
1 2  3 4
r 3
P h o s p h a t e
t r a n s p o r t e r
for successive investigations, the proteins are readily 
accessible and therefore processing times and the amount 
of reagents used are reduced. One major disadvantage 
though, is that the elution of proteins from the gel is 
dependent on value. However, the inclusion of 0.0Zfo 
(w/v) SDS in the original transfer buffer of Towbin et al« 
(1979,) facilitates the elution of higher -M proteins.
Following transfer of proteins to nitrocellulose, 
unbound sites on the paper must be quenched prior to the 
incubation wi th antiserum. Originally, this was achieved 
by supplementing the wash buffer with 3°f° (w/v) BSA, as 
described by Towbin et al. (1979)* Improved backgrounds 
and specificity of interaction were achieved by substituting 
the non-ionic detergent Tween 20 as a blocking agent 
(Batteiger erb al., 1982). An additional advantage of this 
system is that the efficiency of electrophoretic transfer 
would be determined by staining for proteins directly on 
the blot. Comparison of the resultant autoradiogram with 
the stained blot from which it was derived allows accurate 
identification of the immunoreactive protein(s).
The highly sensitive technique of immunoblotting using 
samples prepared in Laemmli sample buffer plus 3°f° (v/v ) 
mercaptoethanol revealed the presence of two non-protein 
bands (M^ 3k 000 and 65 000). These artefactual bands 
have been reported previously (Tasheva and Dasser, 19^3) 
and in contrast to this report, substituting DTT as the 
reducing agent removed this artefact.
i s '  KFig. 4.6: Crosslinking Studies on the PTP using 
Phenylene Dimaleimide (PPM)
Purified bovine heart PTP was incubated with 
a final concentration of 100 pm PDM. The reaction 
was allowed to proceed for 30 min. at room 
temperature before being stopped by precipitating 
the protein in h vol. of acetone. The resultant 
pellets were dried under air and boiled in Laemmli 
sample buffer containing 10 mM DTT> before being 
resolved by SDS-PAGE.
Lane 1» PTP incubated with 100 pM PDM> 5 “P-g?
lane 2> as (l); 10 pg; lane 3> untreated PTP
5 pg; lane 4> untreated PTP> 10 pg; lane 
125^I^labelled low M standard proteins.
x  10
  P h o s p h a t e
3 0  t r a n s p o r t e r
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This method revealed that the antiserum directed 
against the rat liver phosphate transport protein cross- 
reacts very strongly with not only the parent antigen but 
also the carrier protein from bovine heart mitochondria 
(Fig. 4.7)• It can also cross-react with the corresponding 
protein from porcine kidney? bovine kidney and rat liver 
cells (Fig. 4.8). It was not established whether the weaker 
cross-reaction observed against cells derived from the 
bovine kidney tissue reflected a genuine immunological 
difference or simply a lower abundance of the enzyme in 
this tissue since mitochondria from various tissues are 
known to differ significantly in their anion transporting 
capacities (Babcock jet al• ? 1983)* On the basis of the 
cross-reactivity of the antiserum raised against the rat 
liver phosphate transport protein with the carrier from 
different tissues? it can be argued that the primary protein 
sequence must be highly conserved in certain regions and 
that this must result in the preservation of certain 
structural epitopes.
Despite attempts to ensure that only homogeneous protein 
preparations were used in the production of antiserum?
Figures 4.7 and 4.8 demonstrate that this antiserum also 
cross-reacts with a 31 000 polypeptide? tentatively 
identified as the adenine nucleotide translocase (ANT).
It should be noted? however? that this cross-reaction is 
evident only in the hydroxlapatite fraction and is removed 
or only weakly visible following chromatography of this 
sample on Celite.
Fig. 4.7s Crossreaction of Anti-PTP-serum with 
Fractions from the Purification 
Procedure
Fractions were withdrawn at various stages 
of the purification of the phosphate transport 
protein and subjected to SDS-PAGE (lO$>(w/v)). 
The proteins were transferred to nitrocellulose 
and processed for detection of antigen using 
anti-PTP-serum. (Lanes 1-5; rat liver; lanes 6-8? 
bovine heart).
(i) intact mitochondria? 40 ]ig; (2) 0.5$ (w/v) 
Triton X-100 pellet? 20 p,g; (3) 8$ (w/v) Triton 
X-100 extract? 20 p,g; (4) HTP eluate? 10 p,g;
(5) Celite eluate? 10 (6) 8fo (w/v) Triton
X-100 extract? 20 p-g? (7) HTP eluate? 20 p.g;
(8) Celite eluate? 10 p-g? (9) "^^I—labelled 
low standard proteins.
P h o s p h a t e
t r a n s p o r t e r
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Fig. 4.8: Immune Blot Analysis of Cultured 
Mammalian Cell Extracts Using 
Anti-PTP-s erum.
Crude cell extracts and mitochondrial fractions 
from cultured mammalian cells were resolved in 
SDS-polyacrylamide gels ( l O f o (w/v)) prior to 
immune blot analysis.
The autoradiographic profile of the following 
samples is illustrated:
Lane (l) BRL cell extract 80
(2) BRL mi t o chondri a 40 v e
(3) NBL cell extract 80 v-s
W NBL mitochondria 40 v>s
(5) PK 15 mitochondria 40 p-e
(6) 12^I-labelled low
standard proteins.
Mr x 1 0  3
- 6 7
- 4 3
- 3 0
1 2  3 4 5 6
There are therefore two possible explanations for 
this cross-reactivitys
(i) minute amounts (< 2$>) , which are not detectable 
by Coomassie Blue staining, of the contaminating 
protein were present in the final Celite eluate 
used for injection of the rabbit. This subsequently 
resulted in raising a titre to not only the PTP 
but also to the protein identified as the ANT.
or (ii) the antiserum reacts with epitopes on the ANT
which are in common with those on the PTP.
Evidence to date favour^ the second hypothesis. At
the superficial level, the observation that the ANT copurifies 
with the PTP up to chromatography on Celite suggests that 
these proteins have similar properties. The poor affinity 
of both these proteins towards hydroxlapatite has been 
attributed to the extensive hydrophobic areas on the 
periphery of these integral membrane proteins (Klingenberg 
et al., 1978) which probably still have lipid bound but are 
otherwise covered by detergent molecules. Both these 
proteins also possess phosphate binding sites.’ Kolbe and 
Wohlrab (1985) have established that homologies do exist 
in the primary structure of the ANT and the PTP which are 
similar to those preserved in evolution between the ANT 
from beef heart and in N. crassa. In a more recent 
publication (Runswick e_t al_., 1987) the amino acid sequence 
of the phosphate carrier has been compared with both the 
translocase and the uncoupling protein from brown fat 
mitochondria. This analysis demonstrates that all three
proteins contain a three-fold repeated sequence, approximately 
100 amino acids in length and that strong homologies exist 
between these repeats. This result suggests that the three 
proteins have related 3 dimensional structures and mechanisms. 
It may also imply that the three proteins share a common 
evolutionary origin. The importance of three dimensional 
structure in determining the immunoreactivity of a protein 
has been noted previously (Westhof at al., 1984).
This would then suggest that the cross-reaction observed
most probably reflects the common structural epitope(s)
existing between the two proteins. This argument is
strengthened by the observation that the cross-reaction is
more apparent in the hydroxylapatite eluate which still
contains the ANT fraction. Chromatography on Celite removes
this contaminating polypeptide and no (or a very weak)
cross-reaction with a 31 000 M is observed.r
This chapter describes the purification of the PTP 
and raising and characterisation of antiserum directed 
against this protein. On the basis of the strong cross­
reactivity observed with the parent antigen and the 
equivalent antigen from different sources biosynthetic 
and topographical analysis were initiated.
CHAPTER 5
BIOSYNTHETIC AND TOPOGRAPHICAL STUDIES ON THE 
PHOSPHATE TRANSPORT PROTEIN
5*1 INTRODUCTION
ATP is synthesised from ADP and inorganic phosphate 
by oxidative phosphorylation in mitochondria. The supply 
of substrates in the mitochondrial matrix is maintained 
by two proteins in the inner membrane, the adenine 
nucleotide translocase (ANT) and the phosphate transport 
protein.
Although the ANT and PTP are distinct proteins (Section
1.3)> they possess several structural and mechanistic
similarities. Both are proteins catalysing a transmembrane
activity and each carrier possesses a phosphate binding
site. Both proteins are solubilised by the non-ionic
detergent, Triton X-100, and in each case the major
purification step involves adsorption chromatography on
hydroxylapatite (Wohlrab, 1980). The subunit monomer of
the translocase has an M value of 30 000, with two monomersr
in dimeric form constituting the functional carrier unit 
(Hackenberg and Klingenberg, 1980). The subunit value 
of PTP is 34 000, and although a dimeric functional unit 
has been suggested (Kolbe et al•, 1982), no compelling 
experimental evidence exists for this.
One aspect of this study is concerned with mitochondrial 
biogenesis and in particular with the biosynthesis of the 
nuclear encoded PTP. Only two other transmembrane activities 
have been studied with respect to mitochondrial biogenesis, 
one is the PTPfs sister protein, the ANT and the other is 
the uncoupler protein from brown fat mitochondria. Early
studies on the biogenesis of the ADP/ATP translocator, 
provided the first demonstration that mitochondrial 
precursor pools were present in the cytoplasm (Hallermeyer 
et al., 1977). Subsequent analysis revealed that the soluble 
precursor form of the translocator is not synthesised with 
a transient N-terminal sequence which is characteristic of 
most other mitochondrially imported proteins (Hay jet al., 
1984). The precursor was shown to exist in a different 
conformation to that of the mature form (Zimmerman and 
Neupert, 1980) and it has since been established (Adrian 
et al., 1986) that the information required for the in vivo 
targeting of the Saccharomyces cerevisiae ANT is determined 
by residues within the first 115 amino acids.
This chapter is concerned with further characterisation
I
of the PTP and- attempts to use specific antibodies
i  :
directed against this protein to study both the biosynthesis 
and final membrane organisation of this carrier protein.
■When immunological detection of mitochondrial poly­
peptides is performed using an in vitro translation system 
primed with poly A+ RNA, the major translation products 
are the precursor forms of the polypeptides. In vivo 
studies are hindered by the rapid import and processing 
of cytoplasmic pools of precursor molecules. By employing 
uncouplers of oxidative phosphorylation to dissipate the 
transmembrane gradient required for the import of proteins, 
these precursor molecules can accumulate in the cytoplasm, 
given that these molecules are relatively stable.
High titre monospecific antisera have been a key tool 
in studying mitochondrial biogenesis. The criteria for 
initiating such studies are that the antibodies must exhibit 
a cross-reactivity with the equivalent polypeptide from 
different sources and be capable of recognising the precursor 
form of the antigen. This latter condition does not always 
hold in that the antibody to apocytochrome C fails to 
recognise the holocytochrome and vice-versa (Hennig and 
Neupert? 1981). In addition? it was apparent that pre-E2 
was not recognised to any significant extent by antibody 
to native OGDC (Hunter? 1985)*
Preliminary studies carried out in yeast cells grown 
in the presence of uncouplers of oxidative phosphorylation 
(Gibb? 1985) suggested that? like the ANT? the yeast PTP 
is synthesised with the same value as .the mature protein.
Thus as our anti serum (Chapter 4) fulfilled the above ■
' 1
criteria? an in vivo approach was chosen to extend these 
initial observations and to study the biosynthesis of PTP 
in mammalian tissue culture cells.
The second aspect of this chapter is concerned with 
the final organisation of this polypeptide in the inner 
mitochondrial membrane.
To date? very little information is available on the 
orientation of the PTP within this membrane. Topographical 
studies? and as a consequence of these? an understanding of 
the transmembrane activity of ANT? have been facilitated 
by the existence of two inhibitors which are known to bind 
to the translocase in an asymmetric fashion (carboxyatractyl- 
oside at the cytoplasmic face and bongkrekate at the matrix
surface). Also the complete amino acid sequence is known 
(Aquila et al.> 1982) and reveals that the monomeric
0 ; ' ‘ - i <'
protein contains h cysteines . iq: 297 amino acids. Masking
or chemical modification of sulphydryl groups causes 
inhibition of the translocase activity.
In contrast to the ANT* very little information is 
available on the membrane organisation of the PTP. This, 
as discussed in 1«3> is partly due to the lack of specific 
inhibitors and also the low concentration of the protein 
within the membrane (ANT constitutes approximately 10°fo of 
total protein of the mitochondrial inner membrane).
Studies have been undertaken to further characterise 
the reactive sulphydryl groups essential for the activity 
of both proteins (Houstek and Pedersen, 1985) and to extend 
these observations to the catalytic mechanism. Maleimides 
have proven particularly useful in this respect. As their 
reaction with sulphydryl groups of proteins is not readily 
reversed, proteins containing these groups can be radio- 
actively labelled and monitored by gel electrophoresis. 
Unfortunately, the most commonly used radioactive maleimide, 
NEM, is highly permeable (Fonyo, 1976). Analogues of low 
permeability, like carboxylated maleimides (Griffiths et al., 
1981) or N-acetyl-4-sulphamoylphenylmaleimides (Vignais 
et al•, 1973) are either not available commercially in 
radioactive form, or they are not completely impermeable.
Utilising the highly charged fluorescent probe, 
eosin-5-nialeimide, which circumvents some of these problems, 
Houstek and Pedersen (1985) have suggested that the reactive
sulphydryl groups of the PTP are available only at the 
cytoplasmic surface of the inner mitochondrial membrane.
In contrast to the analogous study on the ANT, this group 
has been shown to be reactive with NEM, and therefore 
essential to the catalytic function. These workers were 
unable to detect any reactive sulphydryls at the matrix 
surface of the inner mitochondrial membrane.
Whilst this study provides a new insight into the 
relative locations of the sulphydryl groups of both the 
ANT and PTP, it does not allude to the topographical 
organisation of either protein within the membrane 'structure:. 
Indeed, the extent of fluorescence may reflect a combination 
of a) the abundance and b) the reactivity of each protein 
within the membrane. Although PTP possesses some of the 
most reactive sulphydryl groups in the mitochondrial inner 
membrane, maleimides, as discussed in 1*3, have a broa 
specificity. Thus, interpreting fluorescent labelling 
patterns may prove rather difficult due to a combination
of these factors.
In this chapter the orientation of PTP in the inner
mitochondrial membrane towards the cytoplasm or the matrix
~]— . _ , !'j>'
was investigated by proteolytic digestion of (mitoplasts) 
and submitochondrial particles. With the availability of 
high quality antiserum directed against the rat liver 
enzyme, the opportunity existed to investigate the topo­
graphy of this carrier protein using an approach that had 
not been used in this context i.e. analysis of the protease 
digested mitoplasts or SMP's by immunoblotting to detect
membrane-bound protease-resistant fragments.
5.2 METHODS
5*2.1 Protease treatment of bovine heart submitochondrial 
particles
The incubation of bovine submitochondrial particles 
(SMP) (l6 mg/ml)? prepared as described in Section 2.2.9b? 
with a variety of proteases was performed at 30°C in 50 mM 
potassium phosphate buffer? pH The protease was added?
to a final concentration of 2.°fo (w/w)? to start the reaction. 
Control incubations were carried out in the absence of 
proteases. Samples (l mg) were withdrawn at various time 
points? added immediately to 7 V<1 of 15 mM PMSF or 0.8 y .g /y .1  
leupeptin (or specific protease inhibitors where appropriate). 
The sample was immediately placed on ice before being diluted 
seven-fold with ice-cold phosphate buffer. The membrane 
fraction was collected by centrifugation (26 000 x g for 
20 min.) and resuspended in phosphate buffer containing 
PMSF and 0.15M NaCl. This wash procedure was repeated twice 
before the samples were washed with distilled water (x 2).
The final pellet was resuspended in Laemmli sample buffer 
containing 10 mM DTT and boiled for 3 min. IAA was then 
added to a final concentration of 100 mM. Samples were 
subsequently analysed by SDS-PAGE and immunoblotting with 
the appropriate anti serum. Detection of the antigen was 
by autoradiography.
An identical protocol was followed for protease 
digestion of mitoplasts. In these instances the incubation 
and wash buffers were supplemented with 0.25M sucrose.
5*3 RESULTS
5.3.1 Immunoprecipitation of PTP from mammalian tissue
culture cells
Figure 5*1 shows the cross-reactivity of the antiserum 
directed against the rat liver phosphate transport protein.
As discussed in Chapter 4? this antiserum recognises the 
parent antigen in extracts of cultured cells with a high 
degree of specificity? a requirement for successful in vivo 
studies. It also cross-reacts? however? with a lower Mr
polypeptide? tentatively identified as the adenine nucleotide 
translocase. As the ANT is not made as a larger precursor 
and being of lower molecular weight? it was judged not to 
interfere with the proposed study. Research on biosynthesis? 
translocation and membrane insertion of this carrier was 
initiated using the BRL cell line.
Cultured BRL cells were incubated with [^^sj —methionine 
either overnight in the absence of uncouplers or for 4 h in 
their presence? to accumulate precursor molecules of nuclear 
encoded proteins. Radiolabelled cell lysates were prepared 
(Section 2.2.8b) and after incubating an aliquot of this
[35 Ilysate with specific antisera? the immunoprecipitated SJ 
methionine-labelled polypeptides were analysed by SDS-PAGE and 
fluorography. After treatment of this lysate with anti-Ela- 
serum? from PDC? one major band of value 42 000 was observed 
(Fig. 5*2? lane 2). Since the band was absent from the 
corresponding control incubation (lane l) and was of the 
correct value for Ela? the polypeptide confirmed the 
specificity of the antiserum. In the presence of 2 mM DNP
Fig. 5*1s Immunological Detection of PTP in
Cultured Mammalian Cell Subfractions
and from PTP Purification Fractions
Post-nuclear supernatant and mitochondrial 
fractions were prepared from cultured BRL? PK-15 
and NBL-1 cells (Section 2.2.8) and electrophoresised 
on 10$ (w/v) SDS-polyacrylamide slab gelsj before 
being processed for detection of immunoreactive 
polypeptides using anti-PTP-serum.
Lane 1 Rat liver mitochondrial HTP eluate (20 p,g)
2 Rat liver mitochondrial Celite eluate(20 p.g)
3 Bovine heart mitochondrial 8$ (w/v) Triton 
X—100 extract (40 p,g)
b Bovine heart mitochondrial HTP eluate(20 ]ig)
5 BRL cell lysate (40 p,g)
6 BRL mitochondria (40 p.g)
7 NBL-1 cell lysate (40 p,g)
8 NBL-1 mitochondria (40 jig)
9 PK-15 cell lysate (40 >ig)
10 1^^I-labelled low M standardsr
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or 10 pM FCCP (lanes 3 and 4* respectively) newly 
synthesised (precursor) polypeptides were precipitated 
exhibiting values 2-3000 greater than that of4 the mature 
subunit. Indeed) in the presence of 10 p,M FCCP* processing 
of the precursor polypeptides to the mature counterpart is 
only partially inhibited as some conversion to the k Z 000 
polypeptide can still be detected.
When the analogous incubations were performed with 
anti-PTP-serum* the major radiolabelled products (in the 
absence of uncouplers) exhibited an value in excess 
of 97 000. These polypeptides were specifically immuno- 
precipitated by the anti-PTP-serum* as they were neither 
present in the control track (lane l) or in the precipitation 
with anti-Ela-serum. The immunoprecipitates from cells 
radiolabelled in the presence of uncouplers* again* resulted 
in [35s] -methionine-labelled high polypeptides unique 
to this antiserum. The 3 k  0 0 0 polypeptide demonstrated 
in crude cell extracts to cross-react with anti PTP—serum 
was not detected in the resultant fluorographs. Immune 
replica analysis of cell lysates prepared in the buffer 
system used for immunoprecipitation identified the PTP and 
discounted the possibility that the protein aggregated to 
a high Mr form under these conditions. To cheek that this 
discrepancy was not a characteristic of the BRL cell line* 
the corresponding experiments were performed in 
methionine labelled cell extracts from cultured pig kidney 
cells. The resultant fluorograph is shown in Figure 5*3*
Fig* 5*2: Immune Precipitation from BRL Cells
Labelled wi - methionine in the
Presence and Absence of* Uncouplers
BRL cells were incubated either overnight with
Jj^ s] - methionine (150 - 250 pCi/dish) in the absence
of uncouplers or labelled lor 4 h in the presence of
labelled extracts (Section 2*2*8) indirect immuno- 
precipitation was performed using various antisera
2*2*11c)* The resultant inmunoprecipitates were 
resolved on 1 0 fo (w/v) SDS-polyacrylamide gels and 
identification of radiolabelled bands was by fluoro
serum; lane 2,,overnight label? anti-El a-serum; lanes
3*4*4 h label in the presence of 2 mM DNP or 10 pM
FCCp respectively with anti-Ela-serum; lane 5> overnight
label* anti-PTP-serum; lanes 6*7,4 h label in the
presence of 2 mM DNP or 10 pM FCCP respectively*
125anti—PTP-serum; Lane 8, I—labelled low M^ standard
proteins*
uncouplers* After preparation of
in conjunction with fixed S_. aureus cells (Section
o
pre E 1 a  
E 1 a
1 2 3 4 5 6 7 8
Lanes (l—6) show the immunoprecipitates from cell 
lysates prepared in 3D-TKM buffer (Section 2.2*8a). In 
this instance* using antiserum directed against PTP (lane 2)* 
higher M radiolabelled bands can be detected which are 
neither present in the incubation with control serum (lane 
l)> nor with anti-E3-serum (lane 4) or anti-PDC-serum (lane 
6). Each of these incubations successfully precipitates 
the parent antigen. An interesting result in the precipitation 
with anti-PDC-serum is that it fails to recognise the 
corresponding E3 subunit (lane 6). This has been shown to 
be indicative of the low immunogenecity of the E3 polypeptide* 
which is common to all three 2-oxo acid dehydrogenases 
(de Marcucci et al.* 1985)*
Lanes(7-10)of this figure result from incubations 
performed from cell lysates prepared in Kolbe Buffer 
(Section 2.2.10) containing 2°(o (w/v) Triton X-100 and 
0.15M NaCl. This buffer was chosen as it is known to 
release PTP from rat liver mitochondria; the inclusion 
of 0.15M NaCl was shown to reduce the non-specific background 
binding that previously predominated (data not shown).
This experiment was performed to exclude the possibility 
that the PTP has not been solubilised in the chosen 
detergent system.
Lane 9 shows the resulting immunoprecipitation with 
anti-E3-serum and demonstrates the expected radiolabelled 
polypeptide of 55 000 M • Lane 10 exhibits bands corresponding 
to the subunits of PDC. Both these antigens are solubilised* 
therefore* by the 2$> (w/v) Triton X—100 Kolbe Buffer and
Fig* 5*3 s Immune Precipitation from PK-15 cells 
Labelled with J£M — methionine in the 
Presence and Absence of Uncouplers
PK 15 cells were incubated either overnight 
with methionine (150 - 250 p,Ci/dish) in the
absence of uncouplers or labelled for b h in the 
presence of* uncouplers. After the preparation of
— methionine-labelled extracts (Section 2.2.11c)* 
indirect immunoprecipitation using various antiserum 
in conjunction with formalinised _S. aureus cells was perf 
The resultant immunoprecipitates were resolved on 
10$ (w/v) SDS-polyacrylamide gels prior to
identification of radiolabelled bands by fluorography. In 
lanes (l-6) the immunoprecipitation was performed 
in 3D-TKM buffer whilst in lanes (7-10) Kolbe Buffer 
containing 2$ (w/v) Triton X-100 and 0.15M NaCl was 
used. Lane 1* overnight label* non-immune rabbit 
serum; lane 2* overnight label* anti-PTP-serum; 
lane 3» 4 h label with 10 p.M FCCP* anti-PTP-serum; 
lane b 9 overnight label* anti-E3-serum; lane 5> b h 
with 10 p.M FCCP* anti-E3-serum; lane 6, overnight 
label* anti-PDC-serum; lane 7> overnight label* 
anti-PTP-serum; lane 8* b h label with 10 p,M FCCP* 
anti-PTP-serum; lane 9 * overnight label* anti-E3-
serum; lane 10* overnight label* anti-PDC-serum;
125 .lane 11* I—labelled low standard proteins.
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it appears that the inclusion of 0.15M NaCl has increased 
the stringency of the wash procedure? resulting in a 
decreased background. Following the incubation with
anti-PTP-serum? (lane 7)> the only major polypeptide 
precipitated (approximately 000) is also present
in those resulting from incubating with anti-E3-serum 
and anti-PDC-serum. This band could not be competed out 
by the addition of non-radiolabelling PTP to the incubation 
and thus represents a non-specific contaminant.
To examine the possibility that the anti-PTP—serum 
did not recognise the parent antigen during the immuno­
precipitation procedure? a protocol was devised to immuno- 
precipitate the PTP from solubilised bovine heart mitochondria 
and to detect the polypeptides by immunoblot analysis using 
anti-PTP-serum.
Bovine heart SMPs were solubilised by heating in 1 $
(w/v) SDS and non-specific dissociations were decreased by
a preadsorption with non-immune serum. Immunoprecipitates
(Section 2.2.lid) were resolved on 10$ (w/v) SDS-polyacrylamide
gels before being transferred to nitrocellulose. Detection
125of the antigen was by decorating with ^I-labelled protein 
A followed by autoradiography.
Figure illustrates the results obtained with anti-
SDH-serum. The large subunit of this enzyme (70 000 M^) is 
known to be a component of the inner mitochondrial membrane 
and thus serves as a control for the solubilisation procedures. 
SDH can be detected in intact bovine heart mitochondria 
following immunoblotting? lane 1 establishes the specificity
Fig* 5*^ -5 Immune Blot Analysis of an Immune
Precipitation of SDH from Bovine Heart Sub 
mitochondrial Particles
Bovine heart submitochondrial particles were 
solubilised in 1 °fo  (v/v) SDS and the immune precipit­
ation procedure (Section 2.2.lid) was followed. The 
resultant immune-precipitates were resolved on 10°fo 
(w/v) SDS polyacrylamide gels before being processed 
for immunoblotting. Detection of antigen was by 
iodinated protein A followed by autoradiography*
Lane 1> kO pg of intact mitochondria; lane 2> non- 
immune rabbit serum used in immunoprecipitation; 
lane 10 pi anti-SDH-serum; lane ky 50 pi anti- 
SDH- serum; lane 5>100 pi anti-SDH-serum; lane 6>
50 pi anti—L-serum> used in immune precipitation.
125Lane 7> I-labelled low standard protein.
0.8 mg of solubilised membrane used per incubation.
1 2 3 4 5 6 7
of the antiserum) reacting with both the L and S subunits. 
Lanes (3-5) show the presence of the 70 000 M polypeptide 
following precipitation with anti-SDH-serum. The incubation 
with non-immune rabbit serum (lane 2) further establishes 
the specificity of the antiserum and resolves the heavy 
(30 000 M^) and light chain (23 000 M^) of the immunoglobulin 
molecules. The lower subunit of 27 000 only weakly 
cross-reacts with the antiserum (lane l) and if successfully 
precipitated would co-migrate with the observed lgG 
light chain.
The comparable experiment with anti-PTP-serum is shown 
in Figure 5»5« Lane 5 illustrates the result of the 
immunoprecipitation using non-immune rabbit serum. The heavy 
and light chains of the immunoglobulin molecule are observed 
and a 66 000 polypeptide. This result is replicated in 
lane 5 By anti-PTP-IgG. The 34 000 polypeptide can be 
identified in lanes 1, 2 and 3» By incubating 0.4, 0.8 
and 1.2 mg of solubilised membrane with anti-PTP-serum* the 
parent antigen has been collected during immunoprecipitation 
and identified by immunoblot ting with the antiserum. This 
result is further illustrated in lane 6> where purified PTP 
is added to the incubation.
Thus it appears that the PTP is indeed recognised by 
the corresponding antiserum and can be directly precipitated 
in conjunction with protein A.
Fig. 5*5s Immune Blot Analysis of an Immune
Precipitation of* the PTP from Bovine Heart 
Submitochondrial Particles
Bovine heart submitochondrial particles were
solubilised in 1 $ (v/v) SDS and the immune
precipitation procedure (Section 2.2.lid) was
followed. The resultant immunoprecipitates were
resolved on 10$ (w/v) SDS-polyacrylamide gels
before being transferred to nitrocellulose paper.
125The antigen was detected using ^I-labelled 
protein A followed by autoradiography. Lanes l y 2 f 
3s 0.4 mg* 0.8 mg and 1.2 mg of solubilised membrane 
protein used in the immunoprecipitate with 10 p-l o f  
anti-PTP-serum. In lanes 4*5>6 0.8 mg of solubilised 
membrane protein was used with the following antisera. 
Lane 4> anti-PTP-IgG; lane 5» non-immune rabbit serum; 
lane 6> as 2 but supplemented with approximately 5 V-g 
of purified PTP; lane 7> ^^I-labelled low standard 
proteins.
P h o s p h a t e
t r a n s p o r t e r
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5*3*2 Protease treatment of bovine heart submitochondrial
particles
Submitochondrial particles generated by sonication of 
intact mitochondria are predominantly inverted with respect 
to their orientation in situ (Wehrle pt al^? 1978; Godinot and 
Gautheron? 1979)> in that more than 90$ of the vesicles formed 
are sealed 1inside out*. Therefore? by applying the protease 
treatment/immunoblot procedure? described in Section 5.2? 
to SMPs it was possible to investigate the presence of 
exposed regions of PTP located specifically at the matrix 
surface of the inner mitochondrial membrane.
Various proteases? including pronase? protease K? papain? 
trypsin? chymotrypsin and elastase? were studied for their 
effect on cleavage of PTP in SMPs. The influence of the 
cumulative addition of chymotrypsin and trypsin on the 
polypeptide pattern of submitochondrial particles is shown 
in Figure 5*6* The membrane associated peptides were 
resolved by SDS-PAGE. With increased incubation period and 
protease concentration? a decrease in intensity of stained 
bands in■ the -high. M region? relative to control incubations 
(lanes 1-4)#J
'I" i The two pro teases formed
different proteolytic breakdown products which remained 
unchanged at the higher pro tease concentrations (4$>? w/w) ? 
indicative of the stability of the inner mitochondrial membrane.
For identification of proteolytic fragments derived 
from PTP? samples were subjected to immune-replica analysis- 
individual polypeptides and their immunoreactive cleavage
Fig. 5.6: SDS-Polyacrylamide Gel of Protease
Treated Bovine Heart Submitochondrial 
Particles
B0vine heart submitochondrial particles were 
digested For up to 60 min with increasing 
concentrations of (a) Trypsin or (b) Chymotrypsin. 
The resultant membrane associated peptides were 
resolved on 10$> (w/v) SDS-polyacrylamide gels. 
Lanes (l-4) control incubation in the absence of 
protease; lanes (5-7) 1$ (w/w) protease; lanes 
(8-10) 2fo  (w/w) protease; lanes (11-13) h rfo  (w/w) 
protease*. -h$ p-S o f  protein loaded per track. 
Lane l4j low standard proteins.
*20 min time point not processed in chymotrypsin 
digest.
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products could be identified by subsequent incubation 
with specific antisera and iodinated protein A. Figure 
5*7 illustrates the immunoblot pattern derived from 
incubating bovine heart SMPs with pronase, protease K 
and trypsin for the indicated time intervals and probing 
with anti-PTP-serum. With the exception of the incubation 
with 2 (w/w) protease K for 2 h, the PTP remains resistant 
to digestion i.e. essentially as the control incubation* 
and no cleavage peptides can be observed. This stability 
of PTP to proteolysis was demonstrated also for elastase, 
papain, chymotrypsin and V-8 protease.
On the basis of this result two other explanations 
presented themselves: (i) that for iSOMSi reason, the
proteases were rapidly inactivated during the experiment 
or (ii) the matrix surface of the inner mitochondrial 
membrane was not available to externally added proteases.
t
To test both these hypotheses a parallel incubation with 
the selected proteases and the subsequent immunoblot 
analysis was carried out on succinate dehydrogenase (SDH).
Succinate dehydrogenase, an enzyme involved both in 
the Krebs cycle and the electron transport chain, is 
traditionally regarded as a marker for the inner mitochondrial 
membrane (Ernster and Kuylenstierna, 1970). The asymmetric 
distribution of this enzyme with respect to the matrix 
surface of the mitochondrial inner membrane has been 
documented using both antiserum directed against the holo- 
enzyrae (Merli ejfc al•, 1979) and chemical reagents (Klingenberg 
and Buchholz, 1970; G-irdlestone et al., 1981). Thus,
protease treatment of SMPs and analysis using anti-SDH- 
serum provides an excellent control system for these 
studies.
Figure 3*8 shows the result of the parallel incubation 
of SMPs with the range of proteases used in monitoring the 
accessibility of PTP, and subsequent immunoblot analysis. 
Incubation in the absence of protease (lanes 1,2) shows 
that neither the large nor small subunit of SDH is susceptible 
to degradation under the conditions employed i.e. 3 0 ° C  
for 120 min. Inclusion of either pronase, protease K or 
trypsin during the incubation leads to rapid degradation 
of one or both subunits.
Pronase digestion (lanes 3-6) demonstrates that the 
large 70 000 M^ subunit of SDH is degraded to yield ultimately
32 000 M membrane:-1 bound fragment whilst the j -
i  . . . . .  .   - -  ■
27 000 M^ peptide remains resistant to digestion until 
the lipid bilayer is disrupted. Diminution of the band 
corresponding to the large subunit with the concomitant 
appearance of the immunoreactive 32 000 M  polypeptide is 
evident following incubation with both protease K (lanes 
7-10) and trypsin (lanes 11-14). The incubation with 
pro tease K indicated that the 27 000 M^ small subunit was 
degraded to a slightly smaller peptide (24 000 M^) but 
only under conditions which totally degraded the 70 000 M 
subunit does the S subunit become susceptible to proteases.
The presence of 0.13M NaCl in the wash buffer ensures that 
any weakly interacting peptides are removed and that those 
detected via immunoblot analysis are membrane-bound peptides.
Fig* 5*7s Immune Blot Analysis of the Effect of
Protease on PTP in Bovine Heart Submitochondria] 
Particles
Bovine heart submitochondrial particles were 
incubated with 2$ (w/w) pro tease for 120 min* Aliquots 
were withdrawn at 30 > 60, 90 and 120 min, the pro tease 
added to a final concentration of 2fo (w/w) following 
each time point* The reaction was stopped by the 
addition of protease inhibitors (2 mM PMSF, 0.8 p.g/ 
p.1 leupeptin) and by diluting samples in 7 volumes 
of ice-cold wash buffer. Following washing, the 
membrane fractions were boiled in Laemmli sample 
buffer containing 10 mM DTT, resolved on 10^ (w/v) 
SDS-polyacrylamide gels prior to analysis by immuno- 
blotting with an ti-PTP-serum. 45 Hg of protein was
1 pp
loaded in lanes (l-l4 )inclusive. Lane 15* I- 
labelled low M^ standard proteins.
Fig. 5*8: Immune Blot Analysis of the Effect
of Proteases on SDH in Bovine Heart Sub- 
mitochondrial Particles
Bovine heart submitochondrial particles were
incubated with 2°fo  (w/w) protease for 120 min.
Samples were removed and treated as detailed in
Figure 5*7* Immune—blot analysis was performed
using anti-SDH-serum. 45 V-g of protein was
loaded in lanes (l-l4) inclusive; lane 15*
12■^'T-labelled low standard proteins.

Subsequent investigation* using both anti-SDH-serum and 
subunit-specific antisera (Clarkson* 1987)> of this 
proteolysis pattern has revealed that the 32 000 peptide 
was conclusively derived from the 70 000 subunit and 
was* indeed* embedded within the membrane bilayer i.e. it 
is an integral component of the inner mitochondrial membrane 
Thus* this result provides an ideal marker enzyme for 
further protease studies on the inner mitochondrial membrane 
It also establishes that the vesicles are in the correct 
orientation and that the;proteases are active.
To eliminate the third possibility i.e. that PTP* in 
its membrane environment* is inherently resistant to proteo­
lysis under the conditions described* the above experiment 
was repeated using SMPs that had been solubilised using SDS 
or Triton X-100.
Figure 5«9B illustrates an immunoblot analysis of! the 
control enzyme* SDH. Lanes(l-2 )depict that again* SDH is 
stable under the chosen experimental conditions i.e. 30°C  
for 120 min. The inclusion of either 2 ° [o  (w/w) papain or 
protease K to this incubation results in the enzyme being 
totally degraded. There is no evidence of the 32 000 
membrane bound peptide* previously detected following an 
incubation with these proteases in the absence of detergent. 
This result suggests that the * protecting* lipid bilayer has 
been removed* although it does not exclude the possibility 
of more protease sensitive sites becoming available due to 
the presence of detergent. This is further illustrated in 
tryptic digests of SDS-solubilised membranes (lanes 11-14).
Fig. 3.9 : Immune Blot Analysis of the Effect of 
Proteases on Bovine Heart SMP!s Solub­
ilised in 0.1$> (w/v) SDS
Bovine heart submitochondrial particles were
solubilised with a final concentration of 0.1 °fo
(v/v) SDS before being incubated with proteases
(2# ( w/w)). Aliquots were removed at 5> 30* 60
and 120 min and proteases added to the final
concentration above following each time point.
The reaction was stopped by the addition of
pro tease inhibitors and by diluting into 7 volumes
of ice-cold wash buffer. Analysis of membrane
associated peptides was by SDS-PAGE followed by
immune blotting with (A) anti-PTP-serum* or (b )
anti-SDH-serum•
45 V-g of protein was loaded to lanes (l-l4)
125inclusive: lane 15* I-labelled low M standard. r
proteins.
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The immune profile obtained in these tracks is essentially 
as the control incubation and results from the rapid 
inactivation of the protease by SDS.
Analysis of PTP under these conditions (Fig. 3»9A) 
illustrates that in the absence of proteases the 
protein is stable during the incubation. Immunoblot analysis 
following digestion with papain (lanes 3-6) or protease K 
(lanes 7-10) failed to detect any immunoreactive peptides 
i.e. the protein was completely degraded. The parallel 
study with trypsin in the presence of 0.1$ (w/v) SDS 
demonstrates that the protease is inhibited by the detergent 
and that only following prolonged incubation (120 min) does 
PTP become degraded.
This result strongly suggests that the PTP is not 
inherently resistant to protease digestion by virtue of its 
native structure but that it is protected from proteolysis 
by the membrane bilayer. This analysis results from studies 
on inverted vesicles? and as Figure 3*7 and 3*9A demonstrate 
no shift in mobility to a lower M band? suggests that the 
PTP has no protease-sensitive domains exposed at the matrix 
surface of the mitochondrial inner membrane.
3.3.3 Protease treatment of intact bovine heart mitochondria
It is well documented that in preparations of freshly 
isolated mitochondria? the cytoplasmic surface of the inner 
mitochondrial membrane is accessible to labelling reagents 
such as lactoperoxidase? indicating that the outer membrane 
has been removed by the isolation procedure (Boxer? 1975)*
It was therefore possible to investigate the exposed regions 
of the PTP on the cytoplasmic surface of the mitochondria
by applying the protease treatment coupled to immunoblotting 
analysis? as detailed above.
Figure 5*10 shows the results of incubating freshly- 
isolated bovine heart mitochondria at 30°C for up to 120 min. 
in the absence of protease (lanes 1?2) and after the addition 
of 2$ (w/w) trypsin (lanes 3-6)? pronase (lanes 7-10 ) or 
protease K (lanes 11-14)? as analysed by immunoblotting using 
anti-citrate*synthase serum. Inspection of this figure 
reveals that the parent antigen is stable under the conditions 
employed? both in the presence and absence of added protease. 
The incubation of intact mitochondria with each of the 
proteases had no effect on the intensity of the band 
corresponding to citrate synthase.
Citrate synthase is a component of the Krebs cycle and 
is a soluble enzyme located within the confines of the matrix 
inner membrane compartment. The native enzyme is susceptible 
to the added protease (data not shown) so this observation 
i.e. no diminution of the 50 000 M polypeptide to smaller 
immunoreactive peptides? is consistent with the mitochondria 
being isolated as intact organelles. These mitochondria 
can then be employed in studying the topography of PTP with 
respect to the cytoplasmic surface of the mitochondria.
Analysis of the corresponding investigation using 
anti—SDH—serum could not degrade the large 70 000 M subunit 
to the previously recognised 32 000 peptide. The smaller 
27 000 subunit was also protected from the protease by 
the membrane structure. This observation suggests that 
neither subunit is available at the cytoplasmic surface of
the inner membrane. This result has been verified by G. j
■ ■ \
Clarkson in our laboratory.
Fig* 5 • 10: Immune Blot Analysis of* the Effect 
of Proteases on Citrate Synthase in 
Intact Bovine Heart Mitochondria
Intact mitochondria were prepared' (Section 
2.2.9^) and incubated with a variety of proteases 
at a concentration of 2$ (,w/w )<> which was replenished 
after each time point. Aliquots were withdrawn 
at the indicated time points and the reaction was 
stopped by the addition of protease inhibitors 
(2 mM PMSF; 0.8 ■p.g/p.l leupeptin) prior to dilution 
with 7 vol. of ice-cold wash buffer. Subsequent 
analysis was by SDS-PAG-E followed by iramune- 
blotting using anti-citrate synthase serum. Lanes 
(l-l4) contain 45 V-g of mitochondrial protein.
Lane 15> 0.2 p,g of purified citrate synthase.
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Fig. 5*U s  Immune Blot Analysis of the Effect
of Proteases on SDH in Intact Bovine 
Heart Mitochondria
Intact bovine heart mitochondria were incubated 
at 30°C for up to 120 min in the absence of proteases 
(lanes 1*2) or with 2$> (w/w) trypsin (lanes 3-6); 
pronase (lanes 7—10) or protease K lanes (ll-l4). 
Samples were removed at the given time point* protease 
inhibitors added and the samples diluted with 7 vol. 
of ice-cold wash buffer. After repeated washes 
samples were boiled in Laemmli sample buffer contain­
ing 10 mM DTT. Analysis was by SDS-PAGE followed 
by immune blotting with anti-SDH-serum. 45 V-S o:^  
protein loaded/track.
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Fig. 5*12: Immune Blot Analysis of the Effect
of Proteases on PTP in Intact Bovine 
Heart Mitochondria
Intact bovine heart mitochondria were incubated 
at 30°C For up to 120 min in the absence of proteases 
(lanes 1*2) or with the inclusion of 2fo (w/w) trypsin 
(lanes 5-8), pronase (9-12) or protease K (lanes 13- 
16)• Lanes 3 y k  are intact mitochondria solubilised 
by the addition of 0*5$ (v/v ) Triton X-100 to the 
incubation buffer* prior to digestion with 2^ (w/w) 
trypsin. Aliquots were withdrawn from the incubations 
and the reaction stopped by the addition of protease 
inhibitors (2 mM PMSF* 0.8 ]xg/|il leupeptin) and 7 
volumes of ice-cold wash buffer. V-g of protein
was loaded to each track.
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Parallel research with anti-PTP-serum has also failed 
to demonstrate any immuno re active peptides resulting from 
the incubation of intact mitochondria with the above proteases* 
Figure 5*12 illustrates that the intensity of the band 
corresponding to PTP is essentially as the control incubation 
(lanes 1?2). Subsequent solubilisation of the membrane with 
a final concentration of 0*5$> (v/v) Triton X-100 demonstrates 
that the structure of PTP within the membrane does not render 
it resistant to proteolysis? but rather the lipid bilayer 
protects the protein from added proteases.
5*4 DISCUSSION
i These studies have shown that if was difficult to immuno- 
precipitate PTP from radiolabelled cell lysates? despite 
demonstrating the antigen to be present in the chosen cell 
lines*
In each instance? under conditions whereby both soluble 
and membrane proteins can be precipitated by their respective 
antisera? we have been unable to identify a ; M '"Of 3^ 
polypeptide corresponding to the PTP*
Initially? it was thought that the strong cross-reaction 
elicited by the antibodies in immunoblots was by virtue of 
the antigen being present in a denatured fashi.on*- Our 
anti serum was prepared from purified PTP which had been 
acetone-precipitated. To investigate the importance of 
antigen presentation? radiolabelled cell lysates were 
denatured under a range of standard conditions e*g* heat 
denaturation or acetone-precipitation prior to resuspending 
in 3D-TKM buffer. Each of these failed to precipitate the
parent antigen from the cell lysate. Substitution of the 
detergents used e.g. CHAPS for Triton X-100 in the 3D-TKM 
buffer system did not clarify the resultant immunoprecipitates.
During the immunoprecipitation procedure? the antibody- 
antigen complex is indirectly precipitated by its interaction 
with formalinised £>• aureus cells. The PTP has marked 
hydrophobic properties which may cause the protein to adsorb 
to the bacterial cell wall? subsequent elution of this protein 
may prove difficult. This possibility was investigated by 
the substitution of £>• aureus cells with Sepharose beads.
This did not result in the elution of the 3^ 000 antigen.
Thus under a variety of conditions? a range of buffer 
and detergent systems or source of cell lines it has proven 
difficult to immunoprecipitate a reproducible polypeptide 
pattern that can be identified with the PTP. In each of 
these situations the presence of control incubations has 
demonstrated this to be a specific problem of anti—PTP-serum 
in conjunction with the antigen.
The possibility exists? therefore? that the phosphate 
transport protein? is not being recognised by the antiserum 
during the immunoprecipitation procedure? although Figure 
5*5 demonstrates that immunoblot analysis of an immuno­
precipitation using anti—PTP-serum does? indeed precipitate 
the parent antigen. This was achieved by solubilising the 
membrane system in 1 °fo (w/v) SDS before immunoprecipitation. 
Extension of this protocol to radiolabelled cell lysates 
did not resolve a polypeptide of 3 b  000 with anti—PTP— 
serum? although the previously recognised high bands 
were no longer visible.
The 3D-TKM buffer system (Section 2.2.8a) used in 
these immunoprecipitation studies was selected for its 
proven ability to promote highly specific precipitations 
of maximally dissociated polypeptides from cellular extracts. 
However? on occasions? incomplete dissociation of poly­
peptides has been observed even in the presence of this 
detergent system (Hunter? 1985).
The presence of higher polypeptides in radiolabelled 
immunoprecipitates? in contrast to Figure 3*5 suggests that 
the antiserum may recognise the PTP but that by virtue of 
strong interactions? associated polypeptides may also be 
precipitated. It should be noted that boiling radiolabelled 
lysates in SDS prior to immunoprecipitation seemed to destroy 
these interactions. These polypeptides may be involved with 
phosphate transport in mitochondria and the existence of 
a phosphate transport system has been suggested previously 
(Kolbe jet al • ? 1982) though evidence in support of this has 
not been forthcoming. It is also possible that these bands 
may associate with the antigen by virtue of non-specific 
protein interactions? which arise as a result of the 
hydrophobicity of this protein.
f  ■ . i . : - '
Amino acid composition data (Gibb ejfc al. ? 1986) has 
shown that PTP has a very low methionine content (< 2°fo of 
total amino acids) and this may account for the difficulty 
in fluorographic detection of radiolabelled proteins.
O
Alternative radiolabels are available? e.g. (4?5 — H) 
leucine. Leucine is five-fold more abundant than methionine? 
though experience has shown that any benefit gained from an
increased incorporation of radiolabel resulting from the
higher leucine content has been offset by the markedly
lower specific activity of this isotope and the low
3
sensitivity of detection of H. The low abundance and 
stability of PTP within the inner membrane i.e. turnover 
of newly synthesised protein within the membrane may also 
be a major factor in the immunoprecipitation of this protein.
The function of PTP within the inner mitochondrial 
membrane is inextricably associated with certain structural 
features. For example the location of the reactive sulphydryl 
group available only at the cytoplasmic surface of the 
mitochondria (Houstek and Pedersen* 1985) has been located 
at the N-tenminus of the protein* i.e. at cysteine residue 
k 2  (Kolbe et al.* 1985) within the primary structure. Other 
workers (Tommasino £t a1.* 1987) have carried out preliminary 
studies which will further characterise the phosphate binding 
domain of this protein. It is clear* therefore* that a 
knowledge of the topography of this protein is a pre-requisite 
for understanding the catalytic function of this carrier..
In this chapter* the combined approach of protease 
digestion of proteins exposed at either face of the inner 
mitochondrial membrane and the detection of protease resistant 
fragments by specific antiserum was used. Bovine heart 
mitochondria were chosen for these experiments primarily 
because of the higher inner membrane content of this 
organelle in comparison to liver mitochondria. This system 
has the added advantage that the method commonly used to
prepare these mitochondria (Smith jet al• * 1967) renders . 
the cytoplasmic face of the inner membrane accessible to 
exogenously added enzyme (Boxer* 1975)* Chapter k and 
Figure 5*1 also illustrate the strong cross-reaction elicited 
by the anti serum directed against the rat liver protein 
with the equivalent antigen in bovine heart.
As discussed in this chapter* protease digestion of 
bovine heart mitochondria or submitochondrial particles has 
not demonstrated the presence of any protease sensitive 
domains exposed at either the cytoplasmic or matrix surface 
of the inner mitochondrial membrane. Incubation of sub­
mitochondrial particles with protease K for 120 min.
(Fig. 5.7 ) resulted in a decrease in the intensity of the 
PTP band with concomitant appearance of a 23 000 peptide. 
Analysis of the parallel incubation (Fig. 5*8) with anti- 
SDH-serum demonstrates that the immunoreactive 32 000 
membrane^kssociated domain of the large subunit is also 
decreasing in intensity. This* then* suggests that the 
prolonged incubation with proteases* far from selectively 
degrading exposed regions* is destroying the integrity of 
the membrane structure.
If the stability of the membrane structure is disrupted 
with the inclusion of detergents* SDS or Triton X-100 
buffer* the previously resistant PTP becomes totally 
degraded, as does o u t  control enzyme SDH (Fig. 5*9)*
Fig* 5.13: Comparison of the hydrophobic profiles 
of the PTP with those of bovine ADP/ATP 
translocase and the hamster brown fat 
mitochondria uncoupler protein* The 
calculations were made with HYDROPLOT 
with a window of 11 amino acids. The 
horizontal bar represents an average 
hydrophobic! ty as defined by Kyte and 
Doolittle (1982).
(Adapted from Runswick et al.> 1987)*
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A knowledge of the primary structure of this protein 
would greatly facilitate the extension of this topographical 
information to a possible model structure of its arrangement 
within the lipid bilayer. Attempts* by ourselves in 
conjunction with Professor J. Fothergill at the University 
of Aberdeen, to sequence both the bovine heart and rat liver 
enzymes were unsuccessful. It is thought that the marked 
hydrophobicity and resultant solubility problems may be a 
major factor in this. Indeed, other workers (Kolbe jet al., 
1984) have observed that PTP aggregates in the 1 spinning cup1 
of the sequencer, and hence the N-terminus is inaccessible 
to the chemical reagents required for this analysis. To 
circumvent this problem these workers generated and isolated 
peptides from thermolysin and formic acid treated PTP 
(Section 1.3) and obtained sequence information on the first 
47 amino acids of the N~terminus.
Runswick ejfc al.j (1987) have constructed an oligo­
nucleotide probe to this sequence which has subsequently 
been used to isolate and sequence a cognate cDNA clone 
from a bovine library. Analysis of the deduced amino
acid sequence has demonstrated that the protein contains
a N-terminal extension of 49 amino acids, exhibiting the 
properties of a mitochondrial signal peptide.
Comparison of the sequence with itself and other
mitochondrial membrane proteins has established a strong
homology with both the ANT and the brown fat mitochondrial 
uncoupling protein. This study demonstrates that the protein 
contains three internal repeats, previously noted for the
adenine nucleotide translocase (Saraste and Walker? 1982) 
and for the uncoupling protein (Aquila e_t al_. ? 1985)*
Further analysis shows that all of the repeated elements 
(approximately 100 amino acids) are related to each other 
and that the most highly conserved residues are found in 
a—helices. The regions that connect these helices are 
poorly conserved and are found within the central part of 
the loops and at the N and C-terminal regions. These 
unconserved regions are thought to contribute to the 
specificity of the carrier. The cross-reactivity of the 
anti-PTP-serum with the 31 000 polypeptide may result 
from common epitopes in the highly conserved a-helices? 
seen in both the ANT and the PTP. These may correspond to 
a phosphate binding domain or house a reactive cysteine 
residue.
The significance of these membrane spanning a-helices 
and linking hydrophilic domains (Fig. 5*13) becomes apparent 
when taken into consideration with available topographical 
information. Data illustrated in this chapter suggests that 
PTP is an integral membrane component. This in conjunction 
with sequence analysis and biosynthetic data suggests that 
the hydrophilic regions may form a channel surrounded by 
the markedly hydrophobic a—helices (see Fig. 5*1^0 * with 
neither domains being exposed at the membrane surface.
PTP has been shown to react with DCCD? which at low
concentrations is a specific inhibitor of the . H ATPase?
due to covalent binding to a hydrophobic subunit of Fq.
F is believed to contain a transmembrane channel through o
Fig# 5*1^5 Schematic Representation of the 
Arrangement of PTP within the 
Inner Mitochondrial Membrane
From the hydropathy profile (Fig. 3«13) it 
is predicted that the six membrane spanning regions 
will traverse the bilayer as a-helices. The inter­
vening hydrophilic sequence will allow the formation 
of a pore or channel within which the DCCD-reactive 
lysine residues will be housed. The identification 
of the NEM reactive cysteine at residue h 2 and the 
location of this group at the cytoplasmic surface 
of the membrane requires the N-terminus to be situated 
at the matrix surface. We find no evidence for the 
exposure of the molecule at either surface of the 
membrane nor for existence of a dimeric unit and 
thus propose that six a-helices arrange around an 
ion transporting channel (b)> which is totally 
embedded within the lipid bilayer.
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which the protons flow to F^. How the movement of protons 
through Fq , F^ is coupled to the generation of ATP is 
currently the subject of intense debate and experimentation, 
as is the molecular relationship between the PTP and ATP 
synthesis. The Fq complex and PTP have* thus* certain 
structural features in common, not the least of which is 
the transport of H through what is presumably a membrane 
channel. It is therefore feasible to postulate the moleculari. ■
arrangement illustrated in Figure 5*14, where the tertiary J 
^structure forms a transmembrane channel, analogous to that 
of the Fq complex. This channel may explain the reactivity 
of PTP to DCCD (Houstek at al., 198l). This clustering of 
helices round an aqueous 'pore1 has been proposed for other 
transport proteins which span the membrane several times 
(Eisenberg, 1984; Finer-Moore e t al•> 1984; Kopito and 
Lodish, 1985)•
This model also allows for other Associated* proteins, 
anticipated from biosynthetic data, to interact with the 
PTP either as peripheral proteins or as membrane bound 
components. The proposed structure of PTP also suggests 
that the activity of the transporter could be retained 
within a monomeric unit. This is in agreement with both 
native determination and crosslinking studies which 
propose the 34 000 protein to be a functional carrier.
This chapter has attempted to relate the structure of 
PTP to its biological function. Far less is known about 
the structures of membrane j  related proteins than of soluble 
proteins. In large part this is because X-ray crystallo­
graphy and other biophysical tools are not so easily applied
to membrane proteins* The obvious difficulties associated 
with the PTP have been somewhat circumvented in this study 
by the use of antibodies, which have allowed detection and 
analysis of the protein in its native environment*
In the near absence of information of the three 
dimensional structure of membrane-related proteins, an 
abundance of information on their amino acid sequence has 
been gained from rapid DNA-sequencing methods* This has 
allowed investigators to infer various aspects of three- 
dimensional structures from sequence information* Thus, 
the coupling of the data of Runswick et al *, (1987) to our own
information has allowed us to propose a plausible model 
for the three dimensional structure of PTP within the inner 
mitochondrial membrane* The mapping of particular binding 
domains to amino acid residues within the PTP would clearly 
be of fundamental importance in understanding the, functioning 
of the carrier*
CHAPTER SIX 
DISCUSSION
6.1 BINDING OF PDC TO THE INNER MITOCHONDRIAL MEMBRANE
In recent years there has been considerable interest 
in the possible A organisation of apparently soluble,
metabolically sequential enzymes. In particular, much
■ // //evidence, utilising a variety of techniques, has accumulated
/
in favour of enzymes of the mitochondrial matrix being not 
only sequentially linked to those of the same pathway but 
also that they interact, in a specific manner, with the 
inner mitochondrial membrane (for review, Srere, 1985)* It 
is now clear that specific, reversible protein:protein 
interactions may be the rule rather than the exception.
Indeed, the association of enzymes to structural elements 
of the cell has been described and regulatory significance 
has been postulated for the binding or release of these enzyme 
Among the first experimental reports that there may 
be no freely soluble enzymes were those of Kempner and Muller 
(1968) using Euglena and those of Zalokar using Neu.rospora 
in which it was described that gill enzymes in these cells 
sedimented as high M^ complexes. The range of such high M^ 
complexes is large and sequential site interactions are varied 
These include multidomain proteins such as the arom complex 
in Neurospora, tightly but non-covalently bound multi enzyme 
complexes such as the 2-oxoacid dehydrogenases from most 
organisms studied so far and the weak protein:protein 
interactions proposed for the Krebs cycle enzymes of rat 
liver. The optimal situation is thought to occur when the
active sites are covalently linked on the same polypeptide 
chain, thus allowing for the effective channeling of 
intermediates which would otherwise be diluted as part of 
a larger soluble pool*
The ability to isolate mitochondria free of other 
cellular components has allowed an extensive investigation 
of the organisation of proteins within this organelle. 
Fractionation and characterisation of protein components 
within the compartments created by the two membranes has 
permitted Srere and coworkers (Srere, 19&5 anc* references 
therein) to propose that most enzymes of the mitochondrial 
matrix are organised as high assemblies involving enzymes 
of the same pathway and that these aggregates bind with 
varying affinity to the matrix surface of the inner mito­
chondrial membrane* Some of these interactions have been 
shown to be affected by physiological concentrations of 
their substrates, so it is therefore possible to postulate 
regulatory behaviour based on the formation and dissolution 
of these complexes. Whilst much criticism has been levelled 
at the experimental approach of these studies, the kinetic and 
functional advantages of such interactions are evident e.g. 
they allow intermediates to be maintained at high concentrations 
on the surface of complexes and in the instance of membrane- 
associated enzymes the channeling of products to the next 
stage of metabolism would increase the specificity of 
interaction and the reaction rate.
The membrane association of proteins is still a subject 
of intense debate; Landriscina e^t al. (1970) proposed that
all proteins of* the mitochondrial matrix interact with 
the inner membrane and vary only in their affinity for 
that surface. This hypothesis further suggests that rather 
than existing as two separate phases within the same 
organelle, the matrix and the inner membrane are a semi- 
continuous system. Thus assigning a location to enzymes 
within such a system could be misleading when the organelle 
is subject to powerful disruptive techniques such as 
sonication. It should be noted that cytochrome c, which 
binds to the inner mitochondrial membrane with a Kd in i
the micromolar range is readily released following sonication 
(Erecinska et. al•, 1975)*
With the availability of antisera directed against PDC 
and its constituent subunits we. were able to investigate, 
in a more precise manner than previous workers (Sumegi &
Srere, 1984), the association of this multienzyme complex 
with the matrix surface of the inner mitochondrial membrane. 
This enzyme system offers many advantages to such a study, 
not the least of which is that the complex and its association 
with the inner mitochondrial membrane is stable to 
prolonged sonication. It has been demonstrated, that PDC, 
although commonly regarded as a soluble enzyme, exhibits 
the characteristics of a tightly-bound, peripherally-located 
complex. The interaction is stable to repeated washing in 
buffers containing 0.13 - 3M NaCl. Dissociation of the 
membrane-bound enzymes results in the release of El and E3 
while the E2-X core assembly remains bound to the inner 
membrane. The functional advantages of this association 
have been discussed in Chapter 3*
It is known that the outside surface of proteins 
help to locate the enzyme in the cell and to specify its 
interaction with other related enzymes e.g. the multisubunit 
array of the core of PDC provides the binding site for the 
other constituent enzymes i.e. El and E3* Workers 
investigating the conservation of amino acids within 
cellular proteins have indicated that much more of a protein 
is conserved than its active site (McConkey, 1982). PDC 
has an value several million in excess of the analogous 
BCDC and OGDC. It is feasible to: pos tulafe that the increased 
dimensions of this complex relative to the other enzymes of 
this family, and in particular the size of the core enzyme, 
may serve to provide additional binding sites on the enzyme 
surface. These additional sites may serve to anchor the 
complex to the membrane surface i.e. via the E2 component 
or perhaps to locate component X on the surface of the complex. 
Payens (1983) has suggested that random, non-specific binding 
of the substrate to the additional sites on the enzyme surface 
may serve to trap substrates and enhance diffusion to the 
active site. This may have important implications for the 
transport of pyruvate across the inner mitochondrial membrane.
Work in our laboratory has provided evidence that 
component X is capable of becoming acetylated. It is possible 
that this 50 000 polypeptide may provide an additional 
channel for the movement of acetyl groups to the membrane- 
associated biosynthetic processes e.g. ubiquinone formation 
or perhaps in the transport of acetyl groups to the cytoplasm.
In this context, it has been reported that citrate, in 
brain tissue, represents a poor source of* acetyl groups 
required for the synthesis of acetylcholine. It is therefore 
possible that component X could fulfil this function and 
mediate the transfer of acetyl groups to the cytoplasm 
either as acetate or perhaps pyruvate.
From the wealth of information now available on 
proteinsprotein and protein:membrane interactions it is 
apparent that these levels of organisation are more widespread 
than previously believed. In no biological entity, be it a 
subcellular organelle, bacterial cell or eukaryote does it 
appear that structure depends on random juxtaposition.
Organised arrays of biological components permit effective 
use of elements by the reduction in the number of molecules 
needed to achieve the same chemical reactions with seemingly 
opposite objectives being achieved in the same biospace.
The structural complexity of cells and organelles has 
been made clearly visible by electron microscopy. Despite 
the apparent need for. usefulness of and physical existence 
of compartments and microenvironments within cells, a major 
problem has existed in terms of obtaining experimental 
evidence showing metabolic functioning of compartments in 
vivo.
6.2 FUTURE WORK ON PDC
Future work on the binding of PDC to the inner mitochondrial 
membrane ^rll^involve attempts to identify the putative p
membrane receptor(s). Employing substrate-dependent cross­
linking via the lipoyl-thiol group we would hope to locate 
crosslinked products containing E2 and/or X and specific 
membraneous polypeptides by immunoblotting with the appropriate 
subunit specific antisera. It may be possible to obtain 
subunit specific antisera to components of NADH dehydrogenase? 
in an attempt to make a formal identification of the binding 
site.
The association of the analogous 2-oxoglutarate and 
branched chain 2-oxoacid dehydrogenase with the membrane 
would also be investigated. Parallel studies on these and 
PDC may allude to a possible function of component X? if 
these complexes were found not to associate with the matrix 
surface of the inner membrane.
We would also hope to address the following points: (
(i) does the phosphorylation state of PDC alter its affinity 
for the mitochondrial membrane?
(ii) to assay for the incorporation of acetyl groups from
T 14 112- Cl -pyruvate into E2 and protein X in the membrane- 
bound form in the absence of CoASH. This will allow
r 1
us to ascertain whether I CJ -acetyl groups can be 
transferred into other membrane bound polypeptides or 
to the lipid components.
As these studies have already been initiated on the 
soluble enzyme it will also be of interest to compare the 
properties of the membrane-bound enzyme to that of the 
solubilised complex. This phenomenon of allotopy has 
already been reported for the ATP synthetase complex.
6.3 TOPOGRAPHICAL AND BIOSYNTHETIC STUDIES ON PTP
It is now clear that the limited coding potential
of the mitochondrial genome yecessitatep that > 90$ of 
mitochondrial polypeptides are nuclearly-encoded and 
synthesised on cytoplasmic ribosomes? normally as larger
precursors containing an N-terminal extension (Hay jet al_. ? 
198l). Subsequent uptake to the organelle is a post- 
translational event dependent on the presence of an electro­
chemical potential ( Vljj+) (Gasser et al• ? 1982; Schleyer 
et al.? 1982). Proteolytic cleavage of the precursor molecule 
is achieved by a specific matrix protease during or shortly 
after uptake (Mori jst al. ? 1980; McAda and Douglas? 1982;
Bdhni et al• ? 1983? Schmidt and Neupert? 1984). The final 
stage in the import process is the assembly of the mature 
protein to functional units within the mitochondrion. In 
contrast to the other areas of mitochondrial biogenesis 
this stage is poorly understood.
In recent years? rapid progress has been made in 
delineating the complex sequence of molecular events involved 
in mitochondrial protein import? primarily in yeast and 
fungal synthesis. With the cloning and sequencing of genes 
for several nuclear encoded^mitochondrial proteins? the 
essential features of presequences have been analysed by 
the production of chimeric proteins and many gene fusion/ 
deletion techniques. For example? the 25 amino acid extension 
sequence of yeast cytochrome c oxidase subunit IV can induce 
specific uptake and processing of mouse dihydrofolate
reductase? which is normally a cytoplasmic enzyme (Hurt jet al. ? 
1984). While it appears that a minimum of 12 residues may 
be necessary to direct uptake to the mitochondrion? there 
is considerable variability in the length of transit sequences 
reported to date (M^ 1500 - 70 000). Evidence suggests 
that in addition to directing polypeptides to the surface 
of the mitochondrion? these N-terminal sequences are involved 
in:
(i) regulating uptake to specific mitochondrial subcompartments?
(ii) maintaining hydrophobic membrane proteins in a soluble 
state during transit and (iii) preventing premature assembly 
of multimeric aggregates in the cytoplasm.
In contrast to other areas of mitochondrial biogenesis 
very little information is available on the import of 
transmembrane activities to this organelle. Indeed? only the 
ANT from N. crassa and the brown fat mitochondria uncoupling prot 
have been studied in any detail? each being synthesised as 
precursors with the same value as the mature protein 
(Arends and Sebald? 1984; Baker and Leaver? 1985? -Adrian 
et al.? 1986; Bouilland et al.? 1986).
We studied the biosynthesis of PTP by direct immuno- 
precipitation studies on ["^s| -methionine-labelled detergent 
extracts of cultured mammalian cells which had been incubated 
for 4 h in the presence and absence of uncouplers e.g. FCCP 
or 2?4-DNP. This routine procedure has been utilised for 
the immune-precipitation and identification of several 
mitochondrial precursor polypeptides in permanent cell lines 
with a high rate of aerobic activity. The extension of
these studies to the PTP required the production of high 
quality? monospecific antiserum against this protein.
We and others have experienced considerable difficulty 
in raising monospecific antiserum to this integral membrane 
protein. It is believed that many of these problems have 
arisen due to the highly conserved nature of structural 
epitopes within membrane proteins. Sequence analysis of 
many membrane proteins has predicted that an a-helical 
structure is the most efficient way to reduce energetically 
unfavourable reactions between proteins and lipids in 
membranes. Since the mitochondrial inner membrane contains 
many transport proteins? these a-helical structures are 
thought to predominate and indeed this has been supported 
by spectroscopic evidence. It seems likely? therefore? 
that the poor specificity elicited by our previous antisera 
directed against this protein? has arisen primarily due to 
a cross reaction with epitopes common . other membrane 
proteins.
Despite obtaining antiserum which allows us to detect 
between 5-20 ng of PTP in SDS-extracts of whole cells with 
absolute specificity by immunoblot analysis? we have been 
unable to utilise this strong cross reaction to studying 
the biosynthesis of the PTP. The identification of a 
precursor molecule to the PTP has remained elusive when 
applying the in vivo approach successfully employed for many 
other mitochondrial proteins. This? again? appears to be 
a problem associated with membrane proteins in general.
It seems likely that many of the structural epitopes are 
maintained in a native state during the immunoprecipitation 
procedure and the specificity of interaction obtained with 
the SDS-denatured protein in immunoblotting could be 
obtained due to interaction of the antiserum with other 
proteins.
Many of the difficulties experienced in studying membrane 
proteins have been offset by the recent advances in gene 
sequencing, i .-*'■> Runs wick e_fc al«; (1987) have successfully 
isolated a cDNA clone from a bovine heart library and 
utilising rapid DNA sequencing techniques have deduced the 
amino acid sequence corresponding to the bovine heart PTP.
They have shown that the protein contains an N-terminal 
extension which provides the PTP with a 5 000 
presequence. This result is in contrast to the information 
available on the comparable proteins i.e. the brown fat 
uncoupling protein and the ANT? where the precursors are 
synthesised with the same value as the mature protein. 
Moreover? it has been demonstrated that in yeast? the PTP 
precursor is synthesised as the mature protein.
The additional advantage of DNA sequencing studies 
in deducing the amino acid sequences is that they circumvent 
many of the problems encountered by us and other workers 
(Kolbe and Vohlrab? 1985) utilising conventional protein 
sequencing techniques e.g. Edman degradation. This deduced 
primary structure has allowed Runs wick _et al. (1987) to 
propose? from structure prediction data bases? that the
cyt osol
matrix
Fig. 6.1: Proposed model for the arrangement of PTP in the
inner mitochondrial membrane (Aquila et al.? 1987)*
This suggested arrangement of the phosphate transport 
protein within the mitochondrial inner membrane. The six 
membrane spanning regions are labelled A-F from the amino 
terminus. A possible P strand near a pore (dashed line) is 
shown between helices A and B. The intervening hydrophilic 
segments are indicated by hatched boxes as their structure 
is unclear.
PTP contains six membrane spanning a-helices? a model 
also suggested by Aquila et al.,(l987) who have recently 
obtained sequence information on the majority of the protein. 
Comparison of this sequence information with that available 
for the ANT and the uncoupling protein has prompted Aquila 
ejfc al.?(1987) to propose a common model for all three 
carrier proteins (Fig. 6.l). Aligning the sequence and 
topographical information contained within this model with 
the gene sequence presented by Runswick at aJL* ,(l987) shows 
certain inconsistencies with data obtained from topographical 
studies (Chapter 5)»
Extensive analysis of the susceptibility of the PTP? 
at both the matrix and cytoplasmic surface of the mitochondrial 
inner membrane to externally added proteases has allowed the 
testing of the predicted orientation of this membrane protein. 
As Figure 6.2 demonstrates? there are several chymotrypsin 
and trypsin sensitive sites available at both the matrix 
and cytoplasmic surface of the mitochondrial inner membrane.
If the model predicted by Aquila >et al.',(l987) is correct? 
a shift in mobility corresponding to the digestion 
of protease sensitive domains would be readily detected by 
immunoblot analysis following SDS-PAGE. As discussed in 
Chapter PTP was found to be insensitive to proteolytic 
cleavage at either surface of the mitochondrial inner 
membrane. Thus? if the hydrophilic domains predicted by Aquila 
et al.y(l987) exist at the matrix or cytoplasmic surface 
they must be protected from degradation by other proteins 
or be situated very close to the bilayer.
Fig. 6.2: Deduced amino acid sequence of the bovine
heart mitochondrial phosphate transport 
protein.
The amino acid sequence was deduced from the DNA 
sequence of a cDNA encoding the precursor of the bovine 
heart mitochondrial phosphate transport protein 
(Runswick et al•> 1987)* The import sequence of the 
protein runs from amino acids -49 to -1 and the mature 
protein from 1-313* Regions of the protein which are 
exposed at either surface of the mitochondrial inner 
membrane are illustrated in Figure 6.1. The protease 
sensitive sites within the exposed regions are 
indicated by ( ^ ) for trypsin and ( A  ) P°r
chymotrypsin.
M Y  S S V V H L A R A N P F N A P H L Q L V H D G L A G P  
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A
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In contrast to their model propose that these
hydrophilic domains are arranged within the structure of 
the protein such that they form a hydrophilic channel
the inner mitochondrial membrane* This hypothesis is 
supported by the DCCD-reactivity of the phosphate carrier. 
The predicted N-terminal extension identified by Runswick 
et al. (1987) which is in contrast to the precursors of both
the ANT and uncoupling protein* may serve to maintain the 
precursor molecule in a conformation which will prevent 
its aggregation to the dimeric unit proposed for its 
companion protein* the ANT.
6.4 FUTURE WORK ON THE PTP
Future work on the PTP will concentrate primarily on 
isolating the gene encoding this mitochondrial protein.
For this purpose we would hope to utilise the. cross­
reactivity of the anti-rat liver PTP - IgG to identify 
and develop an isolation procedure for the yeast carrier.
The major aim would be to clone and sequence the gene
housed genomic library derived from S>. cerevisiae. Previous 
work in our laboratory has demonstrated that the yeast 
phosphate carrier is synthesised with the same value as 
the mature protein. It would therefore be of interest to 
establish whether this is a general feature of this protein 
or unique to the yeast protein.
4.
which will allow the movement of phosphate and H across
for the yeast PTP by immunological
The availability of the cloned gene would allow us 
to (a) investigate the structure and mechanism of PTP 
and (b) provide the opportunity for in vitro and in vivo 
studies in the control of its expression and mode of 
integration into the mitochondrial inner membrane.
The yeast system lends itself favourably to the 
technique of gene transplacement* this will allow us to 
produce a PTP” strain and a range of strains in which 
alterations will be incorporated into the PTP. The phenotyp 
of these strains will be assessed by their ability to grow 
on non-fermentable carbon sources e.g. as a criterion for 
the functional assembly of the PTP and hence the presence 
of mitochondria which are active in ATP production.
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